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EUROPEAN PERINATAL HEALTH IN EUROPE IN 2015: 
EXECUTIVE SUMMARY
1.1 A EUROPEAN VISION OF MATERNAL AND NEWBORN HEALTH 
THE CHALLENGES 
Maternal and newborn health are essential indicators of population health and wellbeing. 
Medical advances, universal access to healthcare, changes in population health, and increases 
in knowledge among childbearing women have been the drivers of decades-long decreases in 
newborn and maternal mortality in Europe. Yet despite this progress, there are major challenges 
to the goal of providing an optimal start in life for all children and families. The number of 
families touched by the loss of a child, either a stillbirth or an infant death, remains substantial — 
more than 40 000 families in Europe every year.1 Second, while maternal deaths are increasingly 
rare, up to half are associated with substandard care. Moreover, it is estimated that between 
1 and 3% of women experience severe morbidity during their delivery hospitalization, also 
often due to substandard care, although we lack good tools to measure this indicator.2 Third, 
although the mortality associated with pregnancy complications such as preterm delivery and 
intrauterine growth restriction has decreased, prevention of these complications has been much 
less successful. Preterm birth rates have generally stayed stable in Europe or have risen in some 
countries.3 Further, some major risk factors for maternal and infant complications, including older 
maternal age and obesity, are becoming more common and have the potential to stop or to 
reverse downward trends in mortality. Reducing these risk factors among childbearing women 
requires a holistic focus on population health before and during pregnancy. Finally, economic 
shocks in many countries have created difficult conditions for families that justify a special focus 
on protecting pregnant women and their newborns.
A LIFE COURSE APPROACH
As Europe adopts a life course approach to improving the health, well-being, and productivity of 
its citizens, the importance of maternal and newborn health takes on new weight. Good health 
during pregnancy and at birth extends beyond the perinatal period and is an essential building 
block for later health. Studies have related perinatal exposures and outcomes during pregnancy 
to increased susceptibility to many conditions, including asthma, allergies, obesity, hypertension, 
and other metabolic diseases. Mothers with particular complications during pregnancy, such 
as gestational diabetes or hypertension, are themselves more likely to develop these chronic 
problems later in life. The possibility of disrupting processes in the womb that can lead to poor 
health later in life or of intervening during pregnancy to promote women’s later health provides 
a strong rationale for targeting the perinatal period. As poverty and social disadvantage remain 
key risk factors for a wide range of adverse perinatal outcomes, action in the perinatal period 
might also prevent the intergenerational transmission of poor health. 
A EUROPEAN VISION
Exploring maternal and newborn health through a European lens offers a unique opportunity to 
obtain insight into these challenges and their possible solutions. Despite similar access to medical 
knowledge and universal insurance coverage for mothers and babies in most countries, the 
nations of Europe vary enormously in the care and support they provide during pregnancy and 
to newborn babies and their families.4 By comparing maternal and child health and care across 
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Europe, we can benefit from the success stories and learn from each other through working 
collaboratively, especially in a long-standing European project such as Euro-Peristat. These data 
are of interest for many different groups, but most importantly, for pregnant women, their 
partners and their families, clinicians, researchers, and public health professionals.
1.2 EURO-PERISTAT: BETTER STATISTICS FOR BETTER HEALTH FOR   
 MOTHERS AND THEIR BABIES 
THE EURO-PERISTAT PROJECT
Euro-Peristat aims to monitor health in Europe with valid and reliable indicators. The Euro-
Peristat project began in 1999 as part of the European Union Health Monitoring Programme 
and received funding in successive phases of its Public Health Programme. Euro-Peristat has been 
coordinated by INSERM (the French Institute of Health and Medical Research) since its inception. 
Currently, Euro-Peristat is part of a European Joint Action, InfAct (Information for Action), 
launched in March 2018. InfAct is working to provide a sustainable solution for European health 
information networks and better coordination of health information surveillance and data 
collection in Europe (https://www.inf-act.eu/). Data compilation and analysis for this report was 
co-funded by the BRIDGE Health project, which provided support for Euro-Peristat from May 2015 
to October 2017. Most importantly, however, Euro-Peristat is made possible by the support of the 
participating institutions that provide routine statistical data to the Euro-Peristat coordination 
team. In addition, Euro-Peristat would not be able to validate or to report on these data without 
the invaluable input of our network of experts who contribute their time and expertise. Appendix 
A lists all contributors to this report. We also acknowledge the support of Inserm for coordination 
activities and of our partners in the Netherlands and the UK for contributing funds for the project 
meeting for this report. 
THE EURO-PERISTAT NETWORK
Our network includes over 100 data providers and participating members in 31 European member 
states and other collaborating countries. In each country, one Scientific Committee member is 
responsible for the coordination of data collection, and other data providers and experts make 
up the collaborating team for each country. Since 2016 when Bulgaria and Croatia joined Euro-
Peristat, the network has included all 28 current EU member states, as well as Iceland, Norway, 
and Switzerland. 
THE EURO-PERISTAT INDICATORS 
The Euro-Peristat indicator list includes 10 core indicators and 20 recommended indicators, 
grouped into 4 themes: (i) fetal, neonatal, and child health, (ii) maternal health, (iii) population 
characteristics and risk factors, and (iv) health services.5 We define core indicators as those that 
are essential for monitoring perinatal health and recommended indicators as those considered 
desirable for a more complete comparison of perinatal health between countries. The Euro-
Peristat indicators are compiled from population-based data aggregated at the national level 
from routine sources including civil registration systems, administrative or health registers, other 
statistical systems, or routine surveys.6 7 However, if data are not available at the national level, 
population-based data can be submitted from regions or, as in the UK, from constituent countries.
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REPORTING ON PERINATAL HEALTH IN 2015 
This report includes data for all 10 Euro-Peristat core indicators and two of the 20 recommended 
indicators of maternal and newborn health in 2015. In the absence of funding for a full data 
collection exercise, the network decided to collect core indicators to be able to update essential 
basic information related to maternal and newborn health. Two recommended indicators – 
maternal smoking during pregnancy and prepregnancy body mass index – were also selected 
because their association with adverse perinatal health outcomes makes them of key relevance 
for preventive policies. We are hopeful that in the future, sustainable funding for perinatal data 
collection will make it possible to produce the full set of Euro-Peristat indicators related to the 
broader set of health and healthcare factors, as only these data enable us to address the high 
priority question of health inequalities on a European scale. 
DATA COLLECTION 
Euro-Peristat compiles its indicators from public national data systems. Data collection for this 
report began in January 2017. We asked for data on births in 2015, or for the most recent year 
if 2015 data were not yet available. We collected aggregated data with a standardised Excel-
based instrument developed and adapted by the Netherlands Organisation for Applied Scientific 
Research, TNO Healthy Living in Leiden, the Netherlands. We also experimented with a new 
protocol for collecting data in multivariable aggregate tables, which are less time-consuming 
to output and which enable more flexible analyses. A STATA programme developed by Inserm 
allowed these to be converted into the aggregate tables. Overall, aggregated data files were 
constructed this way in 16 of 31 countries. All data were reviewed by the project coordination 
team based at Inserm in France, and queries were sent to individual Scientific Committee 
members and country data providers for review. Members of the Euro-Peristat network met in the 
Netherlands in April 2018 to review the preliminary tables. They used these to discuss observed 
geographical and temporal variations, with a particular focus on possible differences in indicator 
definitions and data collection. Scientific Committee members checked data for the indicators, 
reviewed and corrected the Euro-Peristat output tables, and contributed to writing and reviewing 
the written text before publication of this report.
COMPARING “LIKE WITH LIKE”
Euro-Peristat focuses on ensuring the development of high quality indicators that are feasible 
to collect and are comparable. The indicator set was originally developed through a DELPHI 
consensus process with national experts and has been updated before each new data collection 
exercise. Euro-Peristat standardises the population of births used to produce the indicators: we 
ask countries to provide numbers of all births at 22 or more weeks of gestation or weighing 500 
grams or more if gestational age is missing or not recorded. Next, we compile data in subgroups 
to allow us to refine our indicators. For the mortality indicators, we derive rates from data from 
which births at 22 and 23 weeks of gestation have been removed, because it is well known that 
these births are not recorded in the same ways in all statistical systems.8 Consequently, because 
almost all of these extremely preterm babies at 22 and 23 weeks die, they have an extensive 
impact on comparisons of mortality statistics. For stillbirths we derive rates from data from which 
births before 28 weeks have been removed, as recommended by the World Health Organization 
to increase comparability. However, as Euro-Peristat argued in an article in the Lancet in 2018,9 
a 24-week cutoff can be used in most European countries, so that stillbirths can be compared at 
earlier gestational ages. We hope in the future to report all deaths from 22 weeks onwards to 
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acknowledge the burden of loss to a greater number of families and identify issues relating to 
variation in provision of care at these earlier gestations. We also collect data by other clinically 
relevant subgroups, such as multiplicity and birth weight. These subgroup analyses increase our 
ability to compare “like with like” and provide additional information about health and care. 
They are also very important for comparing women’s risks of caesarean birth.
1.3 RESULTS: THE BIG PICTURE 
EUROPE CONTINUES TO PROVIDE STRONG MODELS OF MATERNAL AND NEWBORN HEALTH
A first overarching message is that in 2015 rates of stillbirth and neonatal, infant, and maternal 
death were lower for babies and women in Europe than in other parts of the world, including 
other high-income countries outside Europe. Reassuringly, stillbirth and neonatal mortality rates 
continue to decline, albeit unevenly and more slowly than in previous periods. Preterm birth and 
low birthweight rates, while not declining, have stayed stable overall, as observed in previous 
Euro-Peristat reports. Rates of caesarean birth in some Euro-Peristat countries are among the 
lowest in high-income and middle-income countries, in particular, Iceland, Finland, Norway, and 
the Netherlands. Most countries have declining or stable caesarean birth rates, although some, 
including Poland, Romania, Bulgaria, and Cyprus, report worrying increases. These positive 
achievements overall come despite widespread changes in some risk factors that predispose 
women to adverse pregnancy outcomes, such as older age at childbirth and obesity. In this 
respect, Europe offers strong models for providing high quality care to women and newborns. 
BUT WIDE DIFFERENCES PERSIST BETWEEN COUNTRIES
A second message is the continuing striking variation between countries in Europe. Many 
indicators vary by a factor of at least two between countries with the highest and lowest rates. 
This variation is also evident in the changes in indicator values between the data for 2015 
included in this report and our previous report on data from 2010. The comparisons we have 
presented show both significant decreases and increases. The successes in the countries with the 
best outcomes can be used to set goals for other countries. Moreover, this variation challenges 
clinicians, researchers, and policy makers to identify the explanations for changing outcomes, 
which may reflect population as well as healthcare factors. It is also important to consider 
whether there have been changes in data reporting. From a health policy perspective, the 
comparisons of indicators in 2010 and 2015 and the possibility that lower rates of some indicators 
might reflect policy decisions are highly interesting. For example, the Netherlands and the UK 
implemented audits on stillbirths and report a greater reduction in stillbirth rates between 2010 
and 2015 than other countries. Policies to reduce the numbers of multiple pregnancies through 
assisted reproductive technology (ART) in the Czech Republic were accompanied by decreases 
in both multiple pregnancy and preterm birth rates. More investigation of these case studies is 
needed to understand these relationships and could yield important examples of successful policy 
initiatives that could be adopted more widely. 
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1.4 RESULTS: A SUMMARY OF KEY FINDINGS 
THE INCREASE SINCE 2010 IN MANY RISK FACTORS FOR CHILDBEARING WOMEN PRESENTS A 
COMMON CHALLENGE 
The core and recommended indicators in this report describe characteristics of the childbearing 
population that are related to risks of mortality, morbidity, and obstetric interventions. These 
are multiple birth, maternal age, parity, smoking, and maternal prepregnancy body mass index. 
Population characteristics may explain differences between countries as well as changes over 
time.
•	 Women	with	multiple	pregnancies	face	higher	risks	of	preterm	birth	and	perinatal	mortality	
and morbidity. In Europe, the median multiple pregnancy rate is 16.7 per 1000 women 
delivering a live or stillbirth. Countries with high multiple birth rates — over 19 per 1000 — 
are Ireland, Germany, Slovenia, Spain, and Cyprus, whereas low multiple birth rates — under 
14 — are found in Romania, Slovakia, Poland, Greece, Finland, and Lithuania.  
•	 The	median	percentage	of	women	having	babies	at	35	years	of	age	or	older	was	20.8%;	
percentages exceeded 29% in Portugal, Greece, Ireland, Italy, and Spain and were less than 
15% in Bulgaria, Romania, and Poland.
•	 Teenage	pregnancy	is	increasingly	uncommon	in	Europe;	in	21	countries,	fewer	than	3%	of	
women were under 20 years of age at the birth of their child. This percentage exceeded 6% in 
several countries, however: Slovakia, Hungary, Romania, and Bulgaria. 
•	 While	the	age	distributions	of	childbearing	women	differ,	there	is	a	common	trend	toward	
later age at childbirth. Overall the percentage of mothers aged 35 years or older increased by 
16%, with the biggest increases in Cyprus, Hungary, the Czech Republic, and Portugal.   
•	 Maternal	obesity	is	also	increasing,	although	our	vision	is	very	partial	as	only	12	of	the	31	
countries participating in Euro-Peristat could provide this information. The median prevalence 
of obesity before pregnancy, as defined by a maternal body mass index of 30 or greater, was 
13.2% in these countries, ranging from 7.8 to 25.6%. In 7 of the 9 countries that also had data 
for 2010, percentages were higher in 2015.  
•	 Smoking	in	pregnancy	is	a	subject	on	which	there	is	good	news	to	report.	Overall,	the	
percentage of women smoking during pregnancy in 2015 was 13% lower than in 2010. 
However, progress is possible in many countries. In a quarter of the 19 countries able to report 
data on smoking during pregnancy, more than 12.5% of women smoked, with percentages 
highest in Valencia in Spain (18.3), Wales (17.3), France (16.3), and Northern Ireland (14.3). 
In contrast, in Norway, Sweden, and Lithuania, fewer than 5% of women smoked during 
pregnancy.
EUROPEAN DISPARITIES IN MODE OF DELIVERY HAVE WIDENED
•	 In	Europe,	the	median	caesarean	section	rate	is	27.0%	and	one	quarter	of	countries	have	rates	
below 21%. Iceland, Finland, Norway, and the Netherlands have the lowest rates, under 18%, 
while Italy, Hungary, Poland, Bulgaria, Romania, and Cyprus had rates over 35%. 
•	 Overall,	caesarean	birth	rates	were	4%	higher	in	2015	than	in	2010,	but	this	represents	an	
average including much greater increases in countries such as Romania, up by 27% (from 
36.9% to 46.9%), Poland 24% (from 34.0% to 42.2%), Hungary 21% (from 32.3% to 39%), 
and Scotland 17% (from 27.8% to 32.5%). 
•	 In	contrast,	caesarean	section	rates	decreased	in	Lithuania,	Latvia,	Portugal,	Estonia,	Italy,	and	
Norway. 
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•	 These	differences	between	countries	are	also	observed	in	subgroup	analyses.	For	babies	in	a	
breech presentation, the median caesarean rate was 89%, with a range from 64.3% to 100%. 
In 4 countries, Norway, Latvia, Finland, and France, 25% or more of breech babies babies were 
born vaginally. 
•	 Ten	countries	have	no	data	about	risk	subgroups;	unfortunately,	many	of	these	countries	are	
those with high rates of caesarean births, where evaluating current practices is particularly 
important. 
•	 Instrumental	birth	rates	varied	widely.	The	median	was	7.2%,	ranging	from	below	3.5%	in	
a quarter of countries to over 10.9% in another quarter. Rates under 2.5% were observed 
in Romania, Croatia, Lithuania, Slovakia, and Latvia and over 12% in France, Scotland and 
England in the UK, Spain, and Ireland. 
POOR QUALITY STATISTICS CONTINUE TO HAMPER EUROPEAN SURVEILLANCE OF MATERNAL 
DEATHS 
•	 Most	countries	rely	on	routine	cause	of	death	statistics	to	measure	maternal	deaths,	despite	
well-known under-reporting. Because of this, and very low numbers, no firm conclusions can 
be drawn for most countries about whether their maternal mortality ratios (MMRs) are higher 
or lower than in other European countries or whether there have been changes over time. 
This is a major limitation to benchmarking across countries. All European countries should be 
able to provide reliable statistics on maternal deaths, as in the countries that have enhanced 
reporting systems.   
•	 Maternal	mortality	appears	to	have	declined	in	countries	that	carefully	count	and	analyse	
maternal deaths. MMRs computed with data from enhanced systems decreased in the most 
recent five-year period compared to data reported in our previous report, but only 7 countries 
had data from these systems. Since many enhanced systems are accompanied by audits, these 
systems may contribute to improving care for pregnant women and therefore the results from 
these countries may not apply more generally. 
OVERALL, STILLBIRTH AND NEONATAL MORTALITY RATES DECLINED, BUT WITH HIGH 
HETEROGENEITY
•	 The	median	stillbirth	rate	at	28	weeks	of	gestation	and	over	was	2.7	per	1000	births.	Rates	
below 2.3 per 1000 were reported in Cyprus, Iceland, Denmark, Finland, and the Netherlands, 
and rates of 3.5 per 1000 or more in Slovakia, Romania, Hungary, and Bulgaria. When 
stillbirths between 24 and 27 weeks of gestation were included, the median rate was 3.4, but 
the ranking of countries remained similar. 
•	 Overall,	stillbirth	rates	in	2015	were	5%	lower	than	in	2010,	but	this	reflects	an	average	
between large declines in the Netherlands, Scotland, and Poland and stable rates in other 
countries. 
•	 For	neonatal	mortality	rates	at	22	weeks	and	over,	the	European	median	was	2.2	per	1000	live	
births. Countries with rates of 1.5 per 1000 or lower were Slovenia, Iceland, Finland, Norway, 
the Czech Republic, Estonia, and Sweden, while Northern Ireland, Malta, Romania, and 
Bulgaria had rates above 3.5 per 1000.  Some of this variability in neonatal mortality rates is 
related to differences in policies governing terminations of pregnancy for fetal anomalies.
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•	 After	excluding	births	at	22	and	23	weeks	of	gestational	age,	accounting	for	about	19%	of	
all neonatal deaths, the median was lower, 1.7 per 1000, but rankings were similar. Low rates 
were less than 1.2 per 1000 while higher rates exceeded 3.0 per 1000. However, 7 countries 
were unable to provide the information needed for this comparison.
•	 Overall,	neonatal	mortality	declined,	and	these	declines	were	more	marked	when	babies	born	
at 22 and 23 weeks were excluded. In some countries however, neonatal mortality rates were 
higher in 2015, significantly so in Portugal. 
•	 For	infant	mortality,	the	median	was	3.1	per	1000	with	lower	mortality	countries	reporting	
rates of 2 and lower, and higher mortality countries with rates of 5 per 1000 or more. Ten 
countries were unable to provide data to calculate mortality rates without babies born at 22 
or 23 weeks, who were estimated to account for 16% of all deaths.  
PRETERM BIRTH AND LOW BIRTH WEIGHT REMAIN STABLE OVERALL WITH STRONG 
GEOGRAPHICAL PATTERNS
•	 Babies	with	a	low	birth	weight	(<	2500	grams)	accounted	for	less	than	4.5%	of	all	births	
in Iceland, Sweden, Finland, and Estonia and more than 8.0% in Spain, Hungary, Portugal, 
Greece, Bulgaria, and Cyprus. 
•	 When	comparing	2015	to	2010,	there	were	significant	decreases	in	some	counties	(Norway,	
Greece, and Austria) and increases in others (Iceland, France, Ireland, Northern Ireland, and 
Portugal). 
•	 Preterm	birth	rates	ranged	from	less	than	6%	in	Finland,	Latvia,	Estonia,	Sweden,	and	
Lithuania to more than 8.0% in Belgium, Scotland, Romania, Germany, Hungary, Greece, and 
Cyprus, with a European median of 7.3%.
•	 Changes	since	2010	were	highly	heterogeneous,	with	significant	declines	in	7	countries,	
including the Netherlands, Austria, and the Czech Republic and significant increases in 8 
countries. 
 
1.5 THE NEED FOR CONTINUOUS AND MORE COMPLETE MONITORING 
This European Perinatal Health report illustrates the feasibility and the importance of comparable 
data on maternal and newborn health across Europe. It also highlights significant challenges, both 
in data quality and availability. These problems have been highlighted for each indicator in the text. 
The set of Euro-Peristat indicators should represent minimum standards for national reporting. 
Data availability overall is good for the core indicators, but tabulations by subgroups are not 
available for all indicators. Many countries were unable to provide data on maternal smoking 
or prepregnancy body mass index, although these are needed to evaluate policies to improve 
population health.  
In addition to the challenges facing each country in improving their data quality and availability, 
this report suffers from a lack of continuous time series data. We cannot accurately describe 
trends in the indicators without annual data, especially in countries with small numbers of births 
each	year;	consequently,	we	observe	substantial	year	to	year	variation	in	indicator	values.	While	
combining data from 31 countries to undertake “like with like” comparisons requires substantial 
effort, especially with regard to data cleaning and checking, this report shows that it is possible. 
A goal for current health information initiatives should be to create a sustainable structure and 
a funding stream to support collection, data cleaning and validation, and analysis of data from 
routine statistical systems in European countries on an annual basis. This would provide up-to-
date knowledge about key indicators of maternal and newborn health to pregnant women and 
their families, clinicians, and policy makers and enable better monitoring of trends over time.
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2.  THE EUROPEAN PERINATAL HEALTH REPORT ON CORE 
 INDICATORS IN 2015: INTRODUCTION AND METHODS
This report presents the Euro-Peristat perinatal health indicators in 2015 from 31 European 
countries, including the 28 European Union member states and Iceland, Norway, and Switzerland. 
The indicators comprise the full set of 10 core indicators as well as two recommended indicators in 
the Euro-Peristat indicator set.1 Other Euro-Peristat recommended indicators will be published at 
a later date.
2.1  SURVEILLANCE OF PERINATAL HEALTH IN EUROPE 
MATERNAL AND NEWBORN HEALTH IN EUROPE IS A PRIORITY
Promoting healthy pregnancy and safe childbirth is a goal of all European countries. Despite 
continuing and significant reductions in maternal and perinatal mortality over recent decades,1 
mothers and their babies are still at risk during the perinatal period, defined as pregnancy, 
delivery, and the postpartum period. Over 5 million babies are born in European Union member 
states	every	year;	approximately	23	000	are	stillborn,	22	000	die	before	their	first	birthday,	
and 8 per 1000 suffer from severe sensory or cognitive impairments.2,3 The principal pregnancy 
complications leading to perinatal mortality and morbidity are preterm birth, fetal growth 
restriction, and congenital anomalies. The increased or at best stable percentage of children 
born preterm in many countries4,5 reflects limited achievements in prevention, compared with 
the medical advances that have reduced mortality among infants born preterm or with other 
perinatal complications. Maternal deaths are increasingly rare, but up to half are associated 
with substandard care. Although severe maternal morbidity is measured inadequately and 
inconsistently throughout most of Europe, it is estimated that between 1 and 3% of women 
receive a life-threatening diagnosis or require a life-saving procedure during their delivery 
hospitalisation.6,7
Poor maternal and newborn health have long-lasting consequences. Research on the early origins 
of adult diseases underscores the vital importance of perinatal events and underpins calls for 
public health interventions targeting the first 1000 days of life.8,9 For instance, preterm birth 
and fetal growth restriction are associated with the development of chronic illnesses such as 
hypertension and metabolic disease in later life.10 Risk factors for poor perinatal outcome, such 
as smoking and obesity, continue to exert an effect through the child’s increased susceptibility 
to asthma, obesity, and developmental delays. The social context and consequences of these 
effects must also be considered, as the burden of poor health falls disproportionately on socially 
disadvantaged women and babies.11,12 Adverse perinatal health outcomes perpetuate health and 
social inequalities within and between countries.
PERINATAL HEALTH SURVEILLANCE AT A EUROPEAN LEVEL ADDS VALUE TO NATIONAL 
INITIATIVES
High quality health information is needed to support decision-making about health practices 
and policies for pregnant women and newborns. Two principal reasons strongly justify the 
development of a European perinatal health information system from a public health perspective. 
First, European countries face similar economic, demographic, and medical challenges. Many 
common economic and demographic pressures affect women and babies and require surveillance. 
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Because many countries are experiencing very low fertility rates, investments in young families 
and children constitute a strategic priority for them. The increase in almost all countries of risk 
factors for poor perinatal health, such as older age at childbirth and maternal obesity, 
requires healthcare services to adapt to the evolving needs of mothers and children. Similarly, 
questions about the optimal use of new health technologies, such as prenatal genetic screening 
or subfertility procedures, are of concern everywhere. These questions touch on a wide range of 
societal concerns, including quality of care, the expectations and satisfaction of pregnant women 
and their families, ethics decisions, and healthcare costs. 
Second, European countries can benefit from pooling their experiences to improve health care 
delivery and public policy. Understanding how neighbouring countries manage these common 
risks and challenges adds to the range of solutions available for national policy makers. Great 
diversity in cultural, social, and organisational approaches to childbirth and infant care exists 
within Europe and raises important questions about the best use of healthcare interventions and 
the quality of care. Data on medical practices and health are essential benchmarks for evaluating 
these diverse models and identifying possible gains in efficiency and cost-effectiveness. 
The benefits of having statistics on maternal and child health are obvious, and most individual 
countries have data that are used for surveillance on the national level. However, many key 
indicators of maternal and child health and health care are currently not available in international 
databases (Eurostat, OECD, or WHO) or are not sufficiently standardised to permit valid 
comparisons.13 
THE EURO-PERISTAT PROJECT: SURVEILLANCE AND ANALYSIS OF PERINATAL HEALTH IN 
EUROPE 
The Euro-Peristat project’s goal is to develop valid and reliable indicators that can be used for 
monitoring and evaluating perinatal health in Europe. The project began in 1999 as part of the 
Health Monitoring Programme and has enlisted the assistance of perinatal health professionals 
(clinicians, epidemiologists, and statisticians) from European Union member states and Iceland, 
Norway, and Switzerland as well as other networks, notably SCPE (a network of European 
cerebral palsy registries), ROAM (Reproductive Outcomes and Migration Collaboration), and 
EUROCAT (a network of European congenital anomaly registries), to develop its recommended 
indicator list. 
It thus aims to (1) assess maternal and infant mortality and morbidity associated with pregnancy, 
delivery,	and	the	postpartum	period;	(2)	describe	the	changes	in	risk	factors	for	perinatal	health	
outcomes in the population of childbearing women, including demographic, socio-economic and 
behavioural characteristics, and (3) monitor the use and consequences of medical interventions in 
the care of women and babies during these same three periods. 
In its first phase, the Euro-Peristat Project developed a set of indicators with members from the 
then 15 member states of the European Union.14 This indicator set was developed by a procedure 
that began with an extensive review of existing perinatal health indicators and was used as the 
basis of a DELPHI consensus process, a formalised method in which selected experts respond to 
a successive series of questionnaires with the aim of achieving a consensus on key principles or 
proposals. Our first panel of experts in 2002 was composed of clinicians, epidemiologists, and 
statisticians. We also invited the SCPE network to assist with the indicator on cerebral palsy. A 
second DELPHI process was also conducted in 2002, with a panel of midwives to ensure that their 
perspectives on perinatal health were represented. A third DELPHI process was conducted in 2006 
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with a panel of 2 participants (clinicians, epidemiologists, and statisticians) from each of the 10 
newest member states of the European Union. Minor updates to this list were undertaken again 
before collection of 2010 and 2015 data. The changes to the indicator list reflect the emergence 
of new priorities as well as our experience testing the feasibility and utility of collecting and 
presenting the indicators.
This feasibility testing has simultaneously enabled Euro-Peristat to use these indicators to evaluate 
perinatal health in Europe. The first publication was a special issue of the European Journal of 
Obstetrics, Gynecology, and Reproductive Biology. We then produced two European Perinatal 
Health Reports (in 2008 based on 2004 data and in 2013 based on 2010 data).2,3 Our group and 
others using our open access databases have published more than 60 scientific articles based on 
Euro-Peristat data. These publications focus on methods – how to create better, more comparable 
indicators – and on evaluating health and health care across Europe. A list of the Euro-Peristat 
publications is available on our website (http://www.europeristat.com/reports/scientific-
publications.html).
The Euro-Peristat network includes one Scientific Committee representative per country and other 
data providers and experts who make up the team for each country (see http://www.europeristat.
com/our-network/country-teams.html and Appendix A for the list of contributors). Because 
Bulgaria and Croatia joined the network in 2016, it is now able to provide complete coverage of 
all European Union members. 
Currently Euro-Peristat is funded as part of a European Joint Action, InfAct, on health 
information. InfAct (Information for Action), launched in March 2018, includes 40 partners in 
28 EU and associated countries. It aims to provide a sustainable solution for health information 
networks in Europe and better coordination of health information surveillance strategies and 
data collection in Europe (https://www.inf-act.eu/). Data compilation and analysis for this report 
was funded by the BRIDGE Health project, which provided support for Euro-Peristat from May 
2015 to October 2017. This funding did not cover collection of the full set of Euro-Peristat 
indicators, which is why this report focuses on the core indicators and two recommended 
indicators.
Euro-Peristat is also supported by participating institutions that provide routine statistical data to 
the Euro-Peristat coordination team and our network of experts who contribute their time and 
expertise. Appendix A lists all contributors to this report.
EURO-PERISTAT INDICATORS 
The current Euro-Peristat indicator list includes 10 core indicators and 20 recommended indicators 
and are grouped into 4 themes, as shown in the table below: (i) fetal, neonatal, and child health, 
(ii) maternal health, (iii) population characteristics and risk factors, and (iv) health services. 
We defined core indicators as those that are essential for monitoring perinatal health and 
recommended indicators as those considered desirable for a more complete picture of perinatal 
health	across	the	member	states.	We	also	identified	several	indicators	for	further	development;	
they are defined as those that represent important aspects of perinatal health but require further 
work before they can be implemented.
 Table 2.1  Euro-Peristat’s 10 core and 20 recommended indicators.
FETAL, NEONATAL, AND CHILD HEALTH
C1:    Fetal mortality rate by gestational age, birth weight, and plurality
C2:    Neonatal mortality rate by gestational age, birth weight, and plurality
C3:     Infant mortality rate by gestational age, birth weight, and plurality
C4:    Distribution of birth weight by vital status, gestational age, and plurality 
C5:    Distribution of gestational age by vital status and plurality
R1:   Prevalence of selected congenital anomalies 
R2:    Distribution of 5-minute Apgar scores 
R3:  Fetal and neonatal deaths due to congenital anomalies 
R4:     Prevalence of cerebral palsy
MATERNAL HEALTH
C6:    Maternal mortality ratio
R5:    Maternal mortality by cause of death 
R6:    Incidence of severe maternal morbidity 
R7:     Incidence of tears to the perineum
POPULATION CHARACTERISTICS/RISK FACTORS
C7:    Multiple birth rate by number of fetuses 
C8:     Distribution of maternal age
C9:    Distribution of parity
R8:    Percentage of women who smoked during pregnancy 
R9:    Distribution of mothers’ educational level
R10:   Distribution of parents’ occupational classification 
R11:  Distribution of mothers’ country of birth
R12:   Distribution of mothers’ prepregnancy body mass index
HEALTHCARE SERVICES
C10:   Mode of delivery by parity, plurality, presentation, previous caesarean section, and   
 gestational age
R13:   Percentage of all pregnancies following treatment for subfertility 
R14:   Distribution of timing of first antenatal visit
R15: Distribution of births by mode of onset of labour 
R16: Distribution of place of birth by volume of deliveries
R17:  Percentage of very preterm babies delivered in units without a neonatal intensive care unit
R18:  Episiotomy rate
R19:  Births without obstetric intervention 
R20:   Percentage of infants breast fed at birth
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2.2  DATA COLLECTION AND AVAILABILITY 
The Euro-Peristat indicators are compiled from population-based data at the national level from 
routine sources (ie, administrative or health registers, statistical systems or routine surveys). 
However, if data at the national level are not available, countries can submit population-
based data from regions or from constituent countries, as the UK does. Scientific Committee 
representatives are responsible for overseeing data collection for their country in collaboration 
with their country team members.
Data collection began in January 2017. We asked for data on births in 2015 or the most recent 
year if 2015 data were not yet available. Euro-Peristat collects aggregated data by using a 
standardised Excel-based instrument developed and adapted by the Netherlands Organisation for 
Applied Scientific Research, TNO Healthy Living in Leiden, the Netherlands. In this data collection 
exercise, some countries tested a program to automatically generate the aggregated data sheets 
from disaggregated multivariate tables, an approach that Euro-Peristat would like to develop in 
the future to improve quality and standardisation. Information on data sources and data quality 
were also collected. Data were reviewed by the project coordination team based at Inserm in 
France, and queries were then sent to individual country teams (ie, Scientific Committee members 
and data providers) for review. 
Members of the Euro-Peristat network met in the Netherlands in April of 2018 to review the 
preliminary results and discuss explanations for observed geographical and temporal variations, 
with a particular focus on possible differences in indicator definitions. Scientific Committee 
members checked data for the indicators, endorsed the Euro-Peristat output tables, and 
contributed to writing and reviewing the written text before publication of this report.
DATA SOURCES
Countries used multiple sources including civil registers based on birth and death certificates, 
medical birth registers, hospital discharge systems, and survey data. Most countries used at least 
2	separate	data	sources;	the	number	of	sources	varied	between	1	(Greece,	Norway,	and	Sweden,	
for instance) and 15 (for the UK and its four constituent countries). However, some databases 
centralise	data	from	multiple	sources;	for	instance,	Norway’s	medical	birth	register	is	routinely	
linked with civil registration data, the ART registry, and abortion data (for terminations of 
pregnancy) and would therefore be considered a single source. Table 2.2 summarises countries’ 
main sources of data for perinatal health reporting. If several data sources were available for 
a given indicator, Scientific Committee members were asked to select the best source based on 
quality and comprehensiveness. For each indicator, the data source is identified in the summary 
tables in Appendix B. More details on each of these data sources can be found in Appendix C. 
Civil registration systems collect information related to perinatal health and vital statistics related 
to all births and deaths. Some civil registration systems also record background characteristics, 
such as mother’s age, parity, and plurality, or babies’ birth weights, but most countries record only 
a limited number of variables related to perinatal health. Civil registration is required by law and 
is very complete for citizens and permanent residents. Most countries also register information 
about births to women who are non-residents. Many countries derive numbers of live births, 
stillbirths, infant deaths, and maternal deaths from civil registration. This includes a compulsory 
medical certification of causes of death in all countries, although some process this separately. 
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While all countries have civil registration, the majority of Euro-Peristat core indicators are derived 
from medical birth registers. These registers contain more specific information about maternal 
characteristics and about diagnoses, care, and interventions during the perinatal period for 
mothers and children. Data provision is mandatory in most countries, but even registers that 
are voluntary (eg, Luxembourg, Malta, and the Netherlands) have good coverage. Midwives, 
nurses, or doctors record information for the medical birth registers in maternity and neonatal 
units, either on a data collection form or on electronic patient data systems from which they are 
subsequently abstracted. 
Civil registration and medical birth register data are the most comprehensive at the population-
level;	coverage	is	usually	close	to	100%.	Appendix	C	reports	the	percentage	of	coverage	estimates	
for each of the data sources used in this report.
Besides civil registration and medical birth registers, other data sources include hospital discharge 
systems that record information about hospital births. These healthcare system databases include 
information about all care provided in the relevant area, including births to women without 
permanent residence status (immigrants, refugees, and asylum seekers) as well as visitors and 
women from other countries seeking health care. This can cause discrepancies in the total number 
of births when compared with civil registration data, which may have different inclusion rules. 
Hospital discharge systems record data about births and interventions during the hospital stay (ie, 
caesarean or instrumental deliveries, clinical diagnoses during pregnancy and at birth, hospital 
care after delivery, interventions and clinical diagnoses in mothers and babies until discharge). 
However, these systems usually do not cover use of primary healthcare services or home or other 
out-of-hospital births. Use of these databases presents other methodological concerns. For 
instance, their use to estimate incidence or prevalence data may result in overestimates if the 
systems do not use a unique identifier to record multiple admissions of the same person.15 This is 
of particular concern for newborns or mothers who may be admitted to intensive care in another 
hospital. For some countries, such as Portugal, data collection is mandatory only for public 
hospitals. If the diagnoses or interventions in the hospital discharge systems are used for financial 
purposes (ie, health insurance funds), there may be bias related to the tendency to include only or 
especially care with more complicated diagnoses or only the diagnoses or procedures that provide 
funding for the hospitals.
To collect more information about maternal and infant mortality, some countries organise 
confidential enquiries or audits to ascertain all cases and examine whether substandard care or 
other avoidable factors could have contributed to the death.16 Table 2.2 specifies the countries 
performing such audits. Finally, routine surveys are another source of information on births, as in 
France where a national survey is conducted about every five years in all maternity units during 
one week of the year. Further analysis of the data sources used to report on perinatal health in 
participating countries can be found in publications by the Euro-Peristat group.13,15,17
LINKING DATA SOURCES
Euro-Peristat has studied methods for improving data for perinatal health surveillance. Data 
linkage of patient records across population-based registers has been identified as one way 
to improve the range and quality of data available about each birth. Countries that link data 
routinely are able to produce more of the Euro-Peristat core and recommended indicators.18
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For this data collection exercise, 20 of the 31 participating countries reported linking data sources. 
Some countries perform these linkages routinely by linking birth and death certificates or medical 
birth register data to civil registration data to increase the completeness of data on deaths 
after the perinatal period. Other types of linkages, for example to education or specific disease 
registers (ie, cancer, ART, and congenital anomalies) can also enrich the information available on 
outcomes during childhood or later on in life. In a few countries, linkages can only be done for ad 
hoc statistical or research purposes. The availability of unique identification numbers facilitates 
linkage between data sources, but other techniques exist. They rely on probabilistic matching of 
information, such as the mother’s name, date of birth, and address, as well as information about 
the newborn, including, for example, gestational age and birth weight.18
Structural differences in data quality and privacy frameworks across Europe can hamper countries’ 
capacities to link data systems. Nonetheless, Euro-Peristat recommends broader adoption of data 
linkage to increase the breadth and quality of information available for perinatal health research 
and surveillance.13,15,17,18 
INCLUSION CRITERIA FOR BIRTHS AND DEATHS
Euro-Peristat requested data for all stillbirths and live births from 22 weeks of completed 
gestation or, if gestational age was not available, a birth weight cutoff of 500 grams. Because 
most countries do not have legal registration limits for live births, defined as any birth with 
signs of life, they are able to provide data based on Euro-Peristat’s inclusion criteria. For fetal 
deaths, most countries were able to provide data for deaths at or after a gestational age limit 
of 22 weeks, but some countries use other criteria, such as birth weight (ie, 500 grams) or higher 
gestational age limits (eg, 24 weeks). If countries cannot provide data according to the Euro-
Peristat inclusion criteria, they are asked to provide data by using their national criteria. This 
can lead to differences in the lower inclusion limits for births and deaths for data provided to 
Euro-Peristat. In some countries, legal limits for registration are different from those used to 
provide data for Euro-Peristat because the data do not come from civil registration data. The 
Netherlands and Italy, for example, were able to provide data for stillbirths below the lower limit 
for legal registration, ie, over 22 weeks of gestational age in both countries, because they used 
data registers that include stillbirths at lower gestations. The descriptions of the fetal (see C1) 
and neonatal (see C2) mortality indicators include the exact inclusion criteria for participating 
countries. 
Because of differences in legislation and practices for registering births and deaths, it is essential 
to report on mortality statistics that use common gestational age limits, to make these rates more 
comparable between countries. Based on results of research using data collected in previous 
years,19, 20 the Euro-Peristat network excludes deaths at very early gestational ages, which are the 
most likely to be affected by registration differences: 22–23 weeks for neonatal mortality and 
22–27 weeks for fetal mortality.20 We focus on gestational age thresholds because most countries 
base inclusion criteria for stillbirths on gestational age and also because we found that using 
a birth weight of 1000 grams versus a gestational age cutoff of 28 weeks underestimated the 
burden of third trimester stillbirths.19 In this report, we also include comparisons of fetal mortality 
rates between 24 and 27 weeks of gestation, to provide more complete reporting of stillbirths, as 
explained in the section on fetal mortality (see C1).
For this report, we requested data about notification of late terminations of pregnancy. Some 
of the variation in fetal mortality between European countries is due to differences in reporting 
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of terminations at 22 weeks and later.21 Some countries register these terminations as stillbirths, 
whereas elsewhere terminations are recorded in a separate system or not reported at all. This 
information is presented in the section on fetal mortality, and rates are provided with and 
without terminations to allow readers to take these differences into consideration. 
While differences in the recording of births and deaths at the limits of viability can have a large 
impact on mortality rates, they have less impact on other perinatal health indicators because 
these births and deaths account for a very small proportion of all births.22 On average, births 
below 24 weeks of gestation make up less than 0.1% of total births.22
COMPARING PERINATAL HEALTH INDICATORS BETWEEN COUNTRIES  
In defining our indicators, the Euro-Peristat network aims to reduce variation in indicators 
attributable to differences in definitions or recording practices from country to country. This has 
been accomplished by selecting definitions most likely to be feasible and by carefully designing 
the data collection instrument. Nonetheless, not all countries can produce data according to the 
recommended definitions. For example, the requested denominators are not always available 
– such as childbearing women rather than births, or total births rather than live births. Some 
countries were able to provide information for all births, but not separately for singletons and 
multiples. Data for the requested time frames were also not always available. For instance, we 
requested mortality information for 2011-2015, but some countries were only able to provide 
data for 2010-2014 or 2008-2012. These differences are noted in the relevant tables and figures. 
Another issue that can affect the comparability of indicators is the management of missing data. 
Euro-Peristat collects data along with the number of “unknown” or “missing” cases. These data 
are not always available, however. If check-box answers are interpreted as a positive answer (yes), 
missing data tend to be automatically, but erroneously interpreted as a negative answer (no). 
The data tables in Appendix B report the number of missing cases for each indicator, when this 
information is available, in the column labelled “not stated”. In our data exercise, unless noted 
otherwise, we calculated rates and percentages by excluding cases with missing data.  
Finally, account must be taken of random variation in making comparisons. The largest member 
states – France, Germany, Italy, and the UK – each have more than half a million births per year. 
The annual number of births is smallest in Malta and Iceland (around 4500), Luxembourg (around 
6500), and Cyprus (around 9500). Estonia and Slovenia have 14 000-20 000 births per year. For 
smaller countries, the data for a single year may not contain sufficient numbers of events to 
construct reliable rates to measure less frequent maternal or child outcomes. For maternal 
mortality, which is extremely rare, rates are measured using data for five years, but this does 
not solve the problem in smaller countries. The Euro-Peristat group has studied the best ways to 
present data to call attention to the variation in indicators due to small population size.23 In this 
report, we present data on changes in the Euro-Peristat indicators between 2010 and 2015 with 
relative risk ratios and their 95% confidence intervals. We have also included the number of births 
in the first graph of each section so that the reader can interpret the data with the number of 
annual births in mind. 
Because of the importance of these methodological issues, for each indicator in the report, we 
detail the specific questions that should be kept in mind when interpreting variations. We urge 
our readers to look closely at these sections.  
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DATA AVAILABILITY 
All countries provided data for 2015, with the exception of Bulgaria, Poland, Sweden, and 
Switzerland whose data refer to births in 2014. Figure 2.1 presents the percentage of countries 
that provided each of the Euro-Peristat indicators for this report, overall and by subgroup. Partial 
availability refers to situations where some data are available but with significant differences 
from the Euro-Peristat definition or with coverage that is not nationwide. Coverage that is 
complete, but based on several subnational systems that have not been merged to provide a 
national value (as for some indicators in the UK), is considered fully available. Countries using 
different years were similarly considered to have full availability. 
In general, availability for the core indicators was good – as would be expected as these are 
basic population health indicators. However, not all countries can provide these indicators by key 
subgroups, such as gestational age, birth weight, or plurality. This issue is most acute for infant 
deaths. Linkage of birth and death certificates should make this possible in most countries, and 
Euro-Peristat urges all countries to achieve full availability on this core indicator set.  
Data for the two recommended indicators – on smoking (R8) and prepregnancy body mass 
index (R12) – came essentially from medical birth registers and from a perinatal survey in France. 
Data availability for these two indicators in the participating countries is not as good as that 
for the core indicators. Smoking and prepregnancy body mass index are known risk factors for 
adverse perinatal health outcomes and provide useful information for interpreting the baseline 
prevalence and risk of other indicators (ie, low birth weight, preterm birth). 
COMPARISONS WITH 2010 
There have been some positive changes in data availability since our data collection in 2010. 
Cyprus now has national data as opposed to survey data, and Greece is lowering its registration 
criteria for stillbirths to 22 weeks of gestation. France has also put into place a new system for 
monitoring stillbirths and the gestational age and birthweight distribution from its hospital 
discharge	data	since	2012;	in	our	2010	report,	national	data	came	from	the	French	Perinatal	
Survey, which is a nationally representative sample of births. In Belgium, data are now available 
nationally for all births, whereas in our previous reports, data were reported separately by region. 
For this report, several countries provided new or updated data from 2010 which allowed us 
to compare their data for these two years. For instance, Belgium provided national level data 
for 2010 and Greece was able to provide data from 2010 which were not included in our last 
report. Spain provided data on caesarean section rates in 2010, as their new data included private 
hospitals, whereas reported data in 2010 only covered the public hospitals. In comparisons with 
2010, we aimed to maintain the same data sources. For instance, in France, because national data 
were not available in 2010 for stillbirths, preterm births, or low birth weight, comparisons with 
2010 use data from the most recent French Perinatal Survey.  
2.3  PRESENTATION OF DATA IN THE REPORT 
In this report, the figures and tables order countries alphabetically according to each country’s 
official name, in accordance with the convention used for European Union publications. 
This ordering was used in the first Euro-Peristat report and continued in subsequent reports. 
Therefore, figures and tables can be compared between reports as well with other European data 
tables, such as those produced by Eurostat. 
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While sorting indicators – from lowest to highest, for instance – makes graphs easier to read, 
presenting data in this way can lead to erroneous interpretations. Ordering countries creates a 
performance ranking that implies that each country can be clearly placed on a scale with respect 
to all other countries. However, because of random variation from year to year, we would expect 
countries with similar performance on a given indicator to have small differences in values from 
year to year. One option for emphasising this random variation is to add confidence intervals for all 
indicator values. In this report, confidence intervals are used for maternal mortality ratios because 
the variability is very marked for some countries. Because adding confidence intervals makes 
figures more complex, however, we have not included them elsewhere. Nonetheless, as mentioned 
above, some graphs include information on the number of births to highlight differences in 
population sizes between countries. Another problem with sorting indicators is that it is not 
possible to sort countries with no data. Identifying gaps in surveillance capacity is one of key 
objective of Euro-Peristat and presenting countries alphabetically highlights missing information. 
Another issue in reporting European data concerns how to summarise each indicator for Europe 
overall. Providing an average of the indicators for all countries is not very meaningful, as this will 
be affected by outliers and because the number of countries providing data differ depending 
on the indicator. A Europe-wide value based on all contributed births is also not ideal, as a few 
large countries would account for a disproportionate number of births. As a solution, we have 
provided median values and information about the range of values (interquartile and overall). To 
assess Europe-wide changes between 2010 and 2015, we also estimated pooled risk ratios with 
meta-analysis techniques. These statistical techniques, which integrate information about the 
variability in population size, are appropriate for evaluating trends across Europe. We report a 
random effects pooled risk ratio, calculated with the method of DerSimonian and Laird, which 
is interpretable as the association in an average country in Europe. Meta-analysis also makes 
it possible to provide a statistical measure of the heterogeneity in indicator values throughout 
Europe. We report the I2 statistic, which provides an estimate of the proportion of the variation 
from country to country due to real differences and not just chance variation. Finally, we also 
present data with maps that illustrate geographic patterns in the distribution of the indicators. In 
these maps, countries are classified into six groups based on the geometrical interval classification 
method (ArcGIS 10.5).
KEY POINTS 
•	 The	strengths	of	the	Euro-Peristat	indicators	are	their	standardised	definitions,	the	uniform	
collection of aggregated data, and the expertise brought to data collection and interpretation 
by Euro-Peristat Scientific Committee members and data providers, who are statisticians, 
epidemiologists, health researchers, physicians, midwives, and university researchers. 
•	 All	data	were	checked,	based	on	a	protocol	involving	several	rounds	of	internal	validation	
within the network. 
•	 This	and	the	previous	Euro-Peristat	reports	testify	to	the	feasibility	and	importance	of	the	
collection of indicators of maternal and infant health and of routinely compiling currently 
available data. 
•	 Euro-Peristat	also	highlights	shortcomings	in	current	routine	data	systems,	which	must	be	
considered in interpreting variation between countries. 
•	 Regular	reporting	of	perinatal	health	indicators	on	a	European	level	makes	it	possible	to	
identify these weaknesses and to encourage countries to make changes to obtain better 
statistics on maternal and newborn health.  
•	 The	use	of	Euro-Peristat	data	for	research,	by	public	health	policy	planners	and	public	health	
specialists, confirms the importance of routinely compiling available perinatal health data for 
the surveillance of trends in risk factors and outcomes.
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Table 2.2  Main sources of data used by Euro-Peristat 
Register Data Other
Country Births in 
2015*
(N)
Civil registration/
vital statistics
Medical birth 
register or child 
health system
Hospital 
discharge 
system
Routine 
survey
Confidential 
enquiry
Professional 
registry
Linked 
data
Belgium  122 838 x Yes
Bulgaria (2014)  68 079 x x x No
Czech Republic  111 162 x x x No
Denmark  57 847 x x x Yes
Germany  728 825 x x Yes
Estonia  13 961 x x x Yes
Ireland  65 913 x x x No
Greece  92 159 x No
Spain  421 590 x No
France  761 880 x x x x No*
Croatia  37 428 x x Yes
Italy  486 557 x x x x x Yes
Cyprus  9425 x x Yes
Latvia  21 826 x x Yes
Lithuania  31 601 x x Yes
Luxembourg  6862 x x Yes
Hungary  92 206 x Yes
Malta  4453 x x x No
Netherlands  169 234 x x x Yes
Austria  83 884 x x x Yes
Poland (2014)  376 968 x x No
Portugal  86 048 x x No
Romania  201 760 x x Yes
Slovenia  20 336 x x No
Slovakia  55 824 x No
Finland  55 759 x x Yes
Sweden (2014) 115 710 x x x x Yes
United Kingdom x Yes
UK: England 
and Wales
698 970 x Yes
UK: England 645 244 x x Yes
UK: Wales 32 338 x x Yes
UK: Scotland  54 513 x x Yes
UK: Northern 
Ireland
 24 544 x x Yes
Iceland  4098 x x Yes
Norway  59 928 x x Yes
Switzerland 
(2014)
 85 206 x x Yes
Note:  *Linkage was used for enhanced maternal mortality data in France, but the other data are not linked. 
 Figure 2.1 Data availability for core and two recommended Euro-Peristat indicators in 2015 
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Figure 2.1  Data availability for core and two recommended Euro-Peristat indicators in 2015
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3
CHARACTERISTICS OF 
CHILDBEARING WOMEN
3.  CHARACTERISTICS OF CHILDBEARING WOMEN
CORE
Multiple birth rate by number of fetuses (C7) 
Distribution of maternal age (C8) 
Distribution of parity (C9)
RECOMMENDED 
Percentage of women who smoke during pregnancy (R8) 
Distribution of maternal prepregnancy body mass index (R12)
RECOMMENDED INDICATORS NOT INCLUDED IN THIS REPORT
Distribution of mothers’ educational level (R9)
Distribution of parents’ occupational classification (R10) 
Distribution of mothers’ country of birth (R11)
The demographic and social characteristics of childbearing women are related to a wide range 
of pregnancy outcomes, including mode of delivery and maternal and neonatal mortality and 
morbidity. Interpreting variations in indicators of obstetric and neonatal care and outcomes 
between countries requires information about the characteristics of the population of pregnant 
women. 
Euro-Peristat selected three core indicators, considered essential for describing the childbearing 
population – women with multiple pregnancies, maternal age, and parity – as well as five 
recommended indicators. Although this report focuses on the core indicators, we also present 
data on two of the recommended indicators – smoking and maternal prepregnancy BMI. The 
other three recommended indicators – mother’s educational level, parental occupational status, 
and mother’s country of birth – will be published later.  
In the following section we introduce each indicator and describe the rationale for the choice 
and its impact on perinatal outcomes. The three recommended indicators that are not presented 
provide important information on the social context, which affects perinatal outcomes within 
countries and therefore provides a measure of social inequalities in health. Euro-Peristat has 
shown with data from 2010 that stillbirth rates throughout Europe are higher among women 
with lower educational or occupational levels (see section on stillbirth, C1). 
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C7  MULTIPLE BIRTHS BY NUMBER OF FETUSES 
JUSTIFICATION 
Compared with singletons, babies from multiple pregnancies have much higher rates of stillbirth, 
neonatal mortality, infant mortality, preterm birth, low birth weight, congenital anomalies, and 
long-term health and developmental problems associated with complications of the perinatal 
period.  Rates of multiple birth vary between countries and over time. They are influenced by 
differences in the proportions of older women giving birth (see C8), because the probability of a 
multiple pregnancy increases with age. Older women also experience more subfertility and are 
more likely to use ART. The extent of use of ovarian stimulation and assisted conception and the 
policies for preventing multiple pregnancies with ART are therefore also major determinants 
of rates of multiple pregnancy in the population. Use of subfertility procedures is rising across 
Europe	and	policies	related	to	their	use	differ	from	country	to	country;4 for instance, elective 
single embryo transfer (eSET) has been extensively promoted in several countries, including 
Belgium, the Czech Republic, Sweden, Finland, and Austria, and recent studies comparing the use 
of eSET between countries show its impact on the incidence of multiple pregnancies.5 
DEFINITION AND PRESENTATION OF INDICATOR 
Figure 7.1 shows the rates of twin and triplet and higher-order births, expressed as numbers of 
women with twin and with triplet or higher-order births per 1000 women giving birth to one or 
more fetuses.
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES 
All countries provided data for this indicator. Greece, Hungary, and Romania provided data by 
births and not by pregnant women, so we estimated the rates of multiple maternities from 
birth data (by dividing by 2 for twins and 3 for triplets). Data came primarily from medical birth 
registers and perinatal databases as well as from civil registration systems. Most countries had no 
missing data or a very minimal number of women with missing data.  
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR 
The pregnancies included in civil registration systems depend on the laws governing the births 
requiring registration. These affect the extent to which multiple births in which one or more 
babies die before birth or registration are included. In addition, multiple births are rare events. In 
small populations such as those of Cyprus, Iceland, Luxembourg, and Malta, year-to-year random 
variations will be greater and confidence intervals around the rates wide. In comparing these 
data with other data sources, it is important to note that the multiple birth rate is sometimes 
presented with births as the denominator (rather than pregnant women, as in the Euro-Peristat 
definition). 
RESULTS 
Multiple birth rates varied from below 15 per 1000 women with live births or stillbirths in 
Romania, Slovakia, Poland, Greece, Finland, Lithuania, Scotland, Northern Ireland, and the Czech 
Republic to more than 20 per 1000 in Cyprus (27/1000) and Spain (22/1000) in 2015, as shown 
in Figure C7.1, which also provides the number of women in each country with information on 
this indicator. For triplets and more, Cyprus had the highest rate (0.9/1000) in 2015, and Greece, 
Estonia, Slovakia, the Czech Republic, Latvia, and Finland the lowest rates (around 0.1/1000). The 
median twin rate was 16.4/1000 with an interquartile range (IQR) between 14.5 and 17.4, and the 
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triplet rate was 0.2 per 1000 with an IQR of 0.2 to 0.3. Median rates were similar for 2010, 16.4 
per 1000 and 0.3 per 1000, respectively, but changes over time differed. Figure C7.3 presents risk 
ratios	between	the	two	years	with	95%	confidence	intervals	for	twin	pregnancy	rates;	significant	
decreases of 10% or more in twinning rates were observed in Austria, Slovakia, Finland, 
Denmark, and the Czech Republic. Increases of 10% or more were observed in Ireland, Romania, 
Portugal, and Latvia. The heterogeneity between countries in rates between the two periods was 
statistically significant.  
KEY POINTS 
•	 Perinatal	complications	associated	with	multiple	births	impose	considerable	costs	on	health	
services, families, and societies. Accordingly, the high rates due to either delayed childbearing 
or subfertility management raise questions about the need for policies to encourage earlier 
childbearing and to prevent multiple pregnancies in assisted conception. 
•	 The	decrease	in	twinning	rates	in	some	countries	may	be	the	result	of	policies	to	reduce	the	
risks	of	multiple	births	for	women	undergoing	subfertility	procedures;	more	knowledge	about	
how these policies are contributing to the changes in the multiple birth rate would be useful 
for health professionals and policy makers. 
•	 In	the	absence	of	data	about	ovarian	stimulation	and	assisted	conception,	age-specific	
multiple birth rates can provide an indication of the extent of their use.
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Figure C7.1  Multiple birth rates per 1000 women with live births or stillbirths by number of  
  fetuses in 2015
 
NOTE: Numbers in parentheses are number of women for whom there were data about multiple pregnancy (all stated). 
* Estimated from data on babies. 
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Figure C7.2  Twin birth rates per 1000 women in 2010 and 2015  
NOTES: Countries sorted by rate difference between 2010 and 2015.
 First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Hungary 2012, Poland 2014, Sweden 2014, Switzerland 2014.
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Figure C7.3  Comparison of twin pregnancy rates, 2010 and 2015 (risk ratios and 95%   
  confidence intervals)
 
NOTE:  Overall random effects estimate: 0.99 (95% CI: 0.95, 1.03). 
 I2=92.6% Chi squared tests of heterogeneity: 378.65 (d.f. = 28), p <.001.
 First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Hungary 2012, Poland 2014, Sweden 2014, and Switzerland 2014.
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C8 MATERNAL AGE AT DELIVERY
JUSTIFICATION
Both early and late childbearing are associated with higher than average rates of preterm birth, 
growth restriction, and perinatal mortality.1-4 Younger mothers are more likely to have low social 
status, unwanted or hidden pregnancies, inadequate antenatal care, and poor nutrition. Older 
mothers have a higher risk of multiple births, as described in indicator C7, of some congenital 
anomalies, and of pregnancy complications, including hypertension and diabetes. Maternal 
morbidity and mortality are highest among the youngest and oldest women. Older mothers have 
caesarean deliveries more often. The risks of younger age are mainly observed among very young 
mothers.4 For older mothers, risks rise more acutely after age 40.5
Because of the association between maternal age and perinatal health outcomes and because 
the age at which women in European countries bear children differs widely, the maternal age 
distribution should be taken into account in comparisons between countries. Furthermore, 
mothers are increasingly having children later in life throughout Europe, and this could affect 
trends in perinatal health indicators. 
Policy issues include integrating into prenatal care services that address the specific needs of older 
pregnant women and providing information about the risks associated with early and delayed 
childbearing. Younger mothers may be exposed to less favourable social conditions, which have 
long-term consequences for themselves and their children. The prevention of teenage pregnancy 
is a policy concern in some countries of Europe, but many others have already attained very 
low rates.6 The challenges of managing later childbearing are widely shared across European 
countries. 
DEFINITION AND PRESENTATION OF INDICATOR
This indicator is defined as the distribution of age in years at delivery for women delivering a live 
born or stillborn baby. The recommended presentation is: 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 
40-44, and 45 and older. This summary presentation focuses on the extremes of the childbearing 
distribution, defined as younger than 20 years and 35 years and older.
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THIS 
INDICATOR
Some civil registration systems record the age the mother reaches during the year of birth and 
not her age at delivery. In some situations, age may be recorded during antenatal visits but not 
updated at delivery. These data are presented in relation to total births in the Czech Republic and 
Greece and to live births in Hungary and Romania, rather than to women, as recommended by 
Euro-Peristat. The differences between these two numbers are due to multiple births, which are 
a relatively small proportion of total births even among women aged 35 or more, so this is not a 
major problem.
Data in France come from hospital statistics in 2015 and also from a representative survey in 2016, 
to enable a comparison with data provided in 2010, which came from the 2010 version of the 
same survey. 
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES
All countries were able to provide this indicator. Data correspond to births in 2014 in Bulgaria, 
Poland, Sweden, and Switzerland and in 2016 in France for the comparison with 2010.
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RESULTS
The percentage of mothers aged younger than 20 varied from 0.8% in Switzerland to 10.2% in 
Bulgaria. This percentage was 9.7 in Romania, 6.3 in Hungary and Slovakia, and under 4 in the 
other countries (Figure C8.1). The median percentage was 2.1% with an IQR of 1.4% to 3.5%. The 
percentage of older mothers, defined as women giving birth at 35 years or older, ranged from 
about 14% in Bulgaria, Poland, and Romania to 36.3% in Italy and 37.3% in Spain. The median 
for all countries was 20.8, with an IQR of 18.8 to 22.8. The group of women aged between 25 
and 34 years, at the lowest perinatal risk, is proportionally small (53% to 55%) in Bulgaria and 
Hungary because of the high proportion of women under 25, and in Ireland, Spain, and Italy 
because of the high proportion of births to women aged 35 or more.
Figures C8.2 and C8.3 provide a geographical representation of the distribution of maternal age 
at childbirth in participating countries based on the percentages of younger and older mothers. 
These figures show clustering of countries in eastern Europe, where women are having children 
at earlier ages, as well as higher proportions of older mothers in southern Europe. 
Having children later in life is a general trend in Europe (Figure C8.4). Only four countries 
(Estonia, Germany, the Netherlands, and Sweden) experienced a decrease between 2010 and 2015 
in the percentage of women aged 35 years or more, and the absolute decrease was less than 1%. 
The increase was large with an absolute increase of about 8% in Portugal and Spain. This change 
is more pronounced when seen as a relative change, as in Figure C8.5, which presents risk ratios 
between the two years with 95% confidence intervals. The pooled measure of change for all the 
countries participating in Euro-Peristat is 1.16 (1.11-1.20), with highly significant heterogeneity.
KEY POINTS
•	 In	more	than	60%	of	the	countries	in	Euro-Peristat,	births	to	teenage	mothers	account	for	less	
than 3% of all deliveries. 
•	 The	proportion	of	women	bearing	children	later	in	life	varies	substantially	but	in	over	60%	
of countries, at least one in every five births was to a women aged 35 years or older, and 
the percentage of births to women in this age group increased substantially in almost every 
country.  
•	 Policies	should	be	developed	to	inform	young	women	of	the	consequences	of	having	children	
later in life so that they can make informed choices about when to have their children.
•	 Encouraging	earlier	childbearing	may	also	require	policies	to	support	young	parents	and	
working mothers. Health services in countries with a higher percentage of women having 
babies at older ages need to make sure their health needs are met during pregnancy.
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Figure C8.1  Age distributions of women delivering live births or stillbirths in 2015
  
NOTE: In parentheses: the number of women with data for age at delivery. 
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Figure C8.2  Mothers aged <20 years as a percentage of all pregnancies with  known maternal  
  age in 2015
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Figure C8.3  Mothers aged ≥ 35 years as a percentage of all pregnancies with known maternal  
  age in 2015
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Figure C8.4  Percentage of mothers  aged ≥ 35 years in 2010 and differences between 2010  
  and 2015 
NOTES: First-period data not from 2010: Greece 2009, Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014. 
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Figure C8.5  Comparison of the percentages of mothers aged ≥ 35 years, 2010 and 2015  
  (risk ratios and 95% confidence intervals)
 
NOTE:  Pooled random effects estimate: 1.16 (95% CI: 1.11-1.20). 
 I2=99.6% Chi squared tests of heterogeneity: 7611.48 (d.f. = 30), p < 0.001.
 First-period data not from 2010: Greece 2009, Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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C9 DISTRIBUTION OF PARITY
JUSTIFICATION
Parity refers to a women’s number of previous births. Women with no previous births and 
giving birth for the first time are described here as primiparous and women with one or more 
previous births as multiparous. Compared with multiparous women, primiparous women have 
a higher incidence of some pregnancy complications and conditions, such as hypertension and 
preeclampsia, as well as higher than normal risks of adverse outcomes, such as low birth weight, 
fetal growth restriction, preterm birth, and stillbirth.1,2  Primiparity is also associated with a greater 
use of health services during pregnancy and with health behaviour, including greater adherence 
to recommendations about folic acid supplementation, smoking cessation, and attendance for 
antenatal care.3-5 Use of obstetric interventions differs as well. Primiparous women have higher 
rates of caesarean births than multiparous women, although the magnitude of this difference 
differs between countries (see C10).6 Caesarean delivery in the first pregnancy has a major impact 
on the risk of caesareans in subsequent pregnancies, with caesarean rates for multiparous women 
with a uterine scar ranging from 40% to 94% in Euro-Peristat countries in 2010.6 Similar trends 
appear for 2015 (see C10). Grand multiparae, defined as women with 4 or 5 previous births, may 
also face greater risks of poor pregnancy outcome, although this has not been observed in all 
studies.2,7
Fertility patterns influence the distribution of parity, and countries with lower fertility rates 
will have higher proportions of primiparous women. Parity should therefore be considered in 
comparing health outcomes between low and high fertility countries or across time when fertility 
is changing, for it may mean higher overall rates of adverse outcomes in populations where 
fertility is lower. 
DEFINITION AND PRESENTATION OF INDICATOR
Parity is defined as the number of previous total live births and stillbirths (0, 1, 2, or 3+ births) for 
women having a live birth or a stillbirth. 
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES
Most countries were able to provide data on parity. Greece, Hungary, Romania, and Bulgaria 
provided data on parity at the level of the child (number of births) rather than the mother. Spain 
could provide the proportions of primiparous and multiparous women, but did not have details 
about the number of previous births for multiparous women. Most countries had low proportions 
of missing data. 
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR
There are differences in the definition of parity related to the way in which previous multiple 
births are counted.8 In obstetrics, previous births most often refer to the number of pregnancies,9 
meaning that twins would be counted as one birth whereas demographers and some health 
databases tend to refer to number of babies, ie, twins are counted as two births.10 When 
extracting data from routine sources it is usually not possible to distinguish which of these 
definitions are used, and there is confusion among clinicians about how to measure parity.8 Data 
from Finland, where it is possible to compute this indicator based on both definitions, however, 
show that the difference in definition does not have a large impact on the distribution of this 
indicator (Table C9.1). When the number of births is used, there are slightly more high-parity 
women. 
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Other issues are related to the omission of stillbirths, as many civil registration systems do not 
count	previous	stillbirths	as	a	birth	in	the	computation	of	parity	(for	instance,	Switzerland);	
similarly, there are different gestational age cutoffs for defining what constitutes a birth. This may 
differ between countries, for instance, starting at 20 weeks, 22 weeks, or 24 weeks. Nonetheless, 
these births are infrequent and unlikely to have a large impact.
RESULTS
The percentages of women giving birth for the first time ranged from lows of 38%-39% in 
Ireland, Northern Ireland, and England and Wales to over 50% in Bulgaria, Italy, Portugal, Spain, 
Malta, and Romania, as shown in Figure C9.1. The median in participating European countries 
was 47.6%. Fewer than 3% of women had three or more previous births in Italy, Portugal, 
Slovenia, or Switzerland, compared with 9% or more in Ireland, Slovakia, Finland, and the UK 
(England, Wales, and Northern Ireland). The percentage of women with four or more previous 
births ranged from less than 1% to over 4% in Slovakia, Finland, and Romania (see Table C9 in  
Appendix B).  
Figure C9.2 displays the percentages of primiparous women in 2010 and their differences in 2010 
and 2015. For most countries, there was a slight decrease or no change. In Latvia, Scotland, the 
Netherlands, Ireland, Sweden, and Northern Ireland, however, the percentage of primiparous 
mothers decreased by 3 percentage points. Absolute increases of close to 2 percentage points 
were seen in Slovakia and Denmark. Figure C9.3, which presents risk ratios between the two 
years with 95% confidence intervals, illustrates the larger number of countries experiencing slight 
decreases. The pooled measure of change across all the countries in Europe is 0.98 (0.97-0.99), 
with highly significant heterogeneity.
KEY POINTS
•	 As	fertility	is	relatively	low	in	Europe,	more	attention	is	paid	to	women	giving	birth	for	the	
first time and the risks associated with it than to women with several previous births.
•	 The	percentage	of	primiparous	women	ranges	from	about	38%	to	54%	in	participating	
countries, and this may affect perinatal indicators, given the higher risks, on average, 
experienced by women in their first pregnancy. 
•	 Since	2010,	the	percentage	of	primiparous	women	among	all	childbearing	women	has	
decreased slightly or stayed stable in most countries. 
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Table C9.1:  Differences in distribution of parity when calculated based on previous deliveries  
  or previous births in Finland in 2015
Previous deliveries (pregnancies) Previous births (babies)
N % N %
0 22 856 41.6 22 856 41.6
1 18 885 34.3 18 746 34.1
2 7921 14.4 7839 14.3
3 2684 4.9 2627  4.8
4 or more 2661 4.8 2939  5.3
Source: National Institute for Health and Welfare, Medical Birth Register 2015. Data on previous deliveries are based on mothers’ self-report, verified from the Medical Birth     
 Register. Data on previous births come from the Medical Birth Register 1987-2015, which takes live births and stillbirths in multiple pregnancies into account.
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Figure C9.1  Distribution of parity in 2015
 
Notes:  * Based on babies not mothers.
 ** Based on live births only. 
 *** Can only identify primiparous vs. multiparous 
 (numbers in parentheses: women with live births and stillbirths)
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Figure C9.2  Differences between the percentages of primiparous mothers in 2010 and 2015
 
NOTE: Countries sorted by rate difference between 2010 and 2015.
First-period data not from 2010: Cyprus 2007.
Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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Figure C9.3  Comparison between the percentages of primiparous women, 2010 and 2015 (risk  
  ratios with 95% confidence intervals)
 
NOTE: Pooled random effects estimate: 0.98 (95% CI: 0.97-0.99). 
 I2=98.2% Chi squared tests of heterogeneity: 1556.24 (d.f. = 28), p < 0.001.
 First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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R8 SMOKING DURING PREGNANCY 
JUSTIFICATION
Maternal smoking is one of the most important preventable factors associated with adverse 
pregnancy outcome. Maternal smoking during pregnancy impairs normal fetal growth and 
development and is associated with low birth weight, fetal growth restriction, stillbirth, preterm 
birth, and some congenital anomalies.1-3 Moreover, its influence on outcomes is not limited only 
to	the	perinatal	period;	increasing	evidence	suggests	it	also	has	lifelong	consequences	for	the	
child, with elevated risks of childhood obesity, neurobehavioural and cognitive deficits, and 
impaired lung function, including wheezing and asthma.4-7
Smoking among pregnant women has declined in high-income countries, but it nonetheless 
continues to account for a substantial proportion of fetal and infant morbidity and mortality. 
Smoking before pregnancy and the likelihood of stopping smoking are associated with lower 
maternal educational level and poverty. Smoking thus contributes to the creation of social 
inequalities in perinatal health.8,9
Public health interventions exist to reduce smoking and to tackle social inequalities in tobacco 
use.10 A preventive population approach is important to reduce the prevalence of smoking before 
pregnancy in the childbearing population. Furthermore, smoking cessation interventions have 
been shown to be effective in improving pregnancy outcomes11 and can serve as an indicator of 
the quality of antenatal preventive healthcare services.
DEFINITION AND PRESENTATION OF INDICATOR
Smoking during pregnancy is defined as the proportion of women who smoked during pregnancy 
among those with live born or stillborn babies. When possible, data were collected for two time 
periods: an earlier (ideally, first trimester) and a later (ideally, third trimester) phase.  
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES
The data were provided by 19 of 31 countries. Some countries, including France and the 
Netherlands, provided data based on routine surveys. It is striking, however, that this important 
indicator of perinatal health as well as of the effectiveness of preventive public health policies is 
not available in many countries.  
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR
To be able to compare countries or regions or to evaluate time trends, a common time frame 
is essential. This is important because many women stop smoking during pregnancy. If a single 
measure is the most practical option, it should relate to the last trimester of pregnancy so that the 
length and timing of exposure can be taken into account. Many data sources include information 
on smoking in pregnancy, but without further clarification.
Differences in the type of data (antenatal care records, medical records in maternity units, and 
birth surveys including interviews with mothers before and after birth), as well as the questions 
asked are additional sources of potential bias. Accordingly, the quality of the information is 
variable. Some data sources may record a woman as a non-smoker if smoking is not recorded in 
medical records. The rate of missing data ranges from 0% (the Czech Republic, Latvia, Lithuania, 
Malta, and Slovenia) to 17% in Croatia, 19% in England, 25% in Austria, and 29% in Germany. 
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Finally, there is evidence that some women may under-report smoking, as they know that they 
should not be smoking during pregnancy. Misclassification and inaccurate estimates of smoking 
may thus result. Many of the data providers expressed reservations about the quality of these 
data because they were based on self-report, and missing data were not well recorded. Euro-
Peristat does not collect information on amount smoked, so these data cover both women who 
smoked daily and those who smoked occasionally. 
RESULTS
Table R8.1 presents information on the time periods covered by the data and the proportions of 
smokers during both periods. Eight countries provided information during pregnancy without 
clearly specifying the time period, 11 countries provided data for two periods (either before and 
during pregnancy or during the first and the second or third trimesters), 2 countries provided 
information on smoking prevalence early in pregnancy only. The prevalence of smoking in 
the second period (during pregnancy or in the last trimester) was between 5 and 8% in most 
countries providing data, but Norway, Sweden, and Lithuania reported prevalence rates below 
5%, while more than 10% of pregnant women smoked in Valencia (18.3%), France (16.3%), 
Catalonia (13.0%), Austria (12.5%), the UK (between 12 and 17%), and Luxembourg (10.7%). 
When prevalence was available for two periods, the percentage of smokers was always lower 
closer to delivery.
Overall, in countries that provided data for 2010 and 2015, there were lower proportions of 
smokers during pregnancy in 2015, but in a few countries, prevalence was stable or rose slightly. 
Reductions of more than two percentage points were observed in Denmark, Estonia, Germany, 
Cyprus, Latvia, Luxembourg, Finland, and Norway. In Scotland, the data in 2015 relate to smoking 
at booking, whereas in 2010, the period was an unspecified moment during pregnancy. The 
pooled measure of change between 2010 and 2015 for all countries reflects the predominance 
of countries reporting decreases in smoking: 0.87 (95% confidence intervals: 0.79-0.95), but 
heterogeneity was highly significant.
KEY POINTS
•	 Not	all	countries	could	provide	data	on	maternal	smoking	during	pregnancy,	and	standardised	
collection procedures are necessary to improve comparability for those countries that did. 
•	 In	some	European	countries,	more	than	10%	of	women	smoke	during	their	pregnancy.	
•	 Declines	in	maternal	smoking	during	pregnancy	were	observed	when	recent	data	were	
compared	with	2010,	although	there	were	differences	in	the	magnitude	of	the	decrease;	
policies should be reviewed in countries where smoking prevalence is high with only slight 
decreases.  
•	 Given	the	adverse	effects	of	smoking	on	fetal	and	infant	health	and	since	pregnancy	care	
is considered an ideal setting for intervention, obtaining high quality and comparable 
information on smoking before and during pregnancy should be a priority.
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Table R8.1.  Percentages of women who smoked during pregnancy in 2010 and comparisons  
  with 2015
NOTE: *N/A available in 2010, but no longer available in 2015. 
 ** Data for England, Wales and Northern Ireland in 2010 came from the Infant Feeding Survey. This was not done in 2015, so the data source in all three countries has 
changed.
 Second-period data not from 2015: Spain Valencia 2016, France Survey 2016, Croatia 2016, Italy 2013, UK England 2015-2016, UK Wales 2016, Sweden 2014.
  
Time period Smokers in 2015 Smokers in 2010 Time period
Country/
coverage
Period 1 Period 2 Period 1
%
Period 2
%
Latest period
%
Latest period
Belgium
Bulgaria
Czech Republic During pregnancy 7.2 6.2 during
Denmark 1st trimester 2nd trimester 11.0 7.5 12.8 during
Germany During pregnancy 9.0 10.7 during
Estonia 1st trimester During pregnancy 7.6 6.1 7.8 during
Ireland
Greece
Spain: Catalonia Before pregnancy 3rd trimester 22.8 13.0 14.4 3rd trimester
Spain: Valencia End of pregnancy 18.3 15.8 1st trimester
France Before pregnancy 3rd trimester 29.8 16.3 17.1 3rd trimester
Croatia During pregnancy 8.1
Italy Before pregnancy During pregnancy 20.5 5.3
Cyprus During pregnancy 6.3 11.5 1st trimester
Latvia During pregnancy 7.9 10.4 during
Lithuania Before pregnancy During pregnancy 8.0 4.4 4.5 during
Luxembourg 1st trimester 3rd trimester 13.3 10.7 12.5 3rd trimester
Hungary
Malta At booking 7.7 8.2 1st trimester
Netherlands During pregnancy 6.0 6.2 after 1st trimester
Austria 3rd trimester 12.5
Poland N/A* 12.3 3rd trimester
Portugal
Romania
Slovenia During pregnancy 9.5 11.0 during
Slovakia
Finland 1st trimester After 1st trimester 14.7 7.5 10.0 after 1st trimester
Sweden 1st trimester 3rd trimester 5.1 3.8 4.9 3rd trimester
United Kingdom N/A 12.0 during
UK: England * At booking Delivery 14.2 12.3 12.0 during
UK: Wales* 3rd trimester 17.3 16.0 during
UK: Scotland At booking 16.4 19.0 during
UK: Northern 
Ireland*
During pregnancy 14.3 15.0 during
Iceland
Norway First visit End of pregnancy 5.5 3.6 7.4 3rd trimester
Switzerland
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2015 
Percentage of women delivering a live birth or a stillbirth
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Figure R8.1.  Smoking during pregnancy in 2010 and and 2015
NOTE:  * First trimester or at booking in 2010 and during pregnancy in 2015. 
 ** At booking in 2015, during pregnancy in 2010. 
 Second-period data not from 2015: Spain Valencia 2016, France Survey 2016, UK England 2015-2016, UK Wales 2016, Sweden 2014.
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Figure R8.2.  Comparison of smoking during pregnancy, 2010 and 2015 (risk ratios and 95%  
  confidence intervals)
 
NOTE:  Cyprus and Scotland not included because smoking was not recorded at the same period in both years. 
 Pooled random effects estimate: 0.87 (95% CI: 0.79-0.95). 
 I2=99.0% Chi squared tests of heterogeneity: 1852.89 (d.f. = 18), p <0.001.
 Second-period data not from 2015: Spain Valencia 2016, France Survey 2016, UK England 2015-2016, UK Wales 2016, Sweden 2014.
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R12 DISTRIBUTION OF MATERNAL PREPREGNANCY BODY MASS INDEX 
JUSTIFICATION
Promoting a healthy weight before pregnancy is one way to improve maternal and newborn 
health. Compared to women with normal weight before pregnancy, those who are overweight or 
obese, as well as those who are underweight, are at higher risk of adverse pregnancy outcomes. 
The rising prevalence of overweight and obesity worldwide has important implications for 
pregnancy and childbirth. Prepregnancy overweight and obesity both increase the risks of 
pregnancy complications, such as gestational diabetes and preeclampsia. Perinatal and infant 
outcomes are less favourable, including higher rates of congenital anomalies, in particular, neural 
tube and congenital heart anomalies, stillbirth, fetal growth restriction, early preterm birth 
before 32 weeks of gestation, and macrosomia.1-4 These risks explain in part why overweight and 
obese women are more likely to deliver by caesarean, but less effective uterine contractions also 
play a role.5,6 Overweight and obesity affect maternal outcomes, and these women have higher 
rates of severe maternal morbidity and maternal death.2 All these risks increase with the level 
of obesity. Research also suggests that obesity may affect the longer-term health of the child 
through fetal programming in utero, changes in the newborn’s body composition, epigenetic 
processes, and changes in the gut microbiome.7 Potential longer term health and developmental 
consequences include childhood and adult obesity, the metabolic illnesses associated with obesity, 
asthma, and neurodevelopmental delay.4,7 
While much of the current focus of public health policy and practice is on overweight and obesity, 
being underweight also increases the risks of having a preterm or a low birthweight baby.8 Both 
underweight and overweight are associated with lower socioeconomic status and thus create 
inequalities in health starting at birth.9
DEFINITION AND PRESENTATION OF INDICATOR
This indicator is defined as the percentage of women delivering live births or stillbirths by their 
prepregnancy body mass index (BMI) defined in accordance with WHO guidelines as follows: 
<18.5 (underweight), 18.5-24.9 (normal), ≥25.0 (overweight and obese).10 Obese women can be 
subdivided as obese class I (BMI 30.0-34.9), obese class II (BMI 35.0-39.9), and obese class III (BMI 
≥40.0).
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES
This indicator has limited availability in routine sources in Europe. It was provided by 12 of 31 
countries. Poland was able to provide this indicator in 2010, but not in 2015. 
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR
In most countries for which data are available, prepregnancy BMI is recorded at the first antenatal 
visit, which may slightly overestimate the mother’s BMI before pregnancy. Weights recalled by 
women themselves, as for instance in France, tend to be slightly under-reported.11 Some countries 
had high proportions of missing data for this indicator, with ranges from 0 to 20% or more 
(Malta, England, and Norway). In general, BMI was missing for around 10% of women.  
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RESULTS 
Figure R12.1 shows that women with a low prepregnancy BMI accounted for 2.4 to 7.4% of 
mothers giving birth in countries for which data were available, with highs in France (7.4%) and 
Austria (6.4%) and lows in the UK, Malta, and Sweden (<3.0%). The proportion of overweight or 
obese women ranged from around 30% to 50% of all women, with prevalence less than 30% in 
Croatia, Austria and Slovenia and around 50% in the UK. Between 8 and 26% of all women were 
obese. 
In comparison with the 2010 data in the last Euro-Peristat report, the proportions of obese 
women in 2015 increased slightly in most countries that provided data at both time points, 
as shown in Figure R12.2. The exceptions are Denmark, where the prevalence was stable, and 
Norway, where it decreased slightly. In interpreting data from Norway, it should be noted that 
BMI was recently added and proportions of missing data were high in both 2010 and 2015. 
Figure R12.3 shows risk ratios with 95% confidence intervals for the change in the prevalence 
of obesity among pregnant women between 2010 and 2015. The pooled risk ratio was positive 
and significant – 1.15 (95% confidence intervals: 1.08-1.22) with significant heterogeneity across 
countries. 
KEY POINTS
•	 Maternal	weight	before	and	during	pregnancy	affects	the	course	of	pregnancy,	its	outcome,	
and the offspring’s lifelong health. 
•	 Despite	its	importance	for	describing	the	risks	facing	childbearing	women,	this	indicator	is	not	
available in most European countries. 
•	 There	is	a	high	variation	in	the	distribution	of	prepregnancy	BMI,	but	in	most	countries	
reporting data, more than 10% of women were obese at the onset of pregnancy
•	 Adding	information	about	women’s	prepregnancy	BMI	to	routine	surveillance	systems	for	
maternal and newborn health should be a priority in countries where these data are not 
available. 
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Figure R12.1  Distribution of maternal prepregnancy body mass index 
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Figure R12.2  Percentages of women with a prepregnancy body mass index ≥ 30 in  2010 and 2015
NOTE:  Second-period data not from 2015: France Survey 2016.
Figure R12.3.  Comparison of the percentages of women with a prepregnancy body
  mass index ≥ 30, 2010 and 2015 (risk ratios and 95% confidence intervals)
NOTE:  Pooled random effects estimate: 1.15 (95% CI: 1.08-1.22). 
 I2=97.7% Chi squared tests of heterogeneity: 352.50 (d.f. = 8), p <0.001.
 Second-period data not from 2015: France Survey 2016.
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4.  MODE OF DELIVERY 
CORE
Mode of delivery according to parity, plurality, presentation, previous caesarean section, and 
gestational age (C10)
RECOMMENDED HEALTHCARE INDICATORS NOT INCLUDED IN THIS REPORT 
Percentage of all pregnancies following treatment for subfertility (R13) 
Distribution of timing of first antenatal visit (R14)
Distribution of births by mode of onset of labour (R15) 
Distribution of place of birth by volume of deliveries (R16)
Percentage of very preterm births delivered in units without a neonatal intensive care unit (R17)
Episiotomy rate (R18)
Percentage of births without obstetric intervention (R19) 
Percentage of infants breast fed at birth (R20)
The Euro-Peristat indicator list includes one core indicator of health care, which is mode of 
delivery, as well as eight other recommended indicators, as shown above. Only mode of delivery is 
included in this report on core indicators. 
Pregnancy is not an illness, but a physiological process associated with health risks for some 
women and babies. When all pregnant women have access to comprehensive antenatal care 
and deliveries are attended by clinically qualified staff, as is the case in European countries, most 
women and newborns will not experience complications. A major concern in these and similar 
countries is to guarantee an adequate level of clinical safety for this group while avoiding over-
medicalisation of the pregnancy and, in particular, procedures with side effects. 
The development of systematic reviews and the promotion of the concept of evidence-based 
health care in the field of maternity care began in the late 1980s. The tradition of evaluating 
clinical practices and working to find a balance between insufficient or excessive intervention 
might have been expected to lead to similarities between the patterns of maternity care. In 
Europe, however, Euro-Peristat and many other European projects have documented wide 
diversity in approaches to providing care during pregnancy, childbirth, and the postpartum 
period. Mode of delivery provides a clear-cut example of these differences. By collecting this 
indicator by subgroups defined by their levels of risk, as recommended by Euro-Peristat, it is 
possible to show that differences in the childbearing population are not major drivers of these 
differences.  
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C10 MODE OF DELIVERY
JUSTIFICATION
Caesarean delivery can be a lifesaving procedure for both mother and child. Ability to provide 
access to timely caesarean delivery in emergency situations is a key quality indicator for 
maternity care services.1 However, in the absence of maternal and fetal complications, vaginal 
delivery is associated with less maternal morbidity and is at least as safe as caesarean delivery 
for the newborn.2,3 It is also the preferred option for a very substantial majority of pregnant 
women. Furthermore, caesarean delivery increases the risks of some pregnancy complications in 
subsequent pregnancies, including placenta accreta, placenta praevia, placental abruption, and 
stillbirth.4 There is also a growing body of research showing that caesarean delivery is associated 
with elevated risks of asthma and obesity for the child.4 The large rise in the caesarean rate since 
the 1970s is therefore a long-standing and continuing cause for concern.5-7 
In 1985, a World Health Organization conference concluded that the caesarean delivery rate 
should be no more than 10-15%.8 Recently, WHO updated this statement to recommend that 
“Every effort should be made to provide caesarean sections to women in need, rather than 
striving to achieve a specific rate.” Nonetheless, after a review of the literature on country-level 
associations between caesarean rates and perinatal mortality, the WHO expert group continued 
to support the previous statement that increases in the caesarean delivery rate over the threshold 
of 9-16% do not appear to be related to better population health outcomes.9 However, they also 
conclude that further research on perinatal morbidity is needed. 
Caesarean rates vary widely in participating countries, from 15% to over 40%.10 Countries also 
vary in their use of operative vaginal delivery, either with forceps or vacuum extraction.10 The 
common objective of these other interventions is to facilitate labour with the aim of ensuring a 
natural delivery with mother and newborn in good health. However, while we might expect to 
find a trade-off between instrumental delivery and caesarean delivery, a Euro-Peristat analysis 
using data from 2010 did not find that countries with higher rates of instrumental deliveries had 
lower caesarean delivery rates.10
Variations in obstetric intervention rates are affected by the distribution of demographic and 
clinical characteristics among childbearing women, such as parity, older maternal age, multiple 
births, fetal presentation, and maternal obesity. They are also related to the health system and 
specific related factors, such as fear of litigation, financial incentives when payments are higher 
for caesarean delivery, women’s requests for caesarean delivery, and differences in clinical 
assessments of risks associated with continued pregnancy for some pregnancy complications.11-14 
To monitor practices for all countries, Euro-Peristat collects data not only for all deliveries, but 
also by subgroups defined by levels of risk. These subgroups make it possible to standardise 
comparisons between countries and to gain knowledge about practices in specific situations. For 
instance, it is useful to compare caesarean delivery rates among primiparous women because 
operative delivery, especially by caesarean section, increases the risk of operative delivery in 
subsequent pregnancies. Moreover, the complication rates of primiparous women are higher than 
those of women who have already given birth (see C9 on parity). Furthermore, there are on-going 
debates about the need for systematic caesarean delivery for breech presentations, multiple 
births, and women with a previous caesarean birth, and it is useful to highlight differences in 
practices by comparing rates of caesarean delivery among these subgroups. 
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Investigation by subgroup also helps to explain variations in the overall caesarean rate. The 
Robson 10-group classification, which takes these subgroups into consideration, has been 
recommended by WHO for the evaluation of caesarean rates at the hospital level.15,16 The Euro-
Peristat	project	collected	data	according	to	the	Robson	classification	for	the	first	time	in	2015;	
these data are in the process of validation and will be published at a later date. 
DEFINITION AND PRESENTATION OF INDICATOR
This indicator is defined as the percentage distribution of all births, live born and stillborn, by 
method of delivery for all women and then subdivided by parity, previous caesarean delivery, 
presentation, and plurality. Data were also requested for caesarean sections as a percentage of 
births at grouped weeks of gestational age.
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR
Countries differ in the ways that they classify caesarean deliveries. Some countries subdivide 
them according to whether they took place before or during labour. Others use the subdivision 
into elective caesarean sections, which include all those planned before the onset of labour 
and thus include a few that take place after labour has started, and emergency or unplanned 
caesareans. Sometimes, emergency caesarean sections may include those performed before the 
onset of labour in response to a clinical emergency. Rates in the Czech Republic, Portugal, Spain, 
and England were reported per woman. This may result in slight underestimates of operative 
deliveries, as multiple births to one woman are counted only once.
DATA SOURCES AND AVAILABILITY OF INDICATOR
Method of delivery was available everywhere except Greece. Data about whether caesarean 
sections took place before labour or were elective were not available for Bulgaria, Ireland, 
Poland, Portugal, or Hungary. In Spain, national data cover all public hospitals but only around 
60% of private hospitals. In Portugal, only the total caesarean rate was available from all 
hospitals. More detailed data were provided from public hospitals and used to describe caesarean 
rates by subgroup. No data were available on instrumental deliveries in Bulgaria, Poland, or 
Portugal. In France, we used the 2016 National Perinatal Survey, which includes all births over a 
one-week period and collects detailed information on caesareans. This data source was used for 
Euro-Peristat in 2010 and the comparison over periods is based on the survey data. These data are 
similar to those from hospital discharge data for France as a whole, provided in Appendix B. 
RESULTS
As shown in Figure C10.1, caesarean delivery rates varied widely throughout Europe, with a 
median of 27.0% and an IQR of 21.2% to 32.7%. Rates were 56.9% in Cyprus and above 40% in 
Bulgaria, Poland, and Romania. The median vaginal instrumental delivery rate was 7.2%, also 
with wide variation between countries: 15% or more in Spain, and Ireland versus below 3% in 
Romania, Lithuania, Croatia, Slovakia, Slovenia, Latvia, and the Czech Republic. Data from 2015 
showed that, as in 2010, instrumental delivery rates were not correlated with caesarean delivery 
rates.
Figure C10.2 shows caesareans subdivided into those initiated before labour (or planned) and 
those during labour (emergency). Prelabour caesarean delivery rates ranged from 3.6% to 40.5%, 
with a median of 11.3% for all of the countries that can provide this breakdown. For caesareans 
during labour, these figures are 8.7% to 43.3% with a median of 12.9%. Unfortunately, some 
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countries with high caesarean rates, including Bulgaria, Hungary, and Poland, are not able to 
provide this information.
Figure C10.3 maps overall caesarean delivery rates in Europe by dividing countries into six groups. 
This map shows that these rates are higher in the southeastern countries of Europe, with some 
exceptions. There is also a cluster of countries with low rates in the Nordic and Baltic regions. 
CHANGES FROM 2010 TO 2015
Countries experienced heterogeneous rate changes between 2010 and 2015, as shown in Figure 
C10.4, which presents the 2010 rates and their differences in 2015. The differences between 
these two periods do not seem to be related to the rates in 2010, as there were both increases 
and decreases in countries with high as well as low caesarean rates. Figure C10.5 displays these 
changes as relative risks and provides information on the confidence intervals around these 
estimates. Decreases range from 2 to 13% of 2010 rates, with the largest decreases observed 
for Lithuania, Latvia, Portugal, Estonia, and Italy. Countries with substantial increases include 
Hungary, Poland, and Romania, where caesarean delivery rates are among the highest in Europe. 
Caesarean rates also rose in Ireland and Scotland. The pooled measure of change across all the 
countries in Europe is 1.04 (95% confidence interval: 1.00-1.08), reflecting the larger number of 
countries	with	increased	rates;	however,	the	heterogeneity	in	changes	is	highly	significant.
CAESAREAN SECTION BY RISK GROUP 
Table 10.1 displays overall caesarean rates by parity (primiparous, multiparous), previous 
caesarean section (no, yes), multiplicity (singleton, multiple), and presentation (vertex, breech). 
For each group, the table reports the number of countries that can provide these data as well as 
their median, IQR, and minimum and maximum rates. The variation in each group is as wide as 
for the overall caesarean delivery rate. However, some of the countries with the highest caesarean 
rates, including Hungary, Bulgaria, Poland, and Romania, cannot provide data in these subgroups. 
For women giving birth for the first time, the median was 27.4% with an IQR of 22.2%-33.2% 
and a minimum and maximum of 18.3% and 57.1%. For women with a previous caesarean, the 
median was 73.9% (range: 44.6%-95.3%), with multiple pregnancies, 63.1% (range: 43.5%-
98.5%), and with breech presentations, 89.4% (range: 64.3%-100%). In general, countries had 
similar practice patterns tending towards lower or higher rates across all subgroups.  
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KEY POINTS 
•	 Mode	of	delivery	differs	markedly	throughout	Europe,	with	lower	levels	of	caesarean	births	
around 16% to 17% in most Nordic countries and the Netherlands, and higher caesarean rates 
in Cyprus, Romania, Bulgaria, Poland, and Hungary, around 40% or higher. Other countries 
with higher than average caesarean rates – around 35% – are Italy and Switzerland.  
•	 Use	of	instrumental	delivery	also	varies	widely	and	is	not	related	to	use	of	caesarean	delivery.	
•	 Marked	differences	are	also	observed	in	key	subgroups;	in	some	countries,	for	example,	
almost all deliveries for women with a fetus in a breech presentation are by caesarean, 
whereas elsewhere vaginal delivery is considered in these situations.
•	 Some	countries	with	high	caesarean	delivery	rates	cannot	produce	data	by	these	subgroups.	
As this information improves capacity to evaluate care and to compare practices across units 
and internationally, health information systems in these countries should be broadened to 
include these items.   
•	 These	differences	in	obstetric	interventions	across	Europe	raise	questions	about	their	impact	
on short-term, but also longer-term, maternal and child health. They also underscore the 
differences in approaches that the countries of Europe have taken to limiting obstetric 
interventions. 
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Figure C10.1  Percentages of births by mode of delivery in 2015
 
Note:  *In the Czech Republic, Spain, Portugal, and England, N corresponds to the number of mothers instead of babies. 
 ** Missing information: in Switzerland, 185 caesareans with unknown mode of onset are excluded and 3 in France (survey); in Scotland, 181 vaginal deliveries with an 
unknown mode of delivery (instrumental or not) are excluded. 
 *** Bulgaria, Hungary, Portugal, and Poland do not have data on vaginal instrumental deliveries. 
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Figure C10.2  Percentages of births by type of caesarean delivery in 2015
 
Note:  *In the Czech Republic, Spain, and England, N corresponds to the number of mothers instead of babies. ** Missing information: in Switzerland, 185 caesarean sections 
with unknown mode of onset are excluded, and 3 in France (survey); in Scotland, 181 vaginal deliveries with unknown mode of delivery (instrumental or not) are 
excluded. 
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Figure C10.3  Caesareans as a percentage of all births in 2015
 
 
n.s  sig.       %
39.1–56.9
32.3–39.0
27.7–32.2
21.7–27.6
18.4–21.6  
16.1–18.3 
Cae arean rate (%)
Iceland
Malta
Cyprus
77
Figure C10.4  Percentages of births by caesarean delivery in 2010 and differences with 2015
 
NOTE:  First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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Figure C10.5  Comparison of caesarean delivery rates, 2010 and 2015 (risk ratios and 95%   
  confidence intervals)
 
NOTE:  Pooled random effects estimate: 1.04 (95% CI: 1.00-1.08). 
 I2=99.7% Chi squared tests of heterogeneity: 9483.02 (d.f. = 30), p <0.001.
 First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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Table C10.1  Caesarean delivery rates by risk subgroup
Total 
births*
Percentage of total births
Caesarean section rates by subgroup
Country/
coverage
Data
Source
Primiparous Multiparous No 
previous 
caesarean
Previous 
caesarean
Singleton 
pregnancy
Multiple 
pregnancy
Vertex Breech
Belgium 1 121 185 22.5 20.5 15.6 68.4 20.0 58.5 17.0 89.7
Bulgaria
Czech Republic 2 107 618 28.0 24.4 20.6 74.9 25.3 80.4 NA 96.9
Denmark 1  57 847 22.2 21.1 18.9 66.8 20.2 63.1 18.3 88.6
Germany 1 728 496 34.5 30.1 26.5 71.5 30.5 75.2 NA NA
Estonia 1  13 961 21.3 18.2 14.6 61.7 18.0 62.7 17.0 89.4
Ireland 1 65 912 33.2 30.1 NA NA 29.9 66.8 NA NA
Greece  
Spain 1 385 478 30.4 22.7 NA NA 24.8 67.8 NA NA
France, Survey 
2016
1  13 301 23.2 18.0 15.3 59.1 19.0 54.3 16.9 74.8
Croatia 1 37 428 24.5 18.7 17.0 68.5 20.3 59.0 NA NA
Italy 9 480 217 35.5 35.4 26.1 88.6 33.7 87.5 32.2 96.3
Cyprus 1    9422 57.1 56.6 45.7 95.3 54.8 93.2 54.8 96.2
Latvia 1 21 826 22.2 21.9 14.4 87.7 20.9 58.0 19.6 73.2
Lithuania 1.2 29 019 22.5 21.2 15.5 76.4 20.8 57.4 19.7 84.5
Luxembourg 1    6861 35.1 30.4 5.4 78.0 30.8 82.7 28.2 96.0
Hungary  
Malta 1    4453 30.9 33.2 23.7 78.1 29.9 98.5 29.3 98.2
Netherlands 1 165 295 19.2 16.0 13.5 61.9 16.6 43.5 14.2 78.8
Austria 1  83 884 31.2 28.3 NA NA 28.1 79.8 25.8 93.6
Poland  
Portugal** 2  86 048 NA NA 22.1 68.4 26.9 64.0 23.8 93.0
Romania  
Slovenia 1   20 336 22.8 19.7 16.7 78.7 19.6 60.7 17.6 86.9
Slovakia 1   55 824 32.9 29.1 22.6 80.8 29.8 78.5 NA NA
Finland 1   55 759 20.8 13.2 12.9 44.6 15.4 49.5 14.0 64.3
Sweden 1  115 710 20.4 16.7 10.2 69.3 17.1 59.0 15.4 88.6
United Kingdom          
UK: England 2  632 784 28.1 26.6 24.2 72.8 26.4 69.4 23.5 88.0
UK: Wales 1   32 128 27.4 25.5 21.2 77.4 25.0 63.1 23.8 87.5
UK: Scotland 1   54 273 33.3 31.9 25.0 83.9 31.2 77.4 24.3 100.0
UK: Northern 
Ireland
1   24 540 30.3 29.6 19.6 78.4 28.6 70.6 26.2 89.6
Iceland 1      4091 18.3 15.8 10.6 65.0 15.8 44.2 13.8 86.2
Norway 1    59 930 18.6 14.9 12.6 52.4 15.5 46.4 13.7 65.5
Switzerland 1,2,3    81 969 35.6 33.0 28.3 88.2 32.4 81.1 28.5 95.5
N or countries   28 28 26 26 29 29 23 24
Median   27.7 23.6 19.3 73.9 25 64 19.7 89
[IQR]  [22.2-33.1]  [18.5-30.1] [14.6-24.2] [66.8-78.7]  [19.6-29.9] [58.5-78.5]  [16.9-26.2]  [85.4-95.8]
Min/Max   18.3/57.1 13.2/56.6 10.2/45.7 44.6/95.3 15.4/54.8 43.5/98.5 13.7/54.8 64.3/100
Note: *Number of total births with at least some data on mode of delivery, but denominators change for each subgroup. 
** Data from public hospitals only.
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5.  MOTHERS’ MORTALITY ASSOCIATED WITH    
 CHILDBEARING
CORE
Maternal mortality ratio (C6)
RECOMMENDED INDICATORS OF MORBIDITY NOT INCLUDED IN THIS REPORT
Maternal mortality by cause of death (R5) 
Incidence of severe maternal morbidity (R6) 
Incidence of tears to the perineum (R7)
Adverse maternal outcomes in pregnancy include mortality, near misses, severe morbidity, long-
term sequelae, and minor morbidity. Each year more than 5 million women give birth in the 
EU. Another 2 million have a pregnancy that does not end in birth: spontaneous and induced 
abortions and both molar and ectopic pregnancies.
Maternal	death	is	a	major	human	tragedy;	it	is	also,	even	in	high-income	countries,	a	key	marker	
of health system performance. The global number of women who die in Europe during and 
because of pregnancy or childbirth ranges from 335 to 1000 according to the estimation method 
used. Such a range of variation is surprising for countries that all have quality birth registration 
systems;	the	discrepancies	in	national	rates	will	be	discussed	later	in	the	chapter.
Maternal mortality results from severe obstetric complications and conditions which mostly do not 
lead to death. This maternal morbidity is not adequately measured, however, because there is no 
international agreement about the definition of the conditions and also because the recording 
of these conditions is not standardised in routine hospital discharge databases, the main source 
of these data. Euro-Peristat contributes to on-going work to harmonise definitions for maternal 
morbidity to make it possible to measure it comparably in all countries. Risks of adverse maternal 
health	outcomes	rise	with	maternal	age,	BMI,	and	multiple	pregnancy;	all	of	these	are	becoming	
more common in the population of childbearing women in many countries. 
In this core report, only the MMR (C6) is presented, including maternal deaths by age, and 
information about enhanced or routine maternal mortality data collection systems. The other 
three recommended indicators are: the causes of maternal death (R5), severe maternal morbidity, 
based on a working definition using ICD10 diagnostic codes, and perineal tears (R7), that is, third-
and fourth-degree lacerations, which are associated with substantial morbidity and considered to 
reflect, in part, the quality of care.
C6 MATERNAL MORTALITY RATIO
JUSTIFICATION
Maternal mortality in Europe has decreased to a very low level, but healthy young women are 
still dying from obstetric causes, up to half of which are potentially avoidable. The maternal 
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mortality ratio (MMR) — the number of maternal deaths per 100 000 live births — is a proxy for 
the probability that a woman will die during a single pregnancy. Although this probability is 
low, maternal deaths in Europe are sentinel events that raise questions about the administration 
of effective care and the avoidance of substandard care.1 They are also more frequent among 
disadvantaged and migrant women2,3 and thus a marker of social inequalities in maternal health 
and of inequities of the healthcare system.
All countries participating in Euro-Peristat produce routine statistics from national civil 
registration and cause-of-death data systems on the frequency of maternal deaths. These have, 
however, been shown to be incomplete. Enhanced systems for reporting maternal deaths 
are necessary because all studies show that routine systems have a twofold problem: they 
underestimate the total numbers of maternal deaths by an order of magnitude of 25 to 70%, 
and they misallocate causes. Accurate information about both numbers is a prerequisite for 
robust public health recommendations.4-6 Only a few European countries use enhanced systems, 
including formal systems of “Confidential Enquiry” or in the current WHO terminology, “Maternal 
Death Surveillance and Response”.7 These systems have especially strong traditions in France, the 
Netherlands, and the United Kingdom.
The most effective enhanced systems implement routine data linkage, in particular, linkage of 
deaths of women of reproductive age with births in the previous year, completed with direct 
information from the registrar about all cases not reported. The persistent lack of completeness 
for deaths during pregnancy, especially early pregnancy, implies that completeness requires 
multiple information channels, as used in the enhanced systems in France, Italy, the Netherlands, 
and the UK. Because of their multiple data linkage and miscarriage and abortion registries, 
it is reasonable to believe that the Nordic systems also provides a reliable rate.8 Because of 
the importance of the data source in determining maternal mortality, Euro-Peristat requests 
information not only from routine systems but also from confidential enquiries and other 
enhanced systems where they exist.
Beyond improving statistics on maternal death, enhanced systems are used to study the 
circumstances that surround maternal mortality and the chain of events leading up to each 
death;	these	findings	contribute	to	the	prevention	of	future	deaths.	These	investigations	serve	
as a powerful tool for identifying weaknesses in the provision of care and recommending 
improvements to health policy makers, as in the recent UK recommendations for general 
practitioners.9 
DEFINITION AND PRESENTATION OF INDICATOR 
Maternal death is defined as the death of a woman while pregnant or within 42 days of the 
termination of pregnancy, regardless of the duration and site of the pregnancy, for any cause 
related to or aggravated by the pregnancy or its management, but not from accidental or 
incidental causes. The MMR is thus the number of all maternal deaths from direct and indirect 
obstetric causes per 100 000 live births. Our definition of maternal death is that published by 
WHO: a special chapter (10.3) of the 10th revision of the International Classification of Diseases 
(ICD-10) is devoted to the obstetric causes of death.10 Because the number of deaths each year is 
so low in most countries, we used data covering a five-year period (2011 to 2015). Providers were 
asked for “routine” as well as “enhanced” data when these exist. 
83
DATA SOURCES AND AVAILABILITY 
Data came from routine and enhanced systems for recording maternal deaths. Routine systems 
are	those	most	generally	available	in	each	member	state	or	country;	the	data	are	generally	
extracted from national civil registration and cause-of-death data systems, in which deaths 
are coded according to ICD-10. All countries provided data from routine systems, with the 
exception of the Czech Republic and the Netherlands, which provided only data from enhanced 
system. Estonia, Ireland, France, Italy, and the United Kingdom provided data from systems with 
enhanced data collection as well as data from routine systems. Not all countries provided data for 
the years requested, ie, the five years between 2011 and 2015. Eight countries provided routine 
data for another period (6 of them from 2010-2014), and three used different time frames for 
data from enhanced systems. 
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR 
The first major difficulty in reporting maternal mortality is that maternal deaths remain generally 
under-reported,11 so much so that WHO continues to consider that official routine statistics from 
high-income countries need to be weighted systematically by a factor of 1.5.12 Because the WHO 
coefficient assumes the same level of under-reporting everywhere, we do not apply it. Instead, 
we provide data from enhanced systems where these exist, to illustrate the extent of under-
reporting. In some cases, however, enhanced systems have wider inclusion criteria, especially for 
indirect and late maternal deaths. For example, data from the UK confidential enquiries system 
suggest that there is minimal under-reporting of direct maternal deaths in the routine system, but 
the confidential enquiry has a wider remit in investigating indirect and late maternal deaths. The 
same applies to the French confidential enquiry. Nonetheless, Euro-Peristat’s previous research 
suggests that countries that establish enhanced systems for ascertaining maternal deaths may 
have less under-reporting of maternal deaths in routine data as well.4
A second difficulty comes from the small numbers recorded and the resulting statistical variation. 
To address the difficulties related to the low numbers of deaths, MMRs were calculated with data 
for the 5 years 2011-2015 and 95% confidence intervals are presented to illustrate the uncertainty 
arising from the small numbers of deaths in some countries. Even with data for 5 years, however, 
the numbers of deaths are still very low in the smallest countries. For example, no deaths were 
registered for the 2011-2015 period in Malta. Countries such as Iceland, Luxembourg, and Malta, 
all with fewer than 10 000 births per year, would need to collect maternal deaths over half a 
century or more to provide data as robust as those of the French or UK confidential enquiries. This 
would not be meaningful, because of the social and medical change that occur over such periods.  
The last two difficulties pertain to possible non-inclusion and misclassification issues: unclear limits 
between indirect and direct deaths, and even between coincidental and maternal deaths, as in 
the case of suicide,13,14 as well as possible prolonged resuscitation or suicide beyond 42 days, which 
would transform a maternal death into a late maternal death, not collected by Euro-Peristat. 
RESULTS 
The total number of maternal deaths officially recorded in routine systems over a five-year period 
varied from none in Malta, fewer than 5 in Cyprus, Estonia, Luxembourg, and Iceland to over 
200 in France and the United Kingdom, as shown in Figure C6.1. The rates for the Czech Republic 
and the Netherlands in this graph are from enhanced systems as routine data were not provided. 
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Rates from enhanced systems, compared with rates from routine systems, are provided in Figure 
C6.2.
Based on data in routine systems, rates above 12 per 100 000 live births are reported by Hungary, 
Romania, and Latvia. Most countries report rates between 5 and 11.9 per 100 000 births, while 
Belgium, Germany, Greece, Poland, Spain, Slovakia, Switzerland, and the Nordic countries report 
rates below 5 per 100 000. The Nordic countries have a strong social and health support system 
and a managed migratory influx, so that their very low rates may reflect the true situation.15 In 
other countries, exceptionally low rates may be related to ineffective ascertainment, especially in 
countries with a high rate of migrant mothers, specifically Belgium, Germany, Greece, and Spain. 
Seven	countries	provided	data	from	enhanced	systems;	five	of	them	also	provided	routine	system	
data (Figure C6.2). In all of these cases, maternal mortality calculated with data from enhanced 
systems was higher than that with data from routine systems, with Estonia’s MMR rising from 
4.3 to 12.9, France’s from 6.4 to 8.9, and Italy’s from 3.6 to 9.7. These examples show the extent 
to which MMR can be under-reported in routine reporting. Italy provides food for thought 
in this area: in the previous Euro-Peristat report, its rate was 2.1 per 100 000, and it is 3.1 per 
100 000 using routine data in 2015. However, an enhanced system based on record linkage with 
hospital discharge records and birth certificates made it possible to improve ascertainment 
and shows that the true ratios are more than double those in routine systems.16 The difference 
between routine and enhanced systems reflects the characteristics of these systems since some 
are more comprehensive in their methods for enhancing ascertainment. In the Czech Republic, 
for instance, because enhanced collection involves case identification through regular contact 
with all the maternity hospitals, it does not improve ascertainment of non-hospital deaths. These 
data are nonetheless considered of higher quality than routine data, which were considered too 
incomplete to be submitted for this report.  
Changes over time between our last Euro-Peristat report covering data from 2006-2010 are 
heterogeneous and confidence intervals overlap in many countries. Changes over time may also 
reflect differences in ascertainment of maternal deaths between the periods. Reassuringly, there 
have been declines in several of the countries performing confidential enquiries, where data 
are more reliable: France from 9.1 to 8.9, the Netherlands from 7.7 to 5.1, and the UK from 11.4 
to 8.5. This result is especially encouraging as maternal mortality has risen in the USA recently,17 
where debate continues about whether this increase is an artefact due to better ascertainment 
or a real effect associated with an increase in risk factors either in the childbearing population or 
related to the healthcare system. 
Figure C6.4 presents MMRs by maternal age group. In view of the small numbers, we pooled the 
data from contributing countries and focused on three age groups: younger than 25 years, 25-34 
years, and 35 years and older. This figure illustrates the association between maternal age and 
maternal mortality. The MMR for women aged 35 years or older is about twice as high as for the 
other age groups. Compared with results from the previous Euro-Peristat reports, however, this 
differential has declined. In the last French report on maternal deaths, the group at lowest risk 
was no longer women aged 20-24, but those 25-29.18 
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KEY POINTS 
•	 The	MMR	is	low	(less	than	10	per	100	000)	in	most	European	countries,	but	we	believe	it	is	
often underestimated. There is good evidence that maternal deaths derived from routine 
statistical systems are under-reported, and this must be suspected particularly where ratios are 
very low.  
•	 There	is	no	agreement	on	the	components	of	an	“enhanced	system”,	which	may	provide	
false reassurance about the completeness of ascertainment. Maternal death surveillance and 
response systems (record linkage, confidential enquiries, and targeted recommendations) are 
of paramount importance to obtain complete data on maternal deaths, as well as to make it 
possible to understand how these deaths happened and make recommendations to prevent 
the recurrence of those that were preventable.  
•	 These	systems	exist	in	some	European	countries	and	are	sometimes	in	place	also	for	perinatal	
deaths and/or severe maternal morbidity. The generalisation of these systems is desirable as 
they make it possible to measure the true burden of maternal death and can thus inform 
policies to improve care. 
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Figure C6.1.  Maternal mortality ratios with 95% confidence intervals, 2011-2015 (except   
  where noted)
 
NOTE:  Number of deaths in parentheses. *Data from enhanced system, routine system data not provided.  
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Figure C6.2  Maternal mortality ratios from routine statistics and from enhanced systems,  
  2011-2015 (except where noted) 
 
NOTE:  *Enhanced only reported. For the UK, routine MMR was recalculated to cover the same years as the enhanced system. 
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Figure C6.3  Changes in maternal mortality ratios from routine sources between 2006-2010  
  and 2011-2015
 
NOTE:  Iceland had no maternal deaths in 2006-2010 and Malta none in 2011-2015. 
 * Second-period ratio data not from 2011-2015: Spain 2010-2014, France 2010-2014, Italy 2006-2012, Luxembourg 2012-2013, Poland 2010-2014, Sweden 2010-
2014, Switzerland 2010-2014.
 ** First-period ratio data not from 2006-2010: Denmark 2005-2009, Italy 2006-2009, Slovenia 2006-2009, France 2005-2009, United Kingdom 2006-2008, Portugal 
2003-2007.
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Figure C6.4  Maternal mortality ratios by maternal age
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BABIES’ HEALTH: MORTALITY AND 
MORBIDITY DURING PREGNANCY 
AND IN THE FIRST YEAR OF LIFE
6.  BABIES’ HEALTH: MORTALITY AND MORBIDITY DURING  
 PREGNANCY AND IN THE FIRST YEAR OF LIFE
CORE
Fetal mortality rate by gestational age, birth weight, and plurality (C1) 
Neonatal mortality rate by gestational age, birth weight, and plurality (C2) 
Infant mortality rate by gestational age, birth weight, and plurality (C3) 
Distribution of birth weight by vital status, gestational age, and plurality (C4) 
Distribution of gestational age by vital status and plurality (C5)
RECOMMENDED INDICATORS NOT INCLUDED IN THIS REPORT
Prevalence of selected congenital anomalies (R1)
 Distribution of 5-minute Apgar scores as a percentage of live births (R2) 
Fetal and neonatal deaths due to congenital anomalies (R3)
Prevalence of cerebral palsy (R4)
Outcomes related to the health of babies in the first year of life, specifically mortality rates, 
are often used as proxy measures of the health status of a population or of the quality of the 
perinatal healthcare system. The main contributory factors to perinatal death include congenital 
anomalies, very preterm birth, and fetal growth restriction. Maternal age, parity, multiple 
pregnancy, maternal conditions such as preeclampsia and diabetes, socioeconomic and migration 
status, and behaviours such as smoking are well-known risk factors for perinatal mortality and 
morbidity in high-income countries. The quality of care during pregnancy, delivery, and the 
neonatal period also influences babies’ chances of mortality and morbidity.
The Euro-Peristat indicators of child health include five core indicators, which are presented 
in this report, and four recommended indicators. The recommended indicators are: prevalence 
of	selected	congenital	anomalies	(provided	by	EUROCAT	congenital	anomaly	registries)	(R1);	
distribution	of	5-minute	Apgar	scores	as	a	percentage	of	live	births	(R2);	fetal	and	neonatal	deaths	
due	to	congenital	anomalies	(R3);	and	prevalence	of	cerebral	palsy	(provided	by	SCPE	cerebral	
palsy registries) (R4).
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C1. FETAL MORTALITY
JUSTIFICATION
Over the past decade, clinicians, researchers, public health advocates, and parents’ groups have 
raised the profile of fetal mortality, also called stillbirth, as a public health problem. Several key 
publications have alerted the international community to the lack of attention to stillbirths in 
maternal and child health policies, the wide gaps in knowledge about how best to prevent them, 
and the unacknowledged suffering faced by bereaved parents.1-3
Stillbirths account for more than half of all deaths occurring in the perinatal period, which 
begins at 22 weeks of gestation.4 The causes of fetal death are multiple and include congenital 
anomalies, fetal growth restriction, abruption associated with placental pathologies, preterm 
birth, and other maternal complications of pregnancy, as well as infections.2,5 However, between 
30 and 50% of fetal deaths remain unexplained, and this gap impedes the development of 
prevention strategies.5 Routine use of post-mortem and histological examinations would reduce 
this proportion, but post-mortem rates are reported to be declining in many countries.2
The principal modifiable risk factors for stillbirth include obesity and overweight, smoking, and 
older maternal age.6 Women having their first birth face a higher risk of stillbirth as do women 
with multifetal pregnancies. Because fetal growth restriction accounts for a high proportion of 
fetal deaths, better detection and management of these cases might be an effective preventive 
strategy.2, 6 Audits of fetal deaths have also called attention to the contribution of suboptimal care to 
their occurrence.7 Finally, women’s risks of stillbirths are correlated with their socioeconomic status. 
For example, stillbirth rates for women with low educational levels can be twice as high as those 
with high educational levels.8
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR
The differences between countries in gestational age and birthweight criteria for reporting fetal 
deaths as stillbirths complicates international comparisons.4,9 It is therefore necessary to calculate 
fetal mortality rates by gestational age and birth weight to derive comparable indicators when 
registration limits differ. Because of these differences between countries, the World Health 
Organization has recommended limiting international comparisons to third trimester stillbirths, 
defined by a birthweight cutoff of 1000 g or a gestational age cutoff of 28 completed weeks.10 
Euro-Peristat chose to use the gestational age cutoff of 28 completed weeks for its comparisons, 
as opposed to a birthweight cutoff, because criteria for registration of stillbirths in most 
countries are based on gestational age. Furthermore, as fetal growth restriction is related 
to stillbirth, a birthweight cutoff excludes a larger proportion of fetal deaths than a 
gestational age cutoff does.9 
While the use of a gestational age limit of 28 weeks has been necessary to ensure valid 
comparisons, it excludes the high proportion of stillbirths before 28 weeks. Recent work by Euro-
Peristat shows that adopting a cutoff of 24 weeks is feasible in many European countries and 
would allow reliable comparisons of stillbirth rates.11 This work showed, however, that reporting 
of stillbirths at 22 and 23 weeks is still highly variable and concluded that these deaths should still 
be excluded from international comparisons to ensure comparability. In this report, therefore, we 
have used both a 28- and a 24-week threshold for our main comparisons. All data, starting at 22 
weeks, are reported in the summary tables. 
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Differences in policies and practices related to terminations of pregnancy at or after 22 weeks of 
gestation also affect fetal mortality rates.12 There are several different approaches to recording 
and reporting terminations of pregnancy in European countries. Terminations can be registered 
as	fetal	deaths	and	reported	in	fetal	mortality	rates;	they	can	also	be	recorded	in	a	separate	
data system (ie, in an abortion registry), or not recorded at all. In some countries, terminations 
at or after 22 weeks are illegal or very rare. Describing each country’s approach is important for 
comparing stillbirth indicators, and countries should be able to distinguish between spontaneous 
stillbirths and terminations. Further, while it is important to recognise the loss to parents 
of babies through terminations for congenital anomaly, the large variation in the timing of 
screening and regulations in Europe also makes it necessary to exclude them from stillbirth rates 
in cross-country comparisons. 
A final issue to consider in reporting and interpreting stillbirth rates is country size. Because 
stillbirths are rare events, countries with small numbers of annual births, such as Cyprus, Iceland, 
Luxembourg, and Malta, experience greater year-to-year random fluctuations and will have wider 
confidence intervals around rates. 
DEFINITION AND PRESENTATION OF INDICATORS
The fetal mortality rate is defined as the number of fetal deaths at or after 22 completed weeks 
of gestation in a given year, expressed per 1000 live births and stillbirths in the same period. When 
gestational age is missing, Euro-Peristat requests that fetal deaths be included if they have a 
birth weight of 500 g or more. Fetal mortality rates overall are presented in Summary Table C1, 
but also for births 1000 g or more and at or after both 28 and 24 completed weeks of gestation. 
Stillbirth rates are presented with and without terminations of pregnancy in the summary 
tables, but the rates presented in the figures in this section are calculated without terminations 
to improve comparability between countries. Because terminations were included in the fetal 
mortality rate we reported for 2010, the comparisons between 2010 and 2015 here use the 2015 
rates with terminations included. 
DATA SOURCES AND AVAILABILITY OF INDICATORS IN EUROPEAN COUNTRIES
Most participating countries and regions were able to provide data on fetal deaths according to 
the Euro-Peristat definition, as Table C1.1 shows. When countries could not provide data on fetal 
deaths according to our definition, they were asked to give data applying their own inclusion 
limits (also shown in Table C1.1). In France, data were provided from hospital discharge data 
as well as from the periodic national perinatal survey. As the hospital discharge data were not 
available for 2010, the periodic survey data are used for comparisons over time. 
Countries that could only provide data with a birthweight cutoff of 500 g, as opposed to 
gestational age, were Austria, Belgium, the Czech Republic, Germany, Poland, and Slovenia. 
Countries that could only provide stillbirths starting at 24 weeks, as opposed to 22 weeks, were 
Ireland, England, Wales, Northern Ireland, and Hungary. Spain provided data based on a 180-
day cutoff, while Bulgaria used 800 g and/or 26 weeks. Note that these cutoffs relate to the data 
sources used for the Euro-Peristat report – for instance, Italy uses an official registration threshold 
of 180 days, but records stillbirths below this threshold in another register that is also used to 
provide data. In Scotland, as in the other countries of the United Kingdom, only fetal deaths at 
24 or more completed weeks of gestation are legally registrable as stillbirths, but fetal deaths at 
22 and 23 weeks of gestation can be ascertained from hospital data. Information was therefore 
provided for all fetal deaths from 22 weeks onwards. These differences in recording practices 
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mostly affect births at 22 and 23 weeks, which is why a threshold of at least 24 weeks is used for 
the data presented in this section. However, all data are presented in the summary tables. 
Table C1.1 also indicates the ability to identify terminations of pregnancy when these take place 
at or after 22 weeks. Most countries either do not allow terminations after 22 weeks or were 
able to provide data on the numbers of stillbirths after excluding terminations. The exceptions 
were Belgium, the Netherlands, and Cyprus, where terminations cannot be distinguished from 
spontaneous stillbirths.
In most countries, information on gestational age was missing for between 0 and 3% of stillbirths. 
Exceptions were Spain (11.7%), Cyprus (22.6%), the Netherlands (4.3%), and Slovakia (3.8%). A 
larger number of countries had proportions of missing data exceeding 3% for birth weight: Spain 
(8.5%), France (12.6%), Italy (14.8%), Cyprus (17.0%), Hungary (12.6%), and Scotland (7.1%). 
Because cases with missing data are not included when a gestational age or birthweight limit is 
imposed, rates in countries with substantial missing data should be interpreted with caution. 
RESULTS
As Figure C1.1 shows, stillbirth rates at or after 28 weeks of gestation in 2015 were 2.2 per 1000 
total births or lower in Cyprus, Iceland, Denmark, Finland, and the Netherlands. At the higher 
end, Bulgaria had a rate of 5.7, while Hungary, Romania, Slovakia, Latvia, and Ireland had rates 
of 3.4 or higher. Some countries with rates at the extremes had a small number of total births, as 
indicated	in	parentheses	after	the	country	name;	their	rates	are	therefore	more	subject	to	random	
variation. 
The general ranking of countries is similar regardless of whether the gestational age threshold was 
24 or 28 weeks of gestation. There were some exceptions, notably Belgium where terminations 
cannot be excluded from the total number of deaths and terminations are more likely to occur at 
the lower gestational ages. France also has a higher number of stillbirths from 24 to 27 weeks than 
would be expected from its stillbirth rates at 28 weeks or higher, but terminations do not explain 
this, as they are not included. The notably small numbers of stillbirths from 24 to 27 weeks in some 
countries, particularly Romania and Slovakia, suggest under-reporting at these gestational ages.
CHANGE IN FETAL MORTALITY RATES BETWEEN 2010 AND 2015 
Figure C1.2 displays rates at and after 28 weeks in 2010 and 2015. The figure reveals highly 
variable changes between 2010 and 2015. To help assess these changes, Figure C1.3 presents 
risk ratios, giving the percentage change over time as well as confidence intervals to show the 
uncertainty around these estimates. The pooled risk ratio estimate between 2010 and 2015 was 
0.95 (95% confidence intervals: 0.90-0.99), with statistically significant heterogeneity across 
countries. This graph shows that some countries experienced significant declines, some had stable 
rates, while rates rose in a few. 
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KEY POINTS
•	 Almost	all	countries	have	stillbirth	rates	between	2.0	and	3.5	per	1000	total	births	at	and	after	
28 weeks of gestation and between 2.5 and 4.5 per 1000 total births at and after 24 weeks of 
gestation. Accordingly, there were around 60-80% more stillbirths in the countries with the 
higher rates than in those with the lower rates.  
•	 Overall,	stillbirth	rates	fell	between	2010	and	2015,	but	trends	were	very	heterogeneous.	
Some countries experienced significant reductions in their stillbirth rates, including the 
Netherlands, Poland, Scotland, and England and Wales, whereas rates were stable or 
increased elsewhere.
•	 This	heterogeneity	in	changes	in	stillbirth	rates	in	2010	and	2015	calls	for	more	investigation	
of the health policies and changes in practices in the countries where stillbirth rates declined.
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Table C1.1  Ability to provide stillbirth data according to Euro-Peristat’s inclusion criteria and  
  ability to remove terminations of pregnancy from stillbirth statistics
Inclusion criteria No terminations of pregnancy** or can 
exclude terminations
Terminations of pregnancy cannot be 
excluded
 Euro-Peristat criteria*:
≥22 weeks of gestational age or if 
gestational age is missing, ≥500 grams
Denmark, Estonia, France, Croatia, Latvia, 
Lithuania, Luxembourg, Greece, Romania, 
Malta, Portugal, Slovakia, Finland, 
Sweden, Norway, Iceland, Switzerland, 
Italy***, UK (Scotland)
Netherlands, Cyprus
Use of other criteria:  
≥ 500 grams Austria, Czech Republic, Germany, 
Poland, Slovenia
Belgium
≥ 24 weeks Ireland, Hungary, UK (England and Wales, 
Northern Ireland)
≥ 180 days  Spain
≥ 800 grams/26 weeks Bulgaria: 800 grams and/or 26 weeks
Note:  * Registration and recording guidelines differ in this group of countries, but all are able to provide stillbirth data starting at 22 weeks of gestation.
 ** Or terminations are rare above the registration limit for stillbirths and unlikely to affect stillbirth statistics.
 *** 180 days or more for stillbirths and < 180 days for spontaneous abortions, but have been combined for this report. 
99
Figure C1.1  Stillbirth rates at and after 24 weeks and 28 weeks of gestation in 2015
NOTE: For countries that register terminations of pregnancy as stillbirths, terminations were removed when this was possible. Total number of births (without terminations, when 
possible) indicated in parentheses after country name; *cannot remove terminations of pregnancy. 
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Figure C1.2  Stillbirth rates at and after 28 weeks of gestation in 2010 and 2015
NOTE:  Data for Luxembourg, France, Slovenia, England & Wales, Scotland, and Switzerland differ between Figure C1.1. and C1.2. because rates in C1.1 were calculated without 
terminations, while those for C1.2 were calculated including terminations. These differences are generally small, except for France.12 Data from France come from a 
different source than that used in Figure C1.1. 
 First-period data not from 2010: Greece 2009, Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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C1.3  Comparison of stillbirth rates at and after 28 weeks, 2010 and 2015 (risk ratios and 95%  
 confidence intervals)
NOTE:  Overall random effects estimate: 0.95 (95% CI: 0.90-0.99). 
 I2=66.2% Chi squared tests of heterogeneity: 37.80. (d.f. = 29), p < 0.001.
 First-period data not from 2010: Greece 2009, Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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C2 NEONATAL MORTALITY
JUSTIFICATION
The neonatal mortality rate is a key indicator of health and care during pregnancy and birth. 
Neonatal deaths are deaths 0-27 days after live birth. They are often subdivided by timing of 
death into early neonatal deaths, 0-6 days after live birth, and late neonatal deaths, 7-27 days 
after live birth. The principal causes of neonatal death in high-income countries are congenital 
anomalies1 and complications associated with very preterm birth (see C5). Babies from multiple 
pregnancies have neonatal mortality rates 4-6 times higher than singletons, primarily because 
they are born at lower gestational ages.2 Neonatal deaths can also be associated with suboptimal 
care, including factors related to health care and the healthcare system. For very preterm births, 
birth in a maternity ward with an on-site neonatal intensive care unit is associated with lower 
mortality,3 while delivery in a less specialised maternity unit or in midwife-led care can offer 
women with uncomplicated pregnancies levels of adverse outcome that are at least as good, 
combined with lower intervention rates.4
The first European Perinatal Health Report showed wide variations in neonatal mortality rates in 
participating countries in 2004, and the second European Perinatal Health Report described their 
persistence in 2010.5, 6 In addition, countries differed in their patterns of early and late neonatal 
deaths. In 2004, new member states of the European Union had high early and late neonatal 
mortality rates, while in other countries patterns of either low early with high late or high early 
and low late rates were observed.7 Similar patterns persisted in 2010.  Large declines in neonatal 
mortality rates in participating countries between 2004 and 2010 affected all gestational ages 
and were observed in both high- and low-mortality countries.8 Neonatal mortality rates due to 
congenital anomalies remained higher in some countries where terminations of pregnancy were 
not legal.9
The wide variation in gestational age-specific neonatal mortality rates at 22-23 weeks in 2004 
suggested that not all births and deaths occurring very early in the neonatal period were 
systematically included, and this too persisted in 2010. This finding was unsurprising as even within 
countries, the reporting of births as stillbirths or live births at these extremely preterm gestational 
ages can show substantial heterogeneity that suggests differential reporting thresholds and 
practices.10 Variations in neonatal mortality rates between countries may also reflect differences 
in policies between European countries related to the resuscitation of babies at the limit of 
viability.10 
DEFINITION AND PRESENTATION OF INDICATORS
Data on neonatal deaths are compiled by timing of death, gestational age, birth weight, and 
plurality and used to construct annual and cohort mortality rates. The annual neonatal mortality 
rate is defined as the number of deaths during the neonatal period after live birth at or after 22 
completed weeks of gestation occurring during the year, expressed as a rate per 1000 live births 
in the same year. The cohort neonatal mortality rate is defined as the number of neonatal deaths 
among babies born at or after 22 completed weeks of gestation in a given year, expressed as a rate 
per 1000 live births in the same year. When gestational-age data were missing, births and deaths 
were included if they had a birth weight of at least 500 g. If both gestational age and birth 
weight were missing, the birth or death was not included. In some countries, however, births and 
deaths with missing gestational age and birth weight could be included if they were known to 
have occurred at 22 or more weeks of gestation.
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Usually the annual and cohort neonatal death rates are very similar as they only reflect 
differences at the beginning and end of the year. However, differences can be more marked in 
countries with a small population or when comparing neonatal mortality rates by subgroups. 
To obtain cohort rates, information about births and deaths need to be available in the same 
source. Although not all countries currently have this data available, Euro-Peristat recommends 
this minimal linkage for all countries.11 This report provides both annual and cohort rates in the 
summary tables. When only one neonatal mortality rate is shown and both cohort and annual 
rates are available, we used the cohort rate. 
DATA SOURCES AND AVAILABILITY OF INDICATORS IN EUROPEAN COUNTRIES
All participating countries were able to provide some data for neonatal deaths. Data were from 
2014 in Bulgaria, Poland, Sweden, England and Wales, and Switzerland. Data about deaths but 
not births were available from UK confidential enquiries. Thirteen countries or regions provided 
only annual neonatal deaths, 12 provided both annual and cohort neonatal deaths, and 9 
submitted only cohort neonatal death data. Differences among the 12 countries where annual 
and cohort neonatal mortality rates could be compared were minimal except in Scotland, where 
difficulties in linking deaths (in particular, early neonatal deaths) back to the corresponding birth 
record meant that the cohort neonatal mortality rate systematically underestimated the actual 
rate. For this reason, the annual neonatal mortality rate (produced from unlinked data and hence 
complete) is preferred for Scotland. Germany, Greece, Italy, Spain, and Portugal were unable 
to provide data on neonatal deaths by gestational age, and the data for Hungary divided all 
gestational ages into only two groups: 24-31 weeks and at and after 31 weeks. Germany, Greece, 
Spain, Italy, and Portugal were unable to contribute data by birth weight, and Bulgaria, Germany, 
Greece, Spain, and Hungary could not contribute data by plurality. Data from Ireland concerned 
only early neonatal deaths.
In many countries, there were no or few (<4%) missing data for the gestational age of neonatal 
deaths. Exceptions included Belgium (5.8%), the Czech Republic (6.5%), Luxembourg (22.2%), 
and Romania (20.5%). In France, 14.0% of the data were missing, but Euro-Peristat received data 
corrected for the missing cases. Proportions of missing birthweight data greater than 4% were 
reported in Belgium (6.3%), Denmark (10.1%), France (13.1%), Lithuania (4.1%), Luxembourg 
(27.3%), and England and Wales (12.0%). Cases with missing data are not included when a 
gestational age or birthweight limit is imposed, therefore rates in countries with high missing 
data rates should be interpreted with caution. For countries with more than 10% missing for 
gestational age, we estimate rates corrected for missing cases in the text below. 
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATORS
Comparisons of neonatal mortality rates at early gestational ages must be combined with analyses 
of fetal mortality rates, since it is possible that some early neonatal deaths may be recorded as 
fetal deaths and vice versa. Some registration and data recording systems impose a lower limit of 
500 grams for inclusion of births. This can create limitations in comparing neonatal mortality rates 
at low gestational ages. Nonetheless, because of the differences in the recording of births before 
24 weeks, Euro-Peristat recommends that comparative analyses use a 24-week threshold.7, 12 
Neonatal deaths are rare events. Therefore, in countries with a small number of annual births, 
such as Cyprus, Iceland, Luxembourg, and Malta, year-to-year random fluctuations are naturally 
greater and the confidence intervals around their rates wide. 
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RESULTS
Neonatal mortality rates ranged from 1.2 per 1000 live births in Iceland to 4.3 per 1000 in 
Romania and 4.4 per 1000 in Bulgaria, as seen in Figure C2.1, which shows neonatal mortality rates 
subdivided by timing of death into early and late neonatal mortality rates. Between 63.3 and 
84.3% of all neonatal deaths in participating countries occurred during the early neonatal period. 
In Bulgaria and Romania, late neonatal mortality rates exceeded 1.0 per 1000 live births. 
After the exclusion of births and deaths before 24 weeks of gestation, neonatal mortality rates 
ranged from 0.4 per 1000 live births in Slovenia to 4.5 in Bulgaria, as shown in Figure C2.2. 
Bulgaria, Malta, Romania, and Northern Ireland had rates exceeding 3.0 per 1000 at gestations of 
24 weeks or more. In contrast, the Czech Republic, Denmark, Estonia, Cyprus, Luxembourg, Austria, 
Slovenia, Finland, Sweden, Norway, and Iceland had rates below 1.5 per 1000 live births. Note that 
some countries had high proportions of missing data for gestational age, which led to excluding 
some cases from these rates. If data are corrected, under the assumption that missing data are 
distributed according to the observed gestational age distribution, rates at or over 24 weeks of 
gestation are: 1.7 instead of 1.6 in Belgium, 1.3 instead of 1.2 in the Czech Republic, 1.4 instead of 
1.2 in Luxembourg, and 4.2 instead of 3.5 in Romania. Countries where terminations of pregnancy 
were either not legal, as in Malta and the Irish Republic, or not usually available, as in Northern 
Ireland, were among those with high neonatal mortality rates, probably attributable to deaths from 
lethal congenital anomalies. 
Babies born before 28 weeks of gestation or weighing less than 1000 grams accounted for 
approximately 40% of all neonatal deaths, as shown in Figure C2.3, which combines all countries 
for which data were available for neonatal deaths at or after 22 weeks of gestation. Data were 
not available by gestational age for Germany, Greece, Spain, Italy, Hungary, Portugal, or Scotland. 
Slightly over a quarter of the deaths were of term babies, while 18.9% were born at 22-23 weeks 
of gestation and 12.8% had a birth weight less than 500 grams.
COMPARISON WITH 2010 DATA 
Comparisons of neonatal mortality rates at or after 24 completed weeks of gestation in 2010 
and 2015 were possible for 22 European countries and are presented in Figures C2.4 and C2.5. 
Neonatal mortality rates declined in most countries. The largest absolute decreases in rates were seen 
in Slovenia, Latvia, Malta, Romania, and Poland. With the exception of Slovenia, these countries had 
higher rates in 2010 than many other European countries. When viewed as percentage changes, as in 
Figure C2.5, Slovenia, Iceland, Latvia, Norway, and the Czech Republic reduced their rates by 25% or 
more. However, the confidence interval in Iceland was wide, and the difference not significant. The 
pooled estimate of the risk ratio between 2010 and 2015 for neonatal mortality at or after 24 weeks 
was 0.86 (95% confidence interval 0.80-0.91) in the 22 countries that could provide data. This risk 
ratio was negative, but less pronounced for neonatal mortality at or after 22 weeks of gestation in 26 
countries providing data. Heterogeneity between the countries was significant in both comparisons. 
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KEY POINTS
•	 Wide	differences	in	neonatal	mortality	rates	persisted	in	participating	countries	in	2015.	
Compared with 2010, rates declined in many of these countries. Some large declines were 
observed among some of the countries that were new member states of the European Union 
in 2004, but also among some countries with low neonatal mortality rates in 2004 and 2010. 
Overall decreases in neonatal mortality were more pronounced after removing births at 22 
and 23 weeks of gestation.
•	 These	data	raise	questions	about	the	reasons	for	these	disparities	in	neonatal	mortality	in	
Europe. While methodological issues related to registration are less problematic for neonatal 
than for fetal mortality rates, the inclusion criteria of 500 grams or 22 weeks used in some 
countries may result in lower neonatal mortality rates than in countries where there is no limit 
for inclusion. Differences in ethical and clinical decisions about babies born very preterm may 
also contribute to the disparities observed.
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Figure C2.1  Early and late neonatal mortality rates at and after 22 weeks of gestation in 2015
 
NOTE:  Total number of live births in parentheses after country name.
 *Cohort data except for Bulgaria, Czech Republic, Germany, Greece, Spain, France, Italy, Luxembourg, Hungary, Poland, Romania, Slovakia, Scotland, Sweden, and Iceland
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Figure C2.2  Neonatal mortality rates at and after 22 and 24 weeks of gestation in 2015
NOTE: * More than 5% data missing for gestational age: Belgium (5.8%), the Czech Republic (6.5%), Luxembourg (22.2%), Romania (20.5%); see text for estimated corrected 
rates. These cases are excluded from rates calculated for births 24 weeks and later.  
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Figure C2.3  Distribution of neonatal deaths by gestational age (A) and by birth weight (B) for all  
  births at and after 22 weeks of gestation for all countries contributing data in 2015
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C2.4  Neonatal mortality rates at and after 24 weeks of gestation in 2010 and 2015 
NOTE:  First-period data not from 2010: Greece 2009, Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014, UK: England and Wales 2014.
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C2.5  Comparison of neonatal mortality rates at and after 24 weeks of gestation, 2010 and 2015
 (risk ratios and 95% confidence intervals) 
NOTE:  Pooled random effects estimate 0.86 (95% CI: 0.80-91). 
 I2 =  50.5%  Chi squared tests of heterogeneity = 42.45 (d.f. = 21), p = 0.004.
 Second period data not from 2015: Poland 2014, Sweden 2014, Switzerland 2014, UK: England and Wales 2014.
 10 .5 1.5 2
Risk ratios with 95% confidence intervals
Slovenia
Iceland
Latvia
Norway
Czech Republic
Poland
Malta
Austria
Romania
Belgium
UK: England and Wales
Netherlands
Finland
Denmark
Switzerland
Luxembourg
Estonia
Lithuania
France
Sweden
Slovakia
UK: Northern Ireland
0.35 (0.16, 0.78)
0.60 (0.11, 3.26)
0.67 (0.46, 0.98)
0.73 (0.54, 0.99)
0.74 (0.59, 0.93)
0.79 (0.73, 0.86)
0.79 (0.39, 1.62)
0.81 (0.63, 1.04)
0.82 (0.74, 0.90)
0.84 (0.70, 1.02)
0.86 (0.80, 0.93)
0.89 (0.77, 1.04)
0.91 (0.65, 1.26)
0.94 (0.70, 1.26)
0.95 (0.75, 1.19)
0.95 (0.36, 2.54)
0.97 (0.51, 1.84)
0.98 (0.70, 1.37)
0.99 (0.93, 1.06)
1.01 (0.80, 1.27)
1.08 (0.82, 1.42)
1.10 (0.80, 1.51)
EUROPEAN PERINATAL HEALTH REPORT
112
C2.6  Comparison of neonatal mortality rates at and after 22 weeks of gestation, 2010 and  
 2015 (risk ratios and 95% confidence intervals)
NOTE:  Pooled random effects estimate: 0.90 (95% CI: 0.85-0.94). 
 I-squared = 66.8% Chi squared tests of heterogeneity = 87.39 (d.f. = 29), p < 0.001. 
 First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Poland 2014, Sweden 2014, Switzerland 2014, UK: England and Wales 2014.
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C3 INFANT MORTALITY
JUSTIFICATION
The infant mortality rate, which measures the number of deaths before one year of age after 
live birth per 1000 live births, is a widely used measure of population health. Although it extends 
beyond the perinatal period, the Euro-Peristat group includes infant mortality as a core indicator 
because it reflects the longer-term consequences of perinatal morbidity. Measuring deaths 
beyond the neonatal period is particularly relevant for very preterm or low birthweight babies or 
babies with congenital anomalies, as they remain at higher risk of death throughout their first 
year of life.1,2 While most infant deaths attributable to perinatal causes occur soon after birth, 
some very ill babies admitted to neonatal units may survive the neonatal period but die later 
in their first year of life. Furthermore, developments in neonatal care for these high-risk babies 
can influence the proportions of infant deaths occurring after the neonatal period and affect 
comparisons of mortality over time and between countries.3 In a study of all US full term infant 
deaths in 2010-2012, perinatal conditions and congenital anomalies accounted for almost 99% of 
all early neonatal deaths and almost two thirds of late neonatal deaths. Nonetheless, 63.5% of 
infant deaths occurred during the post-neonatal period, and 60% of them were due to sudden 
unexpected death in infancy, while perinatal conditions and congenital anomalies accounted 
for barely 20%.4 The post-neonatal mortality rate is more highly correlated with social factors 
than the neonatal mortality rate is.5 Infant mortality is therefore an indicator of both the quality 
of medical care and the effectiveness of services and policies aimed at the reduction of health 
inequalities.
DEFINITION AND PRESENTATION OF INDICATOR
Data about infant deaths are compiled on both an annual and a cohort basis, subdivided by 
gestational age, birth weight, and plurality. They are presented in Summary Table C3. The annual 
infant mortality rate is defined as the number of infant deaths 0-364 days after live birth at or 
after 22 completed weeks of gestation occurring in 2015, expressed as a rate per 1000 live births 
occurring in 2015. The cohort infant mortality rate is defined as the number of deaths 0-364 days 
after live birth at or after 22 completed weeks of gestation among babies born in 2015, expressed 
as a rate per 1000 live births in 2015. Euro-Peristat inclusion rules state that when gestational age is 
missing, deaths should be included if the birth weight is equal to or over 500 grams. To standardise 
comparisons, Euro-Peristat also calculates the infant mortality rate after removing births at very early 
gestational ages (22 and 23 weeks, see C2 for full discussion). 
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES
All countries provided data on the infant mortality rate. Data from Bulgaria, Poland, Sweden, 
England and Wales, and Switzerland were from 2014. As with neonatal mortality, we used cohort 
mortality rates when these were available (Austria, Belgium, Croatia, Cyprus, Denmark, Estonia, 
Finland, Latvia, Lithuania, Malta, Norway, Slovenia, Switzerland, and the countries of the UK). For 
other countries we used annual rates. For the countries that had both (Croatia, Cyprus, Estonia, 
Austria, Finland, Latvia, Lithuania, Norway, and Switzerland), differences were small except in 
Scotland, as mentioned In section C2, above, Scotland’s difficulties in linking deaths (in particular 
early neonatal deaths) back to the corresponding birth record meant that the cohort infant 
mortality rate systematically underestimated the actual rate. For this reason, the annual infant 
mortality rate (produced from unlinked data and hence complete) is preferred for Scotland. Of 
the 33 participating countries, 23 countries were able to provide infant mortality rates subdivided 
by gestational age and 24 by birth weight, numbers similar to those able to provide these data in 
2010. 
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Most countries had small proportions of missing data for gestational age (<3%), with some 
exceptions in Romania (26.3% of deaths had gestational age missing), the Czech Republic (19.1%), 
and Luxembourg (43.8%, but few deaths). Cases with missing data are not included when a 
gestational age or birthweight limit is imposed, therefore rates in countries with high rates of 
missing data should be interpreted cautiously. For countries with more than 10% missing data for 
gestational age, we provide an estimate of corrected rates in the text below. 
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR
Most participating countries had no lower gestational age or birthweight limit for registration 
of live births in 2015. This made it possible to provide data about live births based on the 
Euro-Peristat definition of 22+ weeks of gestation for countries that collect infant deaths by 
gestational age. A few countries specified limits – France, where live birth registration starts at 
22 weeks or 500 grams, and Ireland, where the published reports include data only on births 500 
grams or more, although live births with lower birth weights can be registered legally and were 
provided to Euro-Peristat when born at or after the 22 week of gestation limit. In Norway, live 
births and stillbirths are registered starting at 16 weeks of gestation, but births before 22 weeks 
with a birth weight under 500 grams are considered to be spontaneous abortions. 
In many European countries, data about infant deaths after the perinatal period come from 
general death registration systems, which do not usually include information about birth 
characteristics. If gestational age is not recorded it is not possible to check adherence to the Euro-
Peristat inclusion criteria or to undertake more complete analyses of the infant mortality rate. For 
this reason Euro-Peristat strongly recommends linking birth and death records to obtain complete 
information about infant deaths by gestational age, birth weight, and plurality.6 
An additional note concerns Luxembourg, where it is estimated that about 14% of child deaths 
occur abroad, reflecting transfer for care to specialized centres in neighbouring countries. Cause 
of death registers are not notified about these deaths and they are not included in the statistics 
presented here.  
RESULTS
As shown in Figure C3.1, infant mortality rates at or after 22 completed weeks of gestation 
in 2015 varied widely, ranging from 1.5 per 1000 live births in Iceland to 5.2 in Malta, 5.1 in 
Northern Ireland, 7.4 in Romania, and 7.6 in Bulgaria. The median rate was 3.1, with an IQR of 
2.3 to 3.8. Bulgaria and Romania, relatively new members of the European Union, had very high 
infant mortality rates, similar to those observed among the new member states of the European 
Union in the 2004 data collection. Although not at this level, rates were high in Malta, where 
termination of pregnancy is illegal, and in Northern Ireland, where the legislation enabling legal 
abortion in the rest of the UK does not apply.
When infant mortality rates were computed with a threshold of 24 weeks, rates were reduced 
by between 0.01 and 0.07 per 1000 live births. For the 21 countries that could provide this 
information, the median infant mortality rate with this threshold was 2.1 with an IQR of 1.8 to 
2.8. Among these countries taken together, 16.3% of infant deaths thus occurred after live 
birth at 22 and 23 weeks. A slightly lower percentage of infant deaths involved babies who 
weighed less than 500 grams at birth. Overall two thirds of all deaths were of babies born 
before term or with a birth weight less than 2500 grams. Note that some countries had 
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high proportions of missing data for gestational age, which resulted in the exclusion of 
some cases from these rates. If data are corrected, under the assumption that missing data 
are distributed according to the observed gestational age distribution, rates at or after 
24 weeks of gestation are: 2.1 instead of 1.8 in the Czech Republic, 1.7 instead of 1.2 in 
Luxembourg, and 6.8 instead of 5.4 in Romania.
COMPARISON WITH DATA FROM 2010 
Of the 33 participating countries, 27 had data for infant mortality rates at or after 22 
completed weeks of gestation for both 2010 and 2015. Figures C3.4 and C3.5 present these 
comparisons. Rates decreased in 23 countries and increased in four, Greece, Portugal, 
France, and Northern Ireland, although the difference in France was extremely small, lower 
than 0.1 per 1000 live births, and the confidence intervals for all four included 1 (see Figure 
C3.5). Among the seven countries with the highest rates in 2010, five, Romania, Latvia, 
Hungary, Lithuania, and Poland had substantial further decreases between 2010 and 2015. 
Rates in the other two countries with high rates in 2010, Northern Ireland and Malta, 
decreased only slightly. Other substantial decreases occurred in countries with a wide range 
of rates in 2010. Figures C3.4 and C3.5 present risk ratios between 2010 and 2015, with their 
95% confidence intervals. Overall, infant mortality rates were significantly lower in 2015 
than	in	2010;	comparisons	with	a	24-week	threshold	showed	a	larger	decrease.	However,	
fewer countries were able to provide these data in both periods. The heterogeneity in 
relative risks between countries was significant. 
KEY POINTS
•	 Infant	mortality	rates	declined	in	most,	but	not	all,	participating	countries	between	2015	and	
2010. 
•	 Mortality	rates	continue	to	vary	greatly	between	countries,	with	rates	remaining	highest	
among the newest member states. Rates also remained relatively high in Malta and Northern 
Ireland.
•	 In	countries	with	data	available	about	the	gestational	age	and	birth	weight	of	the	babies	who	
died, more than two thirds were born preterm and three quarters had a birth weight below 
2500 grams. 
•	 Only	two	thirds	of	the	participating	countries	were	able	to	present	infant	mortality	data	by	
gestational age, birth weight, and plurality, data that make it possible to monitor outcomes in 
the first year of life among babies at higher risk of morbidity and mortality. Routine linkage 
between birth data and death statistics should be set up in all countries that lack it to obtain 
this essential information. 
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Figure C3.1 Infant mortality rates at and after 22 weeks of gestation in 2015
Note:  Data are cohort data when available (Belgium, Denmark, Estonia, Croatia, Cyprus, Latvia, Malta, Austria, Slovenia, Finland, Northern Ireland, Iceland, Norway, England 
and Wales, and Switzerland) or annual rates when cohort data were not provided (Bulgaria, Czech Republic, Germany, Ireland, Greece, Spain, France, Italy, Lithuania, 
Luxembourg, Hungary, Netherlands, Poland, Portugal, Romania, Slovakia, and Sweden) and for Scotland due to incomplete reporting for cohort deaths. The total number of 
live births is given in parentheses after country name; data from Bulgaria, Poland, Sweden, and Switzerland are from 2014.
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Figure C3.2 Infant mortality at and after 22 and 24 weeks in 2015
NOTE:  Data are cohort data when available (Belgium, Denmark, Estonia, Croatia, Cyprus, Latvia, Malta, Austria, Slovenia, Finland, Northern Ireland, Iceland, Norway, England 
and Wales, and Switzerland) or annual rates when cohort data were not available (Bulgaria, Czech Republic, Germany, Ireland, Greece, Spain, France, Italy, Lithuania, 
Luxembourg, Hungary, Netherlands, Poland, Portugal, Romania, Scotland, Slovakia, and Sweden). 
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Figure C3.3  Distribution of infant deaths by gestational age (A) and by birth weight (B) for all  
  births at or after 22 weeks of gestation for all countries contributing data in 2015
A. By gestational age group                        B. By birthweight group
NOTES: Calculated for 22 countries (by gestational age) and 21 countries (by birth weight), representing about 2.4 million births.
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C3.4  Infant mortality rates at and after 22 weeks of gestation in 2010 and 2015 
NOTE:  First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014, UK: England and Wales 2014.
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C3.5  Comparison of infant mortality rates at and after 22 weeks of gestation, 2010 and 2015  
 (risk ratios and 95% confidence intervals) 
NOTE:  Pooled random effect estimate: 0.88 (95% CI: 0.84-0.93). 
 I2 = 71.5% Chi squared test for heterogeneity: 94.70 (d.f. = 27), p <0.000. 
 First-period data not from 2010: Greece 2009, Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, UK: England and Wales 2014 and Switzerland 2014.
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Figure C3.6  Comparison of infant mortality rates at and after 24 weeks of gestation, 2010  
  and 2015 (risk ratios and 95% confidence intervals)
NOTE:  Data from Czech Republic and Romania corrected for missing observations.  
 Pooled random effects estimate: 0.84 (95% CI: 0.78-0.90). 
 I2 = 55.3% Chi squared test for heterogeneity= 33.56 (d.f. = 15), p= 0.004. 
 First-period data not from 2010: Greece 2009, Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014, UK: England and Wales 2014.
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C4. DISTRIBUTION OF BIRTH WEIGHT
JUSTIFICATION
The proportion of low-birthweight babies, defined as those weighing less than 2500 grams at 
birth, is a widely used indicator for assessing their risk of adverse perinatal outcomes. Babies 
with a low birth weight are at higher risk of poor perinatal outcome and of long-term cognitive 
and motor impairments than babies with higher birth weights.1, 2 Babies with very low birth 
weights, weighing less than 1500 grams, face the highest short- and long-term risks.3 Birth 
weight is included in many national and international data systems and it is therefore possible to 
compare the percentage of babies with low birth weight over diverse geographic areas and to 
assess trends over time.
Infants with low birth weight include those born preterm (see C5) as well as children with 
fetal growth restriction, regardless of their gestational age at delivery. As with preterm births, 
low birth weight is more common among multiple births than singletons (see C7). Growth 
restriction is associated with many adverse perinatal health outcomes and short- and long-term 
impairments, including risks of high blood pressure, ischemic heart diseases, other cardiovascular 
diseases, diabetes, and metabolic syndromes in adulthood.4, 5 
Some maternal and fetal characteristics are known risk factors for both preterm birth and 
growth restriction. Mothers with pre-existing conditions, chronic diseases, and known 
pregnancy-related disease, such as preeclampsia, are at higher risk, as are fetuses with congenital 
anomalies and pregnancies with reduced uteroplacental flow. Maternal smoking and low 
socioeconomic status also contribute significantly to preterm birth and fetal growth impairment.6 
Management of fetal growth restriction during pregnancy involves monitoring the fetus and, if 
needed, carrying out an indicated early delivery.7 
On the other side of the birthweight spectrum, macrosomia, usually defined as a high birth 
weight of 4500 grams and over, is also associated with pregnancy complications and adverse 
perinatal health outcomes, including shoulder dystocia, neonatal morbidity, and caesarean 
delivery.8, 9 Mothers with diabetes are known to be at higher risk of having a macrosomic fetus. 
The risk of diabetes is also related to a higher proportion of older mothers in many countries. 
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND 
INTERPRETATION OF THE INDICATOR
Wide availability of the distribution of birth weight across countries and in international 
databases provides information about the percentages of infants at risk of mortality and 
morbidity. One of the advantages of this indicator is that it is more easily measured than 
gestational age (see C5) in various high and low income settings. Nonetheless, because the 
distribution of birth weight in a given country reflects both the distribution of gestational age 
and the pattern of fetal growth, differences between countries are harder to interpret. 
To eliminate the impact of varying gestational age at birth, the percentage of newborns who are 
small-for-gestational-age or large-for gestational-age may be used to investigate fetal growth. 
No consensus currently exists, however, on international standards for determining birth weight 
percentiles across European populations. The debate centres on whether all countries should use 
one global standard or construct their own national references.10 This is an important area for 
future research in Europe, as growth restriction is a major perinatal health concern, and we lack 
tools for monitoring its prevalence and trends over times, especially between countries. 
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DEFINITION AND PRESENTATION OF INDICATOR
This indicator is defined as the number of births within a given birth weight interval, expressed 
as a proportion of all registered live births and stillbirths. It is computed by vital status at birth, 
gestational age, and plurality. The indicators selected for inclusion in this summary are live births 
weighing less than 1500 and 2500 grams. Indicators presented by pregnancy type (multiples 
versus singletons) can be found in the summary tables in Appendix B. We focus on live births 
because their registration is more homogenous in Europe than that of stillbirths, so that this 
indicator will be more useful for comparisons (see C1). 
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES
This indicator was available in all countries. Data on the birth weight distribution in France are 
now derived from hospital discharge data, but for comparisons we use data from the French 
perinatal survey, which were also used in 2010. Cyprus also changed data sources (from a survey 
to routine collection) between 2010 and 2015.  
RESULTS
As Figure C4.1 shows, the prevalence of low-birthweight less than 2500 grams in participating 
countries ranged from 4.2% to 10.6% of live births, with lower rates in Estonia, Finland, Sweden, 
Iceland, Latvia, Lithuania, and Norway and higher rates in Romania, Spain, Hungary, Portugal, 
Greece, Bulgaria, and Cyprus. Very low birth weight under 1500 grams occurred in 0.6% to about 
1.4% of live births.
The geographic pattern of the percentage of low-birthweight babies can be seen in Figure C4.2, 
with the highest percentages of low birth weights (under 2500 grams) in southern and eastern 
European countries. The lowest percentages of very low birth weight infants, less than 4.5% of 
live births, were in the Nordic and Baltic countries. Figure C4.3 shows a geographic pattern of 
high birth weight symmetric to that of low birth weight: the highest percentages of high birth 
weight (4500 grams or more) were found in the Nordic and Baltic countries, and the lowest 
percentages in southern Europe, especially in Greece and Cyprus, both countries where these 
rare high birth weights account for only 0.2% of live births.
Between 2010 and 2015, some countries experienced moderate but significant relative 
reductions in their percentages of low birth weight babies, ranging from 2% to not quite 5%, as 
shown	in	Figures	C4.4	and	C4.5;	these	countries	included	Malta,	Norway,	Austria,	and	Slovakia.	
Other countries experienced increases of a similar magnitude (Spain, Poland, Italy, Scotland, and 
Portugal). Increases of 5% or more over percentages in 2010 were observed in Iceland, France, 
Ireland, and Northern Ireland. When all participating countries were considered together, 
there was no common trend over time – the pooled risk ratio is estimated at 1.00 – and high 
heterogeneity was observed in the risk ratios from country to country.
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KEY POINTS
•	 The	percentage	of	low	birth	weight	in	participating	countries	varies	by	a	factor	of	two;	some	
of this reflects differences in preterm birth, as shown by some patterns in common with rates 
of preterm birth. 
•	 This	indicator	shows	marked	geographical	variation	that	may	reflect	physiological	differences	
in	birth	weight;	these	should	be	taken	into	consideration	when	interpreting	between-country	
differences. 
•	 Given	the	perinatal	and	long-term	health	impacts	of	suboptimal	fetal	growth,	research	
is needed on how best to measure and compare fetal growth restriction throughout the 
countries of Europe. 
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Figure C4.1   Percentage of live births with birth weights < 1500 grams and 1500-2499 grams
NOTE:  Number of live births with data on birth weight in parentheses after country name
 
Percentage of live births 
1.0 
0.9 
0.8 
1.1 
1.1 
1.2 
0.9 
0.8 
1.0 
1.1 
1.1 
1.0 
1.1 
1.2 
1.1 
0.9 
1.4 
1.1 
0.8 
0.9 
1.1 
1.0 
0.9 
1.0 
1.0 
1.3 
1.1 
1.1 
1.3 
0.9 
1.1 
1.1 
1.1 
6.2 
5.3 
5.3 
6.3 
7.1 
6.4 
4.8 
5.0 
6.0 
6.4 
7.4 
7.0 
6.2 
6.7 
5.8 
5.8 
7.3 
6.3 
4.6 
4.8 
10.9 
6.6 
5.6 
6.1 
6.6 
10.1 
5.4 
4.7 
7.2 
5.3 
6.4 
6.3 
7.0 
7.2 
6.2 
6.1 
7.4 
8.2 
7.6 
5.6 
5.8 
7.0 
7.5 
8.4 
8.0 
7.3 
7.8 
6.9 
6.8 
8.7 
7.3 
5.4 
5.8 
12.0 
7.6 
6.5 
7.1 
7.6 
11.3 
6.5 
5.7 
8.5 
6.2 
7.5 
7.4 
8.1 
0 2 4 6 8 10 12 14 
Switzerland, 2014 (84,891) 
Norway (59,711) 
Iceland (4,088) 
UK: Northern Ireland (24,462) 
UK: Scotland (54,288) 
UK: England and Wales (696,057) 
Sweden, 2014 (115,246) 
Finland (55,588) 
Slovakia (55,615) 
Slovenia (20,273) 
Romania (201,023) 
Portugal (85,762) 
Poland, 2014 (375,647) 
Austria (83,607) 
Netherlands (168,425) 
Malta (4,435) 
Hungary (91,680) 
Luxembourg (6,832) 
Lithuania (31,475) 
Latvia (21,720) 
Cyprus (9,394) 
Italy (484,777) 
Croatia (37,252) 
France  (758,056) 
Spain (420,283) 
Greece (91,847) 
Ireland (65,623) 
Estonia (13,907) 
Germany (725,937) 
Denmark (57,677) 
Czech Republic (110,764) 
Bulgaria, 2014 (67,585) 
Belgium (122,269) 
<32 weeks 
32-36 weeks 
Percentage of live births 
0.9 
0.8 
0.7 
0.9 
0.9 
1.0 
0.8 
0.6 
1.0 
1.0 
0.9 
1.0 
0.9 
1.0 
1.0 
1.0 
1.4 
0.9 
0.7 
0.7 
1.2 
1.0 
0.8 
1.0 
1.0 
1.1 
0.9 
0.8 
1.3 
0.8 
1.2 
1.4 
0.9 
5.5 
3.7 
3.6 
5.4 
5.9 
6.0 
3.5 
3.6 
6.7 
5.4 
7.0 
7.9 
5.0 
5.5 
5.1 
5.3 
7.1 
5.8 
3.8 
3.8 
9.4 
6.4 
4.3 
6.4 
7.4 
8.2 
4.8 
3.3 
5.7 
4.2 
6.6 
8.5 
6.0 
6.3 
4.5 
4.4 
6.3 
6.8 
7.0 
4.3 
4.2 
7.7 
6.4 
7.8 
8.9 
5.9 
6.5 
6.1 
6.3 
8.5 
6.7 
4.5 
4.5 
10.6 
7.4 
5.1 
7.4 
8.3 
9.3 
5.7 
4.2 
7.0 
5.0 
7.8 
9.8 
6.9 
0 2 4 6 8 10 12 
Switzerland, 2014 (84-881) 
Norway (59-710) 
Iceland (4088) 
UK: Northern Ireland (24-440) 
UK: Scotland (54-231) 
UK: Eng and Wales (683-997) 
Sweden, 2014 (115-210) 
Finland (55-537) 
Slovakia (55-615) 
Slovenia (20-273) 
Romania (201-023) 
Portugal (85-727) 
Poland, 2014 (375-638) 
Austria (83-607) 
Netherlands (168-007) 
Malta (4431) 
Hungary (91-645) 
Luxembourg (6831) 
Lithuania (28-896) 
Latvia (21-720) 
Cyprus (9-358) 
Italy (484-399) 
Croatia (37-252) 
France  (759-099) 
Spain (398-786) 
Greece (90-772) 
Ireland (65-623) 
Estonia (13-906) 
-
Germany (725-913) 
Denmark (57-227) 
Czech Republic (109-141) 
Bulgaria, 2014 (64-813) 
Belgium (120-600) 
<1500 grams 
1500 to 2499 grams 
127
Figure C4.2  Geographical distribution of the percentage of birth weight < 2500 grams   
  among live births in participating countries 
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Figure C4.3  Geographical distribution of the percentage of birth weight ≥ 4500 grams among  
  live births in participating countries 
n.s  sig.       %
2.6–4.3
1.5–2.5
1.0–1.4
0.8–0.9
0.6–0.7
0.2–0.5
> 4500 g %
Iceland
Malta
Cyprus
129
Figure C4.4  Percentage of live births with birth weight < 2500 grams in 2010 and 2015
NOTES:  *Second-period data not from 2015: Poland 2014, Sweden 2014, Switzerland 2014.
  **First-period data not from 2010: Cyprus 2007.
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Figure C4.5  Comparison of percentages of live births with birth weight < 2500 grams, 2010  
  and 2015 (risk ratios and 95% confidence intervals)
NOTE:  Random effects estimate of pooled RR: 1.00 (95% CI: 0.99, 1.02). 
 I2=89.4% Chi squared test of heterogeneity: 258.90 (d.f. = 30), p = <0.001.
 First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
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C5 DISTRIBUTION OF GESTATIONAL AGE
JUSTIFICATION
Preterm newborns, born before 37 completed weeks of gestation, are at higher risk of mortality, 
morbidity, and impaired motor and cognitive development in childhood than infants born at 
term.1 In high-income countries, about three quarters of all neonatal deaths occur to the 6% 
to 12% of infants born before 37 weeks.2 Preterm birth predisposes children to higher risks of 
chronic diseases and mortality later in life.
Health and developmental risks increase with decreasing gestational age, and very preterm 
babies born before 32 weeks of gestation are the most vulnerable, with rates of infant mortality 
between 10% and 15% and of cerebral palsy between 5% and 10%.1 However, babies with 
moderate or late preterm births (32 to 36 weeks of gestation) also have worse health and 
developmental outcomes than term babies.3, 4 
Preterm births follow spontaneous preterm labour or premature rupture of membranes in about 
two thirds of cases.5, 6 Indicated preterm births occur in about one-third of cases and result from a 
medical decision when there are fetal complications, such as fetal growth restriction, or maternal 
complications, such as severe preeclampsia.6 Clinical risk factors for preterm birth include previous 
preterm birth, infection, inflammation, hypertensive and vascular disorders, diabetes, a shortened 
cervix, and placentation disorders. In many cases, however, the cause of the preterm birth remains 
unknown.5
Although the survival of preterm infants has improved markedly over recent decades due to 
medical advances in neonatal care, progress in the prevention of preterm birth has been limited.7 
A WHO survey published in 2012 suggested that globally preterm births may be rising,8 but within 
Europe, countries report heterogeneous trends.9 Population factors related to risks of preterm 
birth include the incidence of multiple pregnancy (see C7), higher maternal age (C8), and both 
low and high maternal body mass index (R12).10 Evidence also suggests that practices related to 
indicated delivery and obstetric intervention within countries affect variations in the preterm 
birth rate. There is mounting evidence that targeting population-based social and environmental 
determinants of early delivery such as stress, air pollution, smoking, and education, could inform 
new paradigms for prevention.10, 11
While most research on gestational age distribution has focused on preterm births, which are at 
highest risk, early term birth at 37-38 weeks and post-term birth (42+ weeks) also confer additional 
risks compared with full term birth (39 to 41 weeks).12 In many countries, policies to induce delivery 
before 42 weeks have led to declines in the post-term birth rate, although there are substantial 
variations.13 
DEFINITION AND PRESENTATION OF INDICATOR
This indicator is defined as the number of live births and fetal deaths at each completed week of 
gestation (starting from 22 weeks), expressed as a proportion of all live births and stillbirths. The 
gestational	age	distribution	is	presented	as	follows:	22-36	weeks	of	gestation	(preterm	births);	37-
38	(early	term),	39-41	weeks	(full	term	births);	42	or	more	weeks	(post-term).	Preterm	births	can	
be subdivided as 22-27 weeks (extremely preterm), 28-31 weeks (very preterm), and 32-36 weeks 
(moderate and late preterm combined). This indicator is calculated by vital status at birth and 
plurality.
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The summary indicators presented below are calculated for live births. We focus on live births 
because	their	registration	is	more	homogenous	in	Europe	than	that	of	 stillbirths;	they	therefore	
provide a more comparable indicator (for a discussion of this issue, see C1). The complete 
distribution of gestational age for total births is provided in the summary tables in Appendix B.
DATA SOURCES AND AVAILABILITY OF INDICATOR IN EUROPEAN COUNTRIES
This indicator is available in all participating countries. In France, national data are available from 
hospital discharge data, but comparisons across time are based on a national survey, which was 
also the data source in 2010. Cyprus also changed data sources between these two periods. 
METHODOLOGICAL ISSUES IN THE CALCULATION, REPORTING, AND INTERPRETATION OF THE 
INDICATOR
Euro-Peristat requests data on gestational age based on the best obstetrical estimate, which 
combines clinical and ultrasound data. However, we do not know how this best estimate 
is derived, and it may vary by country as well as between health providers within countries. 
Ultrasound is widely used for dating pregnancies in Europe, however, and most women receive 
care in the first trimester of pregnancy. The method of determining gestational age can 
influence	the	reported	gestational	age	distribution;	use	of	ultrasound	estimates	tends	to	shift	the	
distribution towards earlier gestations and increase the reported preterm birth rate, although 
not all studies have found this to be the case.10 Research about the methods used within Europe 
for determining gestational age and their impact on the gestational age distribution should be 
undertaken to better elucidate the comparability of this indicator. An analysis of the Euro-Peristat 
data showed that for very preterm births, it is preferable to begin comparisons of births from 24 
weeks of gestation onward.14
RESULTS
As shown in Figure C5.1, the preterm birth rate for live births varied from about 6% to 12% 
in participating countries. Lower preterm birth rates (below 6.5%) were observed in Norway, 
Denmark, Latvia, Finland, Estonia, Sweden, Iceland, and Lithuania, and higher rates (at or above 
8.5%) in Germany, Greece, Hungary, and Cyprus. Rates were around 8% in Belgium, Romania, 
Portugal, Austria, England and Wales, Scotland, Italy, Bulgaria, the Czech Republic, Poland, 
Spain, Slovenia, Northern Ireland, and Luxembourg. Very preterm births, that is, births before 32 
weeks of gestational age, accounted for about 1% of live births (range: 0.8 to 1.4%).
Figure C5.2 provides the full gestational age distribution and shows that the extent of variation 
for early term live births between countries is similar in magnitude to the variation in preterm 
birth rates. Rates varied by more than two-fold – between 16% and 44%. Rates were lowest (less 
than or equal to 18%) in Lithuania, Iceland, Latvia, Estonia, and Finland, and highest (above 27%) 
in Greece, Romania, Italy, Luxembourg, Malta, and Cyprus. Countries with higher early term rates 
tended also to have higher preterm birth rates. 
The percentage of preterm births ranged between 4 and 9% among singletons and from 38 
to 70% among multiples (See summary tables C5_B). Similar variations in preterm birth rates 
between countries were observed for both singleton and multiple births, with the exception of 
Romania where a relatively high proportion of singleton preterm births was accompanied by 
a relatively low proportion of multiple preterm births. Conversely, Slovenia had a relatively low 
proportion of singleton preterm births and a relatively high proportion of multiple preterm births. 
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Proportions of preterm live births were similar to those in 2010 for many of the countries. 
Differences between rates in 2010 and 2015 ranged between -0.8 and +1.5 percentage points, as 
shown in Figure 5.4. Relative changes in the percentages of preterm live births are shown in Figure 
C5.4, which also provides 95% confidence intervals for these changes. These percentages were more 
than 5% higher in 2015 than in 2010 in Portugal, England and Wales, Poland, Ireland, France, Cyprus, 
Scotland, and Iceland. Significant declines were seen in the Netherlands, Austria, the Czech Republic, 
Spain, Sweden, and Germany. Overall, the pooled estimate of relative change between the two years 
was 1.02 with a 95% confidence interval from 0.99-1.04.  
KEY POINTS
•	 Gestational	age	is	an	essential	indicator	of	perinatal	health	but	is	still	not	currently	included	
in international data sets, although the data are available almost everywhere and should be 
routinely reported.
•	 There	are	wide	differences	in	the	percentages	of	preterm	and	early	term	births	between	
European countries. These have been confirmed in other international studies in data from 
1996-2010. Heterogeneous patterns of changes in early delivery between 2010 and 2015 raise 
questions about policies and practices associated with changes and challenge us to rethink 
current preventive approaches. 
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Figure C5.1  Percentages of preterm live births overall and by gestational age (22-31 weeks  
  and 32-36 weeks) in 2015 
NOTE:  Number of live births with data for gestational age in parentheses after country name
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Figure C5.2  Percentages of preterm, early term, full term, and post-term live births in 2015
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Figure C5.3  Geographical distribution of preterm births among live births in Europe  
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Figure C5.4  Percentages of live preterm births in 2010 and 2015  
 
 
NOTE:  First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014,Switzerland 2014.
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Figure C5.5  Comparison of live preterm birth rates, 2010 and 2015 (risk ratios and 95%   
  confidence intervals) 
NOTE:  Pooled random effects estimate: 1.02 (95% CI: 0.99-1.04). 
 I2=95.0%, Chi squared tests of heterogeneity: 605.2 (d.f. = 30), p <0.001.
 First-period data not from 2010: Cyprus 2007.
 Second-period data not from 2015: Bulgaria 2014, Poland 2014, Sweden 2014, Switzerland 2014.
 1.5 .75 1.25 1.5
Risk ratios with 95% confidence intervals
Luxembourg
Netherlands
Austria
Czech Republic
Malta
Spain
Sweden
Germany
Denmark
Norway
Hungary
Slovakia
Lithuania
Latvia
Estonia
Greece
Switzerland
Finland
Belgium
Romania
UK: Northern Ireland
Italy
Slovenia
Portugal
UK: England and Wales
Poland
Ireland
France, Survey
Cyprus
UK: Scotland
Iceland
0.90 (0.80, 1.02)
0.92 (0.90, 0.94)
0.93 (0.90, 0.96)
0.93 (0.91, 0.96)
0.94 (0.80, 1.10)
0.94 (0.93, 0.96)
0.96 (0.93, 0.99)
0.97 (0.96, 0.98)
0.97 (0.93, 1.02)
0.98 (0.94, 1.02)
0.98 (0.95, 1.01)
0.99 (0.95, 1.03)
0.99 (0.93, 1.06)
1.00 (0.92, 1.08)
1.01 (0.92, 1.11)
1.01 (0.99, 1.04)
1.02 (0.99, 1.06)
1.02 (0.97, 1.07)
1.02 (1.00, 1.05)
1.03 (1.00, 1.05)
1.03 (0.97, 1.10)
1.03 (1.02, 1.05)
1.04 (0.97, 1.11)
1.05 (1.01, 1.08)
1.08 (1.06, 1.09)
1.11 (1.09, 1.13)
1.13 (1.09, 1.18)
1.15 (1.05, 1.25)
1.15 (1.06, 1.25)
1.17 (1.12, 1.22)
1.17 (0.99, 1.39)
EUROPEAN PERINATAL HEALTH REPORT
140
141
APPENDICES
APPENDIX A: 
LIST OF CONTRIBUTORS TO THE EUROPEAN PERINATAL HEALTH REPORT: 
HEALTH AND CARE OF PREGNANT WOMEN AND BABIES IN EUROPE IN 2015.
* Scientific Committee member
** Executive board member
Austria 
Gerald Haidinger* 
The Medical University of Vienna, Department 
of Epidemiology, Centre of Public Health
Abteilung für Epidemiologie Zentrum für 
Public Health der Medizinische Universität 
Wien
gerald.haidinger@meduniwien.ac.at
Jeannette Klimont 
Statistics Austria
Jeannette.Klimont@statistik.gv.at
Belgium
Sophie Alexander*/** 
Université Libre de Bruxelles, School of Public 
Health, Epidemiology, Biostatistics and Clinical 
Research Centre
Université Libre de Bruxelles, Ecole de 
Santé Publique, Centre de Recherche en 
Epidémiologie, biostatistique et recherche 
clinique
salexand@ulb.ac.be
Wei-Hong Zhang
Université Libre de Bruxelles, School of Public 
Health, Epidemiology, Biostatistics and Clinical 
Research Centre
Université Libre de Bruxelles, Ecole de 
Santé Publique, Centre de Recherche en 
Epidémiologie, biostatistique et recherche 
clinique
wzhang@ulb.ac.be
Michel Willems 
FPS Economy, SMEs, Self-employed and Energy 
Direction générale Statistique et Information 
économique
Direction thématique Société  
Michel.Willems@economie.fgov.be
Freddy Verkruyssen
FPS Economy, SMEs, Self-employed and Energy
Direction générale Satistique et Information 
économique
Direction thématique Société
Freddy.Verkruysen@economie.fgov.be
Frédéric Debiève
Université Catholique de Louvain, 
Departement Obstetrics
Colleges for maternal and neonatal health
frederic.debieve@uclouvain.be  
Virginie van Leeuw
Centre d’Epidémiologie Périnatale (Cepip)
virginie.vanleeuw@cepip.be
Roland Frédéric Devlieger 
KU Leuven, Departement Obstetrics
roland.devlieger@uzleuven.be
Régine Goemans 
Studie Centrum Perinatale Epidemiologie
Olivier Gillis
Brussels-Capital Health and Social Observatory
ogillis@ccc.brussels 
Erik Hendrickx
Flemish Agency for Care and Health
Vlaams Agentschap Zorg en Gezondheid
erik.hendrickx@zorg-en-gezondheid.be
Dominique Dubour 
Agence pour la qualité de la vie
dominique.dubourg@aviq.be
Francoise Renard
Focal Point for the data collection on national 
health statistics for Eurostat, OECD and WHO 
EUROPEAN PERINATAL HEALTH REPORT
142
Bart van Overmeire
Colleges for maternal and neonatal health
Joachim van Keirsblik
Vlaams Vereniging OG perinatal workgroup
Willem Ombelet
Vlaams Vereniging OG perinatal workgroup
Philippe Petit
GOLFB perinatal workgroup
Patrick Emonts 
GOLFB perinatal workgroup
Samuel Ndame
Office de la Naissance et de l’enfance ONE
Bulgaria
Rumyana Kolarova* 
National Center of Public Health and Analyses
r.kolarova@ncpha.government.bg
Evelin Jordanova 
National Stastitical Institute 
Croatia 
Urelija Rodin* 
Croatian National Institute of Public Health
urelija.rodin@hzjz.hr
Boris Filipovic-Grcic
School of Medicine University of Zagreb
Cyprus 
Vasos Scoutellas*
Ministry of Health, Health Monitoring Unit
vscoutellas@mphs.moh.gov.cy
Despina Stylianou
Ministry of Health, Health Monitoring Unit
dstylianou@moh.gov.cy
Theopisti Kyprianou 
Ministry of Health, Health Monitoring Unit
tkyprianou@moh.gov.cy
Afroditi Elisseou
Gynecologist Obstetrician, Mother and Child 
Medical Centre
afroditi.elisseou@cytanet.com.cy
Thalia Papadouri
Pediatrics Department, Makarios III Hospital
TPapadouri@mphs.moh.gov.cy
Gabriel Kalakoutis
Obstetrics & gynaecology, Aretaeio Hospital
g.kalakoutis@aretaeio.com.cy 
Czech Republic 
Petr Velebil* 
Institute for the Care of Mother and Child
Ustav pro peci o matku a dite
VelebilP@seznam.cz
Denmark 
Laust Hvas Mortensen* 
Statistics Denmark  
LHM@dst.dk
Anne-Marie Nybo Anderson
University of Copenhagen
amny@sund.ku.dk
Estonia 
Luule Sakkeus* 
Estonian Institute for Population Studies, 
School of Governance, Law and Society, Tallinn 
Universityluule.sakkeus@tlu.ee
Kärt Allvee
Estonian Medical Birth Register, National 
Institute for Health Development 
kart.allvee@tai.ee 
Gleb Denissov 
Register of Causes of Death,  National Institute 
for Health Development
gleb.denissov@tai.ee
Finland 
Mika Gissler*/** 
THL National Institute for Health and Welfare
Professor
mika.gissler@thl.fi
143
Anna Heino
THL National Institute for Health and Welfare
Special planning officer
Anna.heino@thl.fi
France 
Béatrice Blondel*/** 
French National Institute of Health and 
Medical Research (INSERM) U1153-EPOPé
Institut national de la santé et de la recherche 
médicale
beatrice.blondel@inserm.fr
Alice Hocquette**
French National Institute of Health and 
Medical Research (INSERM) U1153-EPOPé
Institut national de la santé et de la recherche 
médicale
alice.hocquette@inserm.fr
Marie Delnord**
French National Institute of Health and 
Medical Research (INSERM) U1153-EPOPé
Institut national de la santé et de la recherche 
médicale
marie.delnord@inserm.fr
Catherine Deneux Tharaux
French National Institute of Health and 
Medical Research (INSERM) U1153-EPOPé
Institut national de la santé et de la recherche 
médicale
catherine.deneux-tharaux@inserm.fr
Monica Saucedo
French National Institute of Health and 
Medical Research (INSERM) U1153-EPOPé
Institut national de la santé et de la recherche 
médicale
monica.saucedo@inserm.fr
Mélanie Durox**
French National Institute of Health and 
Medical Research (INSERM) U1153-EPOPé
Institut national de la santé et de la recherche 
médicale
melanie.durox@inserm.fr
Jennifer Zeitlin**
French National Institute of Health and 
Medical Research (INSERM) U1153-EPOPé
Institut national de la santé et de la recherche 
médicale
jennifer.zeitlin@inserm.fr
Grégoire Rey
National Center of Statistics for Medical Causes 
of Death (CépiDc) 
French National Institute of Health and 
Medical Research (INSERM)
Institut national de la santé et de la recherche 
médicale
gregoire.rey@inserm.fr
Jeanne Fresson
Directorate for Research, Studies, Assessment, 
and Statistics (DREES), The Health and 
Solidarity Ministerial
Direction de la recherche, des études, de 
l’évaluation et des statistiques (DREES), 
Ministère des Solidarités et de la Santé
Jeanne.FRESSON@sante.gouv.fr
Annick Vilain
Directorate for Research, Studies, Assessment, 
and Statistics (DREES), The Health and 
Solidarity Ministerial
Direction de la recherche, des études, de 
l’évaluation et des statistiques (DREES), 
Ministère des Solidarités et de la Santé
Annick.VILAIN@sante.gouv.fr
Sylvie Rey
Directorate for Research, Studies, Assessment, 
and Statistics (DREES), The Health and 
Solidarity Ministerial
Direction de la recherche, des études, de 
l’évaluation et des statistiques (DREES), 
Ministère des Solidarités et de la Santé
Sylvie.REY@sante.gouv.fr
EUROPEAN PERINATAL HEALTH REPORT
144
Germany 
Nicholas Lack*
Bavarian Institute for Quality Assurance
n.lack@baq-bayern.de
Guenther Heller*
IQTIG
Institut für Qualitätssicherung und Transparenz 
im Gesundheitswesen
guenther.heller@iqtig.org
Anton Scharl 
Department of Obstetrics and Gynaecology, 
Klinikum Amberg
Greece 
Aris Antsaklis*
Athens University Medical School
Department of Fetal Maternal and Perinatal 
Medicine
arisants@otenet.gr
Peter Drakakis
Athens University Medical School
Konstantinos Voulgaris
Hellenic Statistical Authority ELSTAT 
k.voulgaris@statistics.gr
Hungary 
István Berbik*
Department of Obstetrics and Gynaecology
Vaszary Kolos Teaching Hospital
Vaszary Kolos Kórház 
Iceland 
Helga Sól Ólafsdóttir* 
Landspitali University Hospital 
Department of Obstetrics and Gynaecology
Landspítali v/ Hringbraut
helgasol@landspitali.is
Ragnheiður I. Bjarnadottir, 
Landspitali University Hospital
Landspítali v/ Hringbraut
Hildur Harðardóttir
Landspitali University Hospital
Landspítali v/ Hringbraut
Brynja Ragnarsdóttir
Landspitali University Hospital
Landspítali v/ Hringbraut
Vigdís Stefánsdóttir 
Landspitali University Hospital
Landspítali v/ Hringbraut
Sigríður Haraldsdóttir
Landlaeknis Directorate of Health
Ireland
Sheelagh Bonham* 
The Healthcare Pricing Office (HPO)
sheelagh.bonham@hpo.ie
Edel Manning
University College Cork
Department of Obstetrics and Gynaecology
E.Manning@ucc.ie
Italy
Marina Cuttini*
Clinical Care and Management Innovation 
Research Area, Bambino Gesù Children’s 
Hospital, IRCCS
Area di Ricerca Innovazioni Clinico-Gestionali 
e Tecnologiche, Ospedale Pediatrico Bambino 
Gesù, IRCCS
marina.cuttini@opbg.net
Maria Lacchei
Clinical Care and Management Innovation 
Research Area, Bambino Gesù Children’s 
Hospital, IRCCS
Area di Ricerca Innovazioni Clinico-Gestionali 
e Tecnologiche, Ospedale Pediatrico Bambino 
Gesù, IRCCS
maria.lacchei@opbg.net
Cristina Tamburini
Director of Statistics Unit, Directorate General 
of Digitalization, Health Information System 
and Statistics, Italian Ministry of Health
Direttore dell’Ufficio di Statistica, Direzione 
Generale del Sistema di Digitalizzazione e 
Informativo Sanitario e di Statistica, Ministero 
della Salute
c.tamburini@sanita.it
145
Fulvio Basili
Statistics Unit, Directorate General of 
Digitalization, Health Information System and 
Statistics, Italian Ministry of Health
Ufficio di Statistica, Direzione Generale del 
Sistema di Digitalizzazione e Informativo 
Sanitario e di Statistica, Ministero della Salute
f.basili@sanita.it
Valerio Montorio
Statistics Unit, Directorate General of 
Digitalization, Health Information System and 
Statistics, Italian Ministry of Health
Ufficio di Statistica, Direzione Generale del 
Sistema di Digitalizzazione e Informativo 
Sanitario e di Statistica, Ministero della Salute
v.montorio@sanita.it
Marzia Loghi
Integrated Service System for Health, 
Assistance, Welfare and Justice, Italian 
National Institute for Statistics
Servizio Sistema integrato salute, assistenza, 
previdenza e giustizia, Istituto Nazionale di 
Statistica
loghi@istat.it
Marilena Pappagallo
Integrated Service System for Health, 
Assistance, Welfare and Justice, Italian 
National Institute for Statistics 
Servizio Sistema integrato salute, assistenza, 
previdenza e giustizia, Istituto Nazionale di 
Statistica
pappagal@istat.it
Serena Donati
National Centre for Diseases Prevention and 
Health Promotion, National Institute of Health
Centro Nazionale Prevenzione delle Malattie e 
Promozione della Salute, Istituto Superiore di 
Sanità
serena.donati@iss.it
Alice Maraschini
National Centre for Diseases Prevention and 
Health Promotion, National Institute of Health
Centro Nazionale Prevenzione delle Malattie e 
Promozione della Salute, Istituto Superiore di 
Sanità
alice.maraschini@iss.it
Latvia 
Janis Misins*
Centre for Disease Prevention and Control of 
Latvia 
Slimïbu Profilakses un Kontroles Centrs (SPKC)
janis.misins@spkc.gov.lv
Irisa Zile
Centre for Disease Prevention and Control of 
Latvia
Slimïbu Profilakses un Kontroles Centrs (SPKC)
irisa.zile@spkc.gov.lv
Lithuania 
Jelena Isakova* 
Institute of Hygiene, Health Information 
Centre
Higienos institutas
jelena.isakova@hi.lt
Rita Gaidelyte
Institute of Hygiene, Health Information 
Centre
Higienos institutas
rita.gaidelyte@hi.lt
Luxembourg
Guy Weber* (starting in 2015)
Ministry of Health, Directorate of Health, 
Epidemiology and Statistics Unit
Ministère de la Santé, Direction de la Santé, 
Service Epidémiologie & Statistiques
guy.weber@ms.etat.lu
Nathalie de Rekeneire*
Ministry of Health, Directorate of Health, 
Epidemiology and Statistics Unit
Ministère de la Santé, Direction de la Santé, 
Service Epidémiologie & Statistiques
nathalie.derekeneire@ms.etat.lu
Diane Pivot
Ministry of Health, Directorate of Health, 
Epidemiology and Statistics Unit
Ministère de la Santé, Dirrection de la Santé,
Service Epidémiologie & Satistiques
diane.picot@ms.etat.lu
EUROPEAN PERINATAL HEALTH REPORT
146
Yolande Wagener* (until 2015)
Ministry of Health, Department of Health,
Ministère de la Santé, Direction de la Santé, 
Division de la Médecine Scolaire
Audrey Billy 
Luxembourg Institute of Health, Department 
of Population Health 
audrey.billy@lih.lu
Sophie Couffignal
Luxembourg Institute of Health, Department 
of Population Health 
sophie.couffignal@lih.lu
Aline Lecomte
Luxembourg Institute of Health, Department 
of Population Health 
aline-lecomte@lih.lu
Malta 
Miriam Gatt* 
Directorate for Health Information and 
Research, National Obstetric Information 
Systems (NOIS) Register
miriam.gatt@gov.mt
Netherlands  
Jan Nijhuis* 
Maastricht University Medical Center, 
Department of Obstetrics & Gynecology, 
Maastricht 
Universiteit Maastricht, Medisch Centrum, 
Afdeling Obstetrie en Gynaecologie 
jg.nijhuis@mumc.nl 
Ashna Hindori - Mohangoo** 
TNO Healthy Living, Department Child Health, 
Leiden 
ashna.mohangoo@tno.nl 
Perinatal Interventions Suriname, Perisur 
Foundation, Paramaribo 
ashna.mohangoo@perisur.org
Peter Achterberg 
National Institute for Public Health and the 
Environment (RIVM)
Peter.achterberg@rivm.nl 
Koos van der Velden
The Netherlands Organisation for Health 
Research and Development (ZonMw)
Koos.vanderVelden@radboudumc.nl
Pien Offerhaus
The Royal Dutch College of Midwives (KNOV)
p.offerhaus@av-m.nl
Anneke Kwee
The Netherlands Society of Obstetrics and 
Gynaecology (NVOG)
A.Kwee@umcutrecht.nl
Floris Groenendaal
Paediatric Association of the Netherlands 
(NVK)
F.Groenendaal@umcutrecht.nl
Lisa Broeders 
The Netherlands Perinatal Registry and Audit 
(Perined)
lbroeders@perined.nl 
Chantal Hukkelhoven
Wageningen University
onderzoekerchukkelhoven@perined.nl
Anita Ravelli 
Academic Medical Research Center 
a.c.ravelli@amc.uva.nl 
Adja Waelput 
Erasmus Medical Center 
a.waelput@erasmusmc.nl
Norway 
Kari Klungsoyr* 
Norwegian Institute of Public Health 
Department of Health Promotion
Kari.Klungsoyr@fhi.no
University	of	Bergen;	Department	of	Public	
Health and Primary Care
kari.klungsoyr@uib.no
Rupali Akerkar
Norwegian Institute of Public Health 
Department of Health Data Management and 
Analysis
Rupali.Akerkar@fhi.no
147
Poland 
Katarzyna Szamotulska*/** 
National Research Institute of Mother and 
Child, Department of Epidemiology and 
Biostatistics 
Instytut Matki i Dziecka, Zaklad Epidemiologii i 
Biostatystyki
szamotul@imid.med.pl
Ewa Mierzejewska 
National Research Institute of Mother and 
Child, Department of Epidemiology and 
Biostatistics 
Instytut Matki i Dziecka, Zaklad Epidemiologii i 
Biostatystyki
ewa.mierzejewska@imid.med.pl
with collaboration from The Central Statistical 
Office, the National Health Fund and Ministry 
of Health
Portugal 
Henrique Barros*/**
University of Porto Medical School, 
Department of Hygiene and Epidemiology 
Serviço de Higiene e Epidemiologia, Faculdade 
de Medicina do Porto 
Hbarros@med.up.pt
Sofia Correia 
University of Porto Medical School, 
Department of Hygiene and Epidemiology 
Serviço de Higiene e Epidemiologia, Faculdade 
de Medicina do Porto 
scorreia@med.up.pt
Anna Isabel Ribeiro
EPIUnit – Institute of Public Health, University 
of Porto
EPIUnit - Instituto de Saúde Pública, 
Universidade do Porto
Department of Public Health and Forensic 
Sciences and Medical Education, Faculty of 
Medicine, University of Porto
Departamento de Ciências da Saúde Pública 
e Forenses e Educação Médica, Faculdade de 
Medicina, Universidade do Porto
ana.isabel.ribeiro@ispup.up.pt
Romania 
Mihai Horga*
East European Institute for Reproductive 
Health
mhorga@eeirh.org
Vlad Tica 
East European Institute for Reproductive 
Health
Faculty of Medicine, University “Ovidius” 
Constanta
vtica@eeirh.org
Alexandra Cucu
National Institute of Public Health, Minsitry of 
Health
alexandracucu2003@yahoo.com
Lucian Puscasiu
East European Institute for Reproductive 
Health
University of Medicine and Pharmacy Tirgu-
Mures
lpuscasiu@eeirh.org
Slovakia
Ján Cáp*
National Health Information Center
Národné centrum zdravotníckych informácií
jan.cap@nczisk.sk
Slovenia 
Natasa Tul Mandic*
University Medical Centre, Perinatology Unit, 
Ljubljana University 
Univerze v Ljubljani
natasa.tul@guest.arnes.si
Ivan Verdenik 
University Medical Centre, Department of 
Obstetrics & Gynecology, Research Unit
ivan.verdenik@guest.arnes.si
Spain 
Francisco Bolúmar*
Alcala University Medical School, Department 
of Health Sciences and Social Medicine
Universidad de Alcalá, Departamento de 
Ciencias Sanitarias y Médico Sociales
francisco.bolumar@uah.es
EUROPEAN PERINATAL HEALTH REPORT
148
Óscar Zurriaga 
Subdirector General de Investigación, 
Innovación, Tecnología y Calidad
Dirección General de Investigación, Innovación, 
Tecnología y Calidad
zurriaga_osc@gva.es
Mireia Jané
Sub-directorate General for Epidemiological 
Surveillance and Public Health Emergency 
Response at the Public Health Agency of 
Catalonia
Sub-direcció General de Vigilància i Resposta a 
Emergències de Salut Pública
mireia.jane@gencat.cat
Maria José Vidal
Sub-directorate General for Epidemiological 
Surveillance and Public Health Emergency 
Response at the Public Health Agency of 
Catalonia
Sub-direcció General de Vigilància i Resposta a 
Emergències de Salut Pública
mjose.vidal@gencat.cat
Carmen Barona
Public Health, Generalitat Valenciana
Dirección General de Salud Pública  
Rosa Mas
Public Health, Generalitat Valenciana
Dirección General de Salud Pública  
Adela Recio Alcaide
Senior Statistical State Corps
adelarecioalcaide@gmail.com
Sweden 
Karin Källén*
The National Board of Health and Welfare, 
Department of Evaluation and Analysis, 
Epidemiology and Methodological Support 
Unit
Socialstyrelsen
karin.kallen@socialstyrelsen.se
Karin Gottvall*
The National Board of Health and Welfare 
Department of Statistics, Monitoring and 
Evaluation
Socialstyrelsen
karin.gottvall@socialstyrelsen.se
Ellen Lundqvist 
The National Board of Health and Welfare, 
Department of Statistics 
and Comparisons, Statistics Unit 2
ellen.lundqvist@socialstyrelsen.se 
Switzerland 
Mélanie Riggenbach*
Swiss Federal Statistical Office, Section Health
Office fédéral de la statistique, Section Santé 
de la population
Melanie.Riggenbach@bfs.admin.ch
Suzanne Grylka 
Institut für Hebammen, ZHAW Zürcher, 
Hochschule für Angewandet Wissenschaften 
Andrea Weber-Käser 
Schweizerischer Hebammenverband 
United Kingdom
Alison Macfarlane*/**
Maternal and Child Health Research Centre,
School of Health Sciences,
City, University of London, England
a.j.macfarlane@city.ac.uk
Nirupa Dattani
Maternal and Child Health Research Centre,
School of Health Sciences,
City, University of London, England
n.dattani.1@city.ac.uk
Lucy Smith
MBRRACE collaboration, Department of Health 
Sciences, University of Leicester, England
lucy.smith@leicester.ac.uk
Marian Knight
MBRRACE collaboration, National Perinatal 
Epidemiology Unit, University of Oxford, 
England
marian.knight@npeu.ox.ac.uk
Elizabeth McLaren
Office for National Statistics, Health Analysis 
and Life Events, Titchfield, England
elizabeth.mclaren@ons.gov.uk
https://www.ons.gov.uk/
peoplepopulationandcommunity/
healthandsocialcare/childhealth
149
Nicola Haines 
Office for National Statistics, Health Analysis 
and Life Events, Titchfield, England
Nicola.haines@ons.gov.uk
Vasita Patel
Office for National Statistics, Health Analysis 
and Life Events, Titchfield, England
Vasita.Patel@ons.gov.uk
Dominic Gair 
Analytical Section Head, Secondary Care 
Service, NHS Digital, Leeds, England
dominic.gair@nhs.net
Hannah Knight
National Maternity and Perinatal Audit
Royal College of Obstetricians and 
Gynaecologists
London, England
Craig Thomas
Ystadegau iechyd sylfaenol & chymunedol a 
gwasanaethau cymdeithasol
Primary & community health and social services 
statistics 
Ystadegau iechyd, gwasanaethau cymdeithasol 
a phoblogaeth Iechyd
Health, social services and population statistics
Gwasanaethau Gwybodaeth a Dadansoddi
Knowledge and Analytical Services 
Llywodraeth Cymru
Welsh Government 
Craig.Thomas3@gov.wales
Rhian Osborne
Ystadegau iechyd sylfaenol & chymunedol a 
gwasanaethau cymdeithasol
Primary & community health and social services 
statistics 
Ystadegau iechyd, gwasanaethau cymdeithasol 
a phoblogaeth Iechyd
Health, social services and population statistics
Gwasanaethau Gwybodaeth a Dadansoddi
Knowledge and Analytical Services 
Llywodraeth Cymru
Welsh Government 
rhian.osborne@gov.wales
Mark Piper 
Information Manager (Acute), NHS Wales 
Informatics Service, Gwasanaeth Gwybodeg 
GIG Cymru, Pontypool, Wales
Mark.Piper@wales.nhs.uk 
Rachael Wood
NHS National Services Scotland, Information 
Services Division, Edinburgh, Scotland
rachaelwood@nhs.net
Nicola Steedman
NHS National Services Scotland, Information 
Services Division, Edinburgh, Scotland
Nicola.steedman1@nhs.net
Samantha Clarke
NHS National Services Scotland, Information 
Services Division, Edinburgh, Scotland
samanthaclarke@nhs.net
Kirsten Monteath
NHS National Services Scotland, Information 
Services Division, Edinburgh, Scotland
kirsten.monteath@nhs.net 
Sean Mallon
Hospital Information Branch, Department of 
Health NI, Belfast Northern Ireland
sean.mallon@health-ni.gov.uk
Siobhán Morgan
Hospital Information Branch, Department of 
Health NI, Belfast Northern Ireland
Siobhan.Morgan@health-ni.gov.uk
https://www.health-ni.gov.uk/topics/doh-
statistics-and-research
Sinead Magill
Northern Ireland Maternal and Child Health, 
Public Health Agency, Belfast, Northern Ireland
sinead.magill@hscni.net
Heather Reid
Northern Ireland Maternal and Child Health, 
Public Health Agency, Belfast, Northern Ireland
heather.reid@hscni.net
EUROPEAN PERINATAL HEALTH REPORT
150
APPENDIX B
TABLE OF CONTENTS
Core Indicators
C1_A:  Fetal mortality rate by gestational age and birth weight (numbers)
C1_B:  Fetal mortality rate by gestational age and birth weight (rates per 1000 total births)
C2_A:  Neonatal mortality rate  (numbers and rates per 1000 live births)
C2_B:  Neonatal mortality rate  for births at ≥24 weeks of gestation
C3:  Infant mortality rate  (numbers and rates per 1000 live births)
C4_A:  Distribution of birth weight for live births
C4_B:  Distribution of birth weight by plurality for live births
C5_A:  Distribution of gestational age for live births
C5_B:  Distribution of gestational age by plurality for live births
C6_A:  Maternal mortality ratio (numbers and ratios per 100 000 live births) from  
 routine statistics
C6_B:  Maternal mortality ratio (numbers and ratios per 100 000 live births) from  
 enhanced data systems
C7:  Multiple mortality rate  (rates per 100 women)
C8:  Distribution of maternal age (rates per 100 women)
C9:  Distribution of parity (rates per 100 women)
C10:  Mode of delivery (rates per 100 total births)
Recommended Indicators
R8:  Percentage of women who smoked during pregnancy
R12:  Distribution of maternal pre-pregnancy body mass index
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Number of total births Number of fetal deaths Number of terminations Number of fetal deaths without 
terminations (if possible)
Country/
coverage
Source Inclusion criteria for 
fetal deaths
All* ≥1000 g ≥28
weeks
≥24
weeks
All* ≥1000 g ≥28
weeks
≥24
weeks
All* ≥1000 g ≥28
weeks
≥24
weeks
All* ≥1000 g ≥28
weeks
≥24
weeks
Belgium 1 500+ grams. if BW 
unknown, 22+ weeks; 
cannot distinguish 
terminations
122 838 120 524 120 584 121 109 598 359 368 530 598 359 368 530
Bulgaria 
(2014)1
1,3 a) 800+ grams and 
/ or 26+ weeks of 
gestation;
b) <800 grams and / or 
<26 weeks - provided 
that the foetus was 
born alive and lived at 
least 3 days
68 122 67 719 67 806 68 047 537 367 388 471 43 0 0 0 494 367 388 471
Czech 
Republic
1 500+ grams if BW not 
available 22+ weeks. 
Cannot distinguish 
terminations from fetal 
deaths
111 162 108 962 108 179 108 536 398 274 296 348 398 274 296 348
Denmark 1,2,4 22+ weeks 57 871 57 028 57 558 57 734 194 NA 115 146 24 0 0 0 170 NA 115 146
Germany2 1 500+ grams 728 496 723 416 724 006 NA 2559 1630 1759 NA 2559 1630 1759 NA
Estonia 1,3,4 22+ weeks. 
Terminations register 
includes pregnancies 
up to 20 weeks, thus all 
fetal deaths in Estonia 
are without terminations
13 961 13 897 13 897 13 948 54 39 43 50 0 0 0 0 54 39 43 50
Ireland 1 24+ weeks or 500+ 
grams ( national 
criteria), Source 1: 
500+ grams only. 
Induced abortions not 
included
65 913 65 586 65 627 65 837 290 189 222 273 0 0 0 0 290 189 222 273
Greece 1 22+ weeks 92 159 90 683 91 119 91 447 312 243 270 308 312 243 270 308
Spain 1 180+ days / 500 
grams 
421 590 398 599 356 157 357 270 1307 897 968 1106 1307 897 968 1106
France 5 22 weeks or 500 grams. 
Terminations included
764 704 758 775 758 852 762 961 6648 2501 3359 5172 2824 885 1073 2208 3824 1616 2286 2964
France 
(Survey, 
2016)
1 22+ weeks 13 369 13 211 13 217 13 305 137 58 63 102 58 24 23 45 79 34 40 57
Croatia 1 22+ weeks.Terminations 
not included 
37 428 37 234 37 237 37 391 176 112 119 160 0 0 0 0 176 112 119 160
Italy 8 fetal death: 180+ days 
miscarriage: <180 
days
487 042 483 759 482 647 484 213 2265 1067 1175 1442 485 NA 0 6 1780 1067 1175 1436
Cyprus 1 22+ weeks or 500+ 
grams. Cannot 
distinguish TOP
9425 9333 9219 9247 31 10 13 17 31 10 13 17
Latvia 3 22+ weeks 500 grams 
(if BW < 500 g but 
GA ≥ 22). Induced 
abortions not included
21 826 21 721 21 728 21 798 106 70 73 86 0 0 0 0 106 70 73 86
Lithuania1,3 1,2,3 22+ weeks 31 601 31 483 31 491 31 577 126 84 90 113 0 0 0 0 126 84 90 113
Luxembourg 1 22+ weeks or 500+ 
grams
6889 6837 6842 6873 57 26 27 43 27 12 11 21 30 14 16 22
Hungary 1 Miscarriage/abortion: 
<24 weeks or if GA 
missing, <30 cm or 
<500 grams. Late 
fetal death (stillbirth): 
24+ weeks, or if GA 
missing, 30+ cm or 
500+ grams, while in 
case of twin birth at 
least one of the fetus 
was born alive
92 253 91 386 91 507 92 002 573 311 338 407 47 NA 0 1 526 311 338 406
C1_A: Fetal mortality rate by gestational age and birth weight (numbers)    
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Number of total births Number of fetal deaths Number of terminations Number of fetal deaths without 
terminations (if possible)
Country/
coverage
Source Inclusion criteria for 
fetal deaths
All* ≥1000 g ≥28
weeks
≥24
weeks
All* ≥1000 g ≥28
weeks
≥24
weeks
All* ≥1000 g ≥28
weeks
≥24
weeks
All* ≥1000 g ≥28
weeks
≥24
weeks
Malta 1,2 22+ weeks - if GA 
missing 500+ grams
4453 4425 4429 4448 18 8 11 15 0 0 0 0 18 8 11 15
Netherlands 1 Perined registrates all 
fetal deaths from  16+ 
weeks. However, for 
the core indicators: 
22+ weeks or – if GA 
unknown 500+ grams. 
Induced abortions are 
included
169 234 167 584 165 475 166 113 809 345 358 482 809 345 358 482
Austria 1 Only stillbirths are 
included (defined 
according the WHO 
definition - 500 grams 
limit). Terminations not 
registered
83 884 83 465 83 496 83 788 277 188 202 245 0 0 0 0 277 188 202 245
Poland 
(2014)
1 500+ grams, if BW 
unknown 22+ weeks 
376 968 375 160 375 283 376 612 1321 887 932 1169 0 0 0 0 1321 887 932 1169
Portugal 1 22+ weeks (equivalent 
to 500 grams). If GA<24 
weeks (equivalent to 
<500 grams), death 
certificate is not 
compulsory unless 
the mother wants to 
register it or there is 
a suspicious of an 
induced abortion
86 048 85 448 85 587 85 841 286 NA 218 263 286 NA 218 263
Romania 3 Fetal deaths do not 
include abortions
201 760 201 178 201 298 201 738 737 688 724 734 0 0 0 0 737 688 724 734
Slovenia 1 500+ grams. Induced 
abortions are included
20 397 20 259 20 271 20 370 124 67 72 108 61 26 24 47 63 41 48 61
Slovakia 1 22+ weeks 55 824 55 610 55 647 55 809 209 192 197 201 0 0 0 0 209 192 197 201
Finland 1 22+ weeks 55 832 55 507 55 481 55 638 244 105 114 141 73 NA 0 3 171 105 114 138
Sweden 
(2014)
1 22+ weeks. Induced 
abortions are not 
included
115 710 115 156 115 206 115 586 464 323 350 423 0 0 0 0 464 323 350 423
United 
Kingdom
1 22+ weeks 4429 2289 2486 3501 884 204 197 485 3545 2085 2289 3016
UK: England 
and Wales
2 24+ weeks 699 204 683 190 692 387 695 596 3147 2067 2232 3147 234 110 109 234 2913 1957 2123 2913
UK: Scotland 1 22+ weeks. Fetal 
deaths at 22+ weeks 
can be identified from 
hospital discharge data. 
In addition fetal deaths 
at 24+ weeks are 
registered by law
54 550 54 171 54 033 54 242 262 139 155 208 37 1 2 10 225 138 153 198
UK: Northern 
Ireland
1 24+ weeks. 
Terminations cannot be 
identified from data
24 544 24 420 24 461 24 533 82 56 63 82 82 56 63 82
Iceland 2 Fetal deaths: 22+ weeks. 
Terminations are not 
allowed after 22 weeks
4098 4079 4080 4088 10 8 8 8 0 0 0 0 10 8 8 8
Norway 1 22+ weeks or 500+ 
grams. Induced 
abortions are not 
included. Only 
terminations due to 
fetal anormaly are 
recorded
59 931 59 640 59 467 59 668 220 130 136 181 3 0 1 2 217 130 135 179
Switzerland 
(2014) 
1 22+ weeks or >500 
grams. If <22 weeks 
and <500 grams, 
included only if there is 
a twin alive
85 263 84 741 84 778 85 099 372 176 209 279 57 7 9 25 315 169 200 254
 NOTES: Fetal mortality rate per 1000 total births = ((number of fetal death)/(number of total births))*1000      
Euro-Peristat requested data for all births at 22 completed weeks of gestation or with a birth weight of 500 grams if gestational age was missing.      
* this includes births with unknown GA 22+ weeks          
1. In Bulgaria and Lithuania, all live births with unknown GA (N=2476 for Bulgaria; N=2579 for Lithuania) were considered as live births occurring at 24+ weeks of gestational age and all live births  
with unknown BW (N=2772 for Bulgaria; N=2579 for Lithuania) were considered as live births occurring at 1000+ grams.          
2. In Germany, 124 fetal deaths among 869 infants with birth weight below 500 g were documented in the database.          
3.  In Lithuania, all stillbirths with unknown GA N=3 were considered stillbirths occurring at 24+ weeks of gestational age and all stillbirths with unknown BW N=3 were considered stillbirths occurring at 1000+ grams.   
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 Fetal mortality rate per 1000 total births
 (without terminations, if possible)
Fetal mortality rate per 1000 total births
Country/coverage Source All* ≥1000 g ≥28 weeks ≥24 weeks All* ≥1000 g ≥28 weeks ≥24 weeks
Belgium 1 4.9 3.0 3.1 4.4 4.9 3.0 3.1 4.4
Bulgaria1 1,3 7.3 5.4 5.7 6.9 7.9 5.4 5.7 6.9
Czech Republic 1 3.6 2.5 2.7 3.2 3.6 2.5 2.7 3.2
Denmark 1,2,4 2.9 NA 2.0 2.5 3.4 NA 2.0 2.5
Germany 1 3.5 2.3 2.4 3.1 3.5 2.3 2.4 3.1
Estonia 1,3,4 3.9 2.8 3.1 3.6 3.9 2.8 3.1 3.6
Ireland 1 4.4 2.9 3.4 4.1 4.4 2.9 3.4 4.1
Greece 1 3.4 2.7 3.0 3.4 3.4 2.7 3.0 3.4
Spain 1 3.1 2.3 2.7 3.1 3.1 2.3 2.7 3.1
France 5 5.0 2.1 3.0 3.9 8.7 3.3 4.4 6.8
France (Survey, 2016) 1 5.9 2.6 3.0 4.3 10.2 4.4 4.8 7.7
Croatia 1 4.7 3.0 3.2 4.3 4.7 3.0 3.2 4.3
Italy 8 3.7 2.2 2.4 3.0 4.7 2.2 2.4 3.0
Cyprus 1 3.3 1.1 1.4 1.8 3.3 1.1 1.4 1.8
Latvia 3 4.9 3.2 3.4 3.9 4.9 3.2 3.4 3.9
Lithuania1 1,2,3 4.0 2.7 2.9 3.6 4.0 2.7 2.9 3.6
Luxembourg 1 4.4 2.0 2.3 3.2 8.3 3.8 3.9 6.3
Hungary 1 5.7 3.4 3.7 4.4 6.2 3.4 3.7 4.4
Malta 1,2 4.0 1.8 2.5 3.4 4.0 1.8 2.5 3.4
Netherlands 1 4.8 2.1 2.2 2.9 4.8 2.1 2.2 2.9
Austria 1 3.3 2.3 2.4 2.9 3.3 2.3 2.4 2.9
Poland 1 3.5 2.4 2.5 3.1 3.5 2.4 2.5 3.1
Portugal 1 3.3 NA 2.5 3.1 3.3 NA 2.5 3.1
Romania 3 3.7 3.4 3.6 3.6 3.7 3.4 3.6 3.6
Slovenia 1 3.1 2.0 2.4 3.0 6.1 3.3 3.6 5.3
Slovakia 1 3.7 3.5 3.5 3.6 3.7 3.5 3.5 3.6
Finland 1 3.1 1.9 2.1 2.5 4.4 1.9 2.1 2.5
Sweden 1 4.0 2.8 3.0 3.7 4.0 2.8 3.0 3.7
United Kingdom
UK: England and Wales 2 4.2 2.9 3.1 4.2 4.5 3.0 3.2 4.5
UK: Scotland 1 4.1 2.5 2.8 3.7 4.8 2.6 2.9 3.8
UK: Northern Ireland 1 3.3 2.3 2.6 3.3 3.3 2.3 2.6 3.3
Iceland 2 2.4 2.0 2.0 2.0 2.4 2.0 2.0 2.0
Norway 1 3.6 2.2 2.3 3.0 3.7 2.2 2.3 3.0
Switzerland 1 3.7 2.0 2.4 3.0 4.4 2.1 2.5 3.3
NOTES: Fetal mortality rate per 1000 total births = ((number of fetal death)/(number of total births))*1000      
Euro-Peristat requested data for all births at 22 completed weeks of gestation or with a birth weight of 500 grams if gestational age was missing.   
In Germany, 124 fetal deaths among 869 infants with birthweight below 500 g were documented in the database     
* this includes births with unknown GA 22+ weeks          
1: In Bulgaria and Lithuania, all live births with unknown GA (N=2476 for Bulgaria; N=2579 for Lithuania) were considered as live births occurring at 24+ weeks of gestational 
age and all live births with unknown BW (N=2772 for Bulgaria; N=2579 for Lithuania) were considered as live births occurring at 1000+ grams    
              
     
C1_B: Fetal mortality rate by gestational age and birth weight (rates per 1000 total births)
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 Fetal mortality rate per 1000 total births
 (without terminations, if possible)
Fetal mortality rate per 1000 total births
Country/coverage Source All* ≥1000 g ≥28 weeks ≥24 weeks All* ≥1000 g ≥28 weeks ≥24 weeks
Belgium 1 4.9 3.0 3.1 4.4 4.9 3.0 3.1 4.4
Bulgaria1 1,3 7.3 5.4 5.7 6.9 7.9 5.4 5.7 6.9
Czech Republic 1 3.6 2.5 2.7 3.2 3.6 2.5 2.7 3.2
Denmark 1,2,4 2.9 NA 2.0 2.5 3.4 NA 2.0 2.5
Germany 1 3.5 2.3 2.4 3.1 3.5 2.3 2.4 3.1
Estonia 1,3,4 3.9 2.8 3.1 3.6 3.9 2.8 3.1 3.6
Ireland 1 4.4 2.9 3.4 4.1 4.4 2.9 3.4 4.1
Greece 1 3.4 2.7 3.0 3.4 3.4 2.7 3.0 3.4
Spain 1 3.1 2.3 2.7 3.1 3.1 2.3 2.7 3.1
France 5 5.0 2.1 3.0 3.9 8.7 3.3 4.4 6.8
France (Survey, 2016) 1 5.9 2.6 3.0 4.3 10.2 4.4 4.8 7.7
Croatia 1 4.7 3.0 3.2 4.3 4.7 3.0 3.2 4.3
Italy 8 3.7 2.2 2.4 3.0 4.7 2.2 2.4 3.0
Cyprus 1 3.3 1.1 1.4 1.8 3.3 1.1 1.4 1.8
Latvia 3 4.9 3.2 3.4 3.9 4.9 3.2 3.4 3.9
Lithuania1 1,2,3 4.0 2.7 2.9 3.6 4.0 2.7 2.9 3.6
Luxembourg 1 4.4 2.0 2.3 3.2 8.3 3.8 3.9 6.3
Hungary 1 5.7 3.4 3.7 4.4 6.2 3.4 3.7 4.4
Malta 1,2 4.0 1.8 2.5 3.4 4.0 1.8 2.5 3.4
Netherlands 1 4.8 2.1 2.2 2.9 4.8 2.1 2.2 2.9
Austria 1 3.3 2.3 2.4 2.9 3.3 2.3 2.4 2.9
Poland 1 3.5 2.4 2.5 3.1 3.5 2.4 2.5 3.1
Portugal 1 3.3 NA 2.5 3.1 3.3 NA 2.5 3.1
Romania 3 3.7 3.4 3.6 3.6 3.7 3.4 3.6 3.6
Slovenia 1 3.1 2.0 2.4 3.0 6.1 3.3 3.6 5.3
Slovakia 1 3.7 3.5 3.5 3.6 3.7 3.5 3.5 3.6
Finland 1 3.1 1.9 2.1 2.5 4.4 1.9 2.1 2.5
Sweden 1 4.0 2.8 3.0 3.7 4.0 2.8 3.0 3.7
United Kingdom
UK: England and Wales 2 4.2 2.9 3.1 4.2 4.5 3.0 3.2 4.5
UK: Scotland 1 4.1 2.5 2.8 3.7 4.8 2.6 2.9 3.8
UK: Northern Ireland 1 3.3 2.3 2.6 3.3 3.3 2.3 2.6 3.3
Iceland 2 2.4 2.0 2.0 2.0 2.4 2.0 2.0 2.0
Norway 1 3.6 2.2 2.3 3.0 3.7 2.2 2.3 3.0
Switzerland 1 3.7 2.0 2.4 3.0 4.4 2.1 2.5 3.3
C2_A: Neonatal mortality rate (numbers and rates per 1000 live births)    
           
Number of
live births*
Annual deaths Cohort deaths
Number of neonatal deaths Neonatal mortality rate per 1000 
live births
Number of neonatal deaths Neonatal mortality rate per 1000 
live births
Country/coverage Source All
(day 0-27)
Early
(day 0-6
Late
(day 7-27)
All
(day 0-27)
Early1
(day 0-6)
Late2
(day 7-27)
Source All
(day 0-27)
Early
(day 0-6)
Late
(day 7-27)
All
(day 0-27)
Early3
(day 0-6)
Late4
(day 
7-27)*
Belgium 122 240 NA NA NA NA NA NA 1 254 194 60 2.1 1.6 0.5
Bulgaria (2014) 1 67 585 298 211 87 4.4 3.1 1.3 NA NA NA NA NA NA
Czech Republic 1 110 764 165 106 59 1.5 1.0 0.5 NA NA NA NA NA NA
Denmark 57 677 NA NA NA NA NA NA 1,2,4 109 89 20 1.9 1.5 0.3
Germany 2 737 575 1700 1352 348 2.3 1.8 0.5 NA NA NA NA NA NA
Estonia 1,3 13 907 21 16 5 1.5 1.2 0.4 1,3 21 16 5 1.5 1.2 0.4
Ireland5 65 623 NA NA NA NA NA NA 1 NA 178 NA NA 2.7 NA
Greece 1 91 847 260 179 81 2.8 1.9 0.9 NA NA NA NA NA NA
Spain 1 420 283 771 519 252 1.8 1.2 0.6 NA NA NA NA NA NA
France 2,3 760 421 1860 1285 575 2.4 1.7 0.8 NA NA NA NA NA NA
France (Survey, 2016) 13 232 NA NA NA NA NA NA NA NA NA NA NA NA
Croatia 2 37 252 116 82 34 3.1 2.2 0.9 1 119 84 35 3.2 2.3 0.9
Italy 4 484 777 1055 809 246 2.2 1.7 0.5 NA NA NA NA NA NA
Cyprus 1,2 9394 18 15 3 1.9 1.6 0.3 1,2 18 15 3 1.9 1.6 0.3
Latvia 3 21 720 55 45 10 2.5 2.1 0.5 3 54 45 9 2.5 2.1 0.4
Lithuania 2,3 31 475 74 53 21 2.4 1.7 0.7 1,2,3 74 53 21 2.4 1.7 0.7
Luxembourg 2 6832 11 9 2 1.6 1.3 0.3 NA NA NA NA NA NA
Hungary 1 91 680 245 155 90 2.7 1.7 1.0 NA NA NA NA NA NA
Malta 4435 NA NA NA NA NA NA 1,2 16 12 4 3.6 2.7 0.9
Netherlands 168 425 NA NA NA NA NA NA 1 511 431 80 3.0 2.6 0.5
Austria 1 83 607 163 130 33 1.9 1.6 0.4 1 161 130 31 1.9 1.6 0.4
Poland (2014) 1 375 647 1074 772 302 2.9 2.1 0.8 NA NA NA NA NA NA
Portugal 85 762 NA NA NA NA NA NA 1 177 118 59 2.1 1.4 0.7
Romania 3 201 023 859 595 264 4.3 3.0 1.3 NA NA NA NA NA NA
Slovenia 20 273 NA NA NA NA NA NA 1 15 12 3 0.7 0.6 0.1
Slovakia 1 55 615 110 84 26 2.0 1.5 0.5 NA NA NA NA NA NA
Finland 1,2 55 588 69 53 16 1.2 1.0 0.3 1 73 55 18 1.3 1.0 0.3
Sweden (2014) 1 115 246 177 141 36 1.5 1.2 0.3 NA NA NA NA NA NA
United Kingdom 1 1739 1293 446 2.2 1.7 0.6
UK: England and Wales 
(2014)
1 694 312 1503 1123 380 2.2 1.6 0.5 NA NA NA NA NA NA
UK: Scotland 1,2 54 288 102 73 29 1.9 1.3 0.5 1 82 53 29 1.5 1.0 0.5
UK: Northern Ireland 2 24 462 88 77 11 3.6 3.1 0.4 2 88 77 11 3.6 3.1 0.4
Iceland 1 4088 5 4 1 1.2 1.0 0.2 NA NA NA NA NA NA
Norway 1 59 711 86 70 16 1.4 1.2 0.3 1 87 70 17 1.5 1.2 0.3
Switzerland (2014) 1 84 891 195 159 36 2.3 1.9 0.4 1 192 156 36 2.3 1.8 0.4
1. Annual early neonatal mortality rate per 1000 live births = ((number of early neonatal deaths occurring during the year)/(number of live births occurring during the year))*1000 
2. Annual late neonatal mortality rate per 1000 live births = ((number of late neonatal deaths occurring during the year)/(number of live births occurring during the year))*1000 
3. Cohort early neonatal mortality rate per 1000 live births = ((number of early neonatal deaths occurring to babies born during the year)/(number of total live births occurring 
during the year))*1000            
4. Cohort late neonatal mortality rate per 1000 live births = ((number of late neonatal deaths occurring to babies born during the year)/(number of live births occurring during the 
year))*1000             
5. In Ireland, information on late neonatal deaths is unavailable (see C3 Infant mortality)       
Inclusion criteria were based on gestational age 22+ weeks; if gestational age was missing, births were included if birth weight was at least 500 grams.    
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C2_B: Neonatal mortality rate for births at ≥24 weeks of gestation    
Number of live births Number of neonatal deaths Neonatal mortality rate
Country/coverage Source Inclusion criteria for 
live births
All ≥24 weeks* All ≥24 weeks* All ≥24 weeks*
Belgium 1 22+ weeks or 500+ g 122 240 120 579 254 197 2.1 1.6
Bulgaria1 (2014) 1 22+ weeks 67 585 67 576 298 283 4.4 4.2
Czech Republic 1  22+ weeks or 500+ g, 
if BW unavailable
110 764 108 188 165 131 1.5 1.2
Denmark 1,2,4 22+ weeks 57 677 57 588 109 81 1.9 1.4
Germany 2 22+ weeks 737 575 NA 1700 NA 2.3 NA
Estonia 1,3 22+ weeks 13 907 13 898 21 17 1.5 1.2
Ireland 1 22+ weeks 65 623 65 564 NA NA NA NA
Greece 1 22+ weeks 91 847 91 139 260 NA 2.8 NA
Spain 1 180+ days / 500 g 420 283 356 164 771 NA 1.8 NA
France 2,3 22+ weeks or 500+ g 760 421 757 789 1860 1592 2.4 2.1
France (Survey, 2016) 22+ weeks 13 232 13 203 NA NA NA NA
Croatia 1 22+ weeks 37 252 37 231 119 101 3.2 2.7
Italy 4 22+ weeks 484 777 482 771 1055 NA 2.2 NA
Cyprus 1,2 22+ weeks 9394 9230 18 12 1.9 1.3
Latvia 3 22+ weeks 21 720 21 712 54 48 2.5 2.2
Lithuania1 1,2,3 22+ weeks 31 475 31 464 74 64 2.4 2.0
Luxembourg 2 22+ weeks 6832 6830 11 8 1.6 1.2
Hungary2 1 22+ weeks 91 680 91 595 245 217 2.7 2.4
Malta 1,2 22+ weeks or 500+ g 4435 4433 16 14 3.6 3.2
Netherlands 1 22+ weeks or 500+ g 168 425 165 631 511 328 3.0 2.0
Austria 1 22+ weeks 83 607 83 543 161 113 1.9 1.4
Poland (2014) 1 22+ weeks 375 647 375 443 1074 912 2.9 2.4
Portugal 1 22+ weeks (incomplete 
at 22-23 weeks)
85 762 85 578 177 NA 2.1 NA
Romania 3 22+ weeks 201 023 201 004 859 706 4.3 3.5
Slovenia 1 22+ weeks 20 273 20 262 15 8 0.7 0.4
Slovakia 1 22+ weeks 55 615 55 608 110 106 2.0 1.9
Finland 1 22+ weeks 55 588 55 497 73 65 1.3 1.2
Sweden (2014) 1 22+ weeks 115 246 115 163 177 148 1.5 1.3
United Kingdom 1 22+ weeks 1739 1366
UK: England and Wales 
(2014)
1 22+ weeks 694 312 670 439 1503 1136 2.2 1.7
UK: Scotland 1,2 22+ weeks 54 288 NA 102 NA 1.9 NA
UK: Northern Ireland 1 22+ weeks 24 462 24 451 88 80 3.6 3.3
Iceland 1 22+ weeks 4088 4080 5 2 1.2 0.5
Norway 1 22+ weeks 59 711 59 487 87 71 1.5 1.2
Switzerland (2014) 1 22+ weeks or 500+ g 84 891 84 820 192 149 2.3 1.8
We used cohort data, but when these were not available, we used annual data (except for Scotland where the annual data were considered to be more complete)    
* excluding births with unknown GA 24+ weeks    
Note: 1. In Bulgaria and Lithuania, all live births with unknown GA (N=2476 for Bulgaria; N=2579 for Lithuania) were considered as live births occured at 24+ weeks of gestational age    
2. In Hungary, late neonatal deaths with unknown GA (N=90) were considered as 24+ weeks    
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Number 
of 
live birth
Annual deaths Cohort deaths
Country/coverage Source Inclusion criteria for live births Infant deaths Infant mortality 
rate
Infant deaths Infant mortality 
rate
Belgium 1 22+ weeks or 500+ g 122 240 NA NA 381 3.1
Bulgaria (2014) 1 22+ weeks 67 585 517 7.6 NA NA
Czech Republic 1  22+ weeks or 500+ g, if BW 
unavailable
110 764 272 2.5 NA NA
Denmark 1,2,4 22+ weeks 57 677 NA NA 151 2.6
Germany 2 22+ weeks 737 575 2405 3.3 NA NA
Estonia 5,3 22+ weeks 13 907 35 2.5 40 2.9
Ireland 1,2 22+ weeks 65 623 225 3.4 NA NA
Greece 1 22+ weeks 91 847 364 4.0 NA NA
Spain 1 180+ days / 500 g 420 283 1139 2.7 NA NA
France 2,3 22+ weeks or 500+ g 760 421 2655 3.5 NA NA
France (Survey, 2016) 22+ weeks 13 232 NA NA NA NA
Croatia 1,2 22+ weeks 37 252 154 4.1 143 3.8
Italy 4 22+ weeks 484 777 1506 3.1 NA NA
Cyprus 2 22+ weeks 9394 24 2.6 20 2.1
Latvia 3 22+ weeks 21 720 90 4.1 93 4.3
Lithuania 2,3 22+ weeks 31 475 132 4.2 111 3.5
Luxembourg 2,3 22+ weeks 6832 16 2.3 NA NA
Hungary 1 22+ weeks 91 680 383 4.2 NA NA
Malta 2 22+ weeks or 500+ g 4435 NA NA 23 5.2
Netherlands 3 22+ weeks or 500+ g 168 425 597 3.5 NA NA
Austria 1 22+ weeks 83 607 221 2.6 196 2.3
Poland (2014) 1 22+ weeks 375 647 1573 4.2 NA NA
Portugal 1 22+ weeks (incomplete at 22-23 
weeks)
85 762 254 3.0 NA NA
Romania 3 22+ weeks 201 023 1493 7.4 NA NA
Slovenia 2 22+ weeks 20 273 NA NA 34 1.7
Slovakia 1 22+ weeks 55 615 110 2.0 NA NA
Finland 1,2 22+ weeks 55 588 96 1.7 92 1.7
Sweden (2014) 1 22+ weeks 115 246 261 2.3 NA NA
United Kingdom 22+ weeks NA NA NA NA
UK: England and Wales, 
2014
1 22+ weeks 694 312 2204 3.2 NA NA
UK: Scotland 1,2 22+ weeks 54 288 158 2.9 136 2.5
UK: Northern Ireland 3 22+ weeks 24 462 124 5.1 124 5.1
Iceland 1 22+ weeks 4088 6 1.5 NA NA
Norway 1 22+ weeks 59 711 118 2.0 130 2.2
Switzerland (2014) 1 22+ weeks or 500+ g 84 891 259 3.1 254 3.0
C3: Infant mortality rate (numbers and rates per 1000 live births)
Number of live births Number of neonatal deaths Neonatal mortality rate
Country/coverage Source Inclusion criteria for 
live births
All ≥24 weeks* All ≥24 weeks* All ≥24 weeks*
Belgium 1 22+ weeks or 500+ g 122 240 120 579 254 197 2.1 1.6
Bulgaria1 (2014) 1 22+ weeks 67 585 67 576 298 283 4.4 4.2
Czech Republic 1  22+ weeks or 500+ g, 
if BW unavailable
110 764 108 188 165 131 1.5 1.2
Denmark 1,2,4 22+ weeks 57 677 57 588 109 81 1.9 1.4
Germany 2 22+ weeks 737 575 NA 1700 NA 2.3 NA
Estonia 1,3 22+ weeks 13 907 13 898 21 17 1.5 1.2
Ireland 1 22+ weeks 65 623 65 564 NA NA NA NA
Greece 1 22+ weeks 91 847 91 139 260 NA 2.8 NA
Spain 1 180+ days / 500 g 420 283 356 164 771 NA 1.8 NA
France 2,3 22+ weeks or 500+ g 760 421 757 789 1860 1592 2.4 2.1
France (Survey, 2016) 22+ weeks 13 232 13 203 NA NA NA NA
Croatia 1 22+ weeks 37 252 37 231 119 101 3.2 2.7
Italy 4 22+ weeks 484 777 482 771 1055 NA 2.2 NA
Cyprus 1,2 22+ weeks 9394 9230 18 12 1.9 1.3
Latvia 3 22+ weeks 21 720 21 712 54 48 2.5 2.2
Lithuania1 1,2,3 22+ weeks 31 475 31 464 74 64 2.4 2.0
Luxembourg 2 22+ weeks 6832 6830 11 8 1.6 1.2
Hungary2 1 22+ weeks 91 680 91 595 245 217 2.7 2.4
Malta 1,2 22+ weeks or 500+ g 4435 4433 16 14 3.6 3.2
Netherlands 1 22+ weeks or 500+ g 168 425 165 631 511 328 3.0 2.0
Austria 1 22+ weeks 83 607 83 543 161 113 1.9 1.4
Poland (2014) 1 22+ weeks 375 647 375 443 1074 912 2.9 2.4
Portugal 1 22+ weeks (incomplete 
at 22-23 weeks)
85 762 85 578 177 NA 2.1 NA
Romania 3 22+ weeks 201 023 201 004 859 706 4.3 3.5
Slovenia 1 22+ weeks 20 273 20 262 15 8 0.7 0.4
Slovakia 1 22+ weeks 55 615 55 608 110 106 2.0 1.9
Finland 1 22+ weeks 55 588 55 497 73 65 1.3 1.2
Sweden (2014) 1 22+ weeks 115 246 115 163 177 148 1.5 1.3
United Kingdom 1 22+ weeks 1739 1366
UK: England and Wales 
(2014)
1 22+ weeks 694 312 670 439 1503 1136 2.2 1.7
UK: Scotland 1,2 22+ weeks 54 288 NA 102 NA 1.9 NA
UK: Northern Ireland 1 22+ weeks 24 462 24 451 88 80 3.6 3.3
Iceland 1 22+ weeks 4088 4080 5 2 1.2 0.5
Norway 1 22+ weeks 59 711 59 487 87 71 1.5 1.2
Switzerland (2014) 1 22+ weeks or 500+ g 84 891 84 820 192 149 2.3 1.8
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C3: Infant mortality rate, births ≥22 weeks of gestation in 2010  
Number of live births Percentage of live births
birth weight in grams
Country/coverage Source All stated Not stated <500  500-1499  1500-2499  2500-4499 ≥4500
Belgium 1 120 600 1640 0.0 0.9 6.0 92.2 0.9
Bulgaria (2014) 1 64 813 2772 0.0 1.4 8.5 89.7 0.5
Czech Republic 1 109 141 1623 0.0 1.1 6.6 91.5 0.8
Denmark 1,2,4 57 227 450 0.0 0.7 4.2 92.5 2.5
Germany 1 725 913 24 0.1 1.2 5.7 91.8 1.2
Estonia 1 13 906 1 0.0 0.8 3.3 93.1 2.8
Ireland 1 65 623 0 0.0 0.9 4.8 92.1 2.2
Greece 1 90 772 1075 0.0 1.1 8.2 90.5 0.2
Spain 1 398 786 21 497 0.0 0.9 7.4 91.1 0.6
France 5 759 099 0 0.0 1.0 6.4 91.9 0.7
France (Survey 2016) 1 13 215 17 0.0 1.0 6.4 91.8 0.7
Croatia 1 37 252 0 0.0 0.8 4.3 93.5 1.4
Italy 1 484 399 378 0.0 1.0 6.4 92.1 0.5
Cyprus 1 9358 36 0.0 1.2 9.4 89.2 0.2
Latvia 1 21 720 0 0.0 0.7 3.8 92.7 2.8
Lithuania1 1,2 28 896 2579 0.0 0.7 3.8 93.4 2.1
Luxembourg 1 6831 1 0.0 0.8 5.8 92.7 0.6
Hungary 1 91 645 35 0.0 1.4 7.1 90.5 1.0
Malta 1 4431 4 0.0 0.9 5.3 93.2 0.5
Netherlands 1 168 007 418 0.1 0.9 5.1 92.1 1.8
Austria 1 83 607 0 0.0 0.9 5.5 92.5 0.9
Poland (2014) 1 375 638 9 0.0 0.9 5.0 92.7 1.4
Portugal 1 85 727 35 0.0 1.0 7.9 90.8 0.3
Romania 5 201 023 0 0.0 0.9 7.0 91.6 0.5
Slovenia 1 20 273 0 0.0 1.0 5.4 92.6 1.1
Slovakia 1 55 615 0 0.0 0.9 6.7 91.5 0.8
Finland 1 55 537 51 0.0 0.6 3.6 93.5 2.3
Sweden (2014) 1 115 210 36 0.0 0.7 3.5 92.3 3.4
United Kingdom
UK: England and Wales 1 683 997 8905 0.1 0.9 6.0 91.4 1.6
UK: Scotland 1 54 231 57 0.0 0.9 5.9 91.1 2.0
UK: Northern Ireland 1 24 440 22 0.0 0.8 5.4 91.6 2.1
Iceland 1 4088 0 0.1 0.6 3.6 91.3 4.3
Norway 1 59 710 1 0.0 0.8 3.7 92.5 3.0
Switzerland (2014) 1 84 881 10 0.0 0.9 5.5 92.9 0.8
 
Note 1. In Lithuania, live births with unknown GA and BW are not included.    
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Number of live births Percentage of live births
birth weight in grams
Country/coverage Source All stated Not stated <500  500-1499  1500-2499  2500-4499 ≥4500
Belgium 1 120 600 1640 0.0 0.9 6.0 92.2 0.9
Bulgaria (2014) 1 64 813 2772 0.0 1.4 8.5 89.7 0.5
Czech Republic 1 109 141 1623 0.0 1.1 6.6 91.5 0.8
Denmark 1,2,4 57 227 450 0.0 0.7 4.2 92.5 2.5
Germany 1 725 913 24 0.1 1.2 5.7 91.8 1.2
Estonia 1 13 906 1 0.0 0.8 3.3 93.1 2.8
Ireland 1 65 623 0 0.0 0.9 4.8 92.1 2.2
Greece 1 90 772 1075 0.0 1.1 8.2 90.5 0.2
Spain 1 398 786 21 497 0.0 0.9 7.4 91.1 0.6
France 5 759 099 0 0.0 1.0 6.4 91.9 0.7
France (Survey 2016) 1 13 215 17 0.0 1.0 6.4 91.8 0.7
Croatia 1 37 252 0 0.0 0.8 4.3 93.5 1.4
Italy 1 484 399 378 0.0 1.0 6.4 92.1 0.5
Cyprus 1 9358 36 0.0 1.2 9.4 89.2 0.2
Latvia 1 21 720 0 0.0 0.7 3.8 92.7 2.8
Lithuania1 1,2 28 896 2579 0.0 0.7 3.8 93.4 2.1
Luxembourg 1 6831 1 0.0 0.8 5.8 92.7 0.6
Hungary 1 91 645 35 0.0 1.4 7.1 90.5 1.0
Malta 1 4431 4 0.0 0.9 5.3 93.2 0.5
Netherlands 1 168 007 418 0.1 0.9 5.1 92.1 1.8
Austria 1 83 607 0 0.0 0.9 5.5 92.5 0.9
Poland (2014) 1 375 638 9 0.0 0.9 5.0 92.7 1.4
Portugal 1 85 727 35 0.0 1.0 7.9 90.8 0.3
Romania 5 201 023 0 0.0 0.9 7.0 91.6 0.5
Slovenia 1 20 273 0 0.0 1.0 5.4 92.6 1.1
Slovakia 1 55 615 0 0.0 0.9 6.7 91.5 0.8
Finland 1 55 537 51 0.0 0.6 3.6 93.5 2.3
Sweden (2014) 1 115 210 36 0.0 0.7 3.5 92.3 3.4
United Kingdom
UK: England and Wales 1 683 997 8905 0.1 0.9 6.0 91.4 1.6
UK: Scotland 1 54 231 57 0.0 0.9 5.9 91.1 2.0
UK: Northern Ireland 1 24 440 22 0.0 0.8 5.4 91.6 2.1
Iceland 1 4088 0 0.1 0.6 3.6 91.3 4.3
Norway 1 59 710 1 0.0 0.8 3.7 92.5 3.0
Switzerland (2014) 1 84 881 10 0.0 0.9 5.5 92.9 0.8
 
Note 1. In Lithuania, live births with unknown GA and BW are not included.    
C4_B:  Distribution of birth weight by plurality for live births in 2010
% live births  % of live singleton 
births
% of live multiple 
births
Birth weight (g) Birth weight (g) Birth weight (g)
Country/
coverage
Source <1500  1500-
2499
All 
stated
<1500  1500-
2499
All 
stated*
<1500  1500-
2499
All 
stated*
Belgium 1 0.9 6.0 120 600 0.7 4.5 116 452 8.1 48.2 4148
Bulgaria (2014) 1 1.4 8.5 64 813 0.9 6.8 62 533 12.6 54.4 2280
Czech Republic 1 1.2 6.6 109 141 0.8 5.2 105 930 11.5 52.4 3211
Denmark 1,2,4 0.8 4.2 57 227 0.5 3.1 55 320 7.4 38.3 1907
Germany 1 1.3 5.7 725 913 0.9 4.1 11.9 45.9
Estonia 1 0.8 3.3 13 906 0.5 2.4 13 453 10.8 30.9 453
Ireland 1 0.9 4.8 65 623 0.6 3.3 63 158 8.8 41.3 2465
Greece 1 1.1 8.2 90 772 0.7 5.4 86 096 9.2 59.6 4676
Spain 1 1.0 7.4 398 786 0.7 5.4 381 254 7.1 51.2 17 532
France 5 1.0 6.4 759 099 0.8 5.0 735 321 8.0 47.8 23 778
France (Survey, 
2016)
1 1.1 6.4 13 215 0.8 5.0 12 757 9.8 45.6 458
Croatia 1 0.8 4.3 37 252 0.7 3.2 36 150 6.6 39.0 1102
Italy 1 1.0 6.4 484 399 0.7 4.8 468 226 9.2 53.0 16 173
Cyprus 1 1.2 9.4 9358 0.6 6.7 8 876 11.0 60.2 482
Latvia 1 0.7 3.8 21 720 0.6 2.8 21 073 5.7 34.6 647
Lithuania1 1 0.7 3.8 28 896 0.5 2.9 28 097 6.9 33.4 799
Luxembourg 1 0.9 5.8 6831 0.5 4.2 6 590 10.8 49.4 241
Hungary 1 1.4 7.1 91 645 NA NA NA NA NA NA
Malta 1 1.0 5.3 4431 0.7 3.9 4 299 11.4 52.3 132
Netherlands 1 1.0 5.1 168 007 0.8 3.8 162 728 7.8 43.6 5279
Austria 1 1.0 5.5 83 607 0.7 4.1 81 012 9.6 49.2 2595
Poland (2014) 1 0.9 5.0 375 638 0.7 3.8 365 900 8.4 49.4 9738
Portugal 1 1.0 7.9 85 727 0.7 6.0 82 771 9.5 59.7 2956
Romania 5 0.9 7.0 201 023 0.7 6.1 196 892 8.7 50.7 4131
Slovenia 1 1.0 5.4 20 273 0.7 3.7 19 497 8.6 48.5 776
Slovakia 1 1.0 6.7 55 615 0.8 5.6 54 217 8.8 50.6 1398
Finland 1 0.6 3.6 55 537 0.5 2.6 54 061 6.8 38.2 1476
Sweden (2014) 1 0.8 3.5 115 210 0.6 2.6 111 811 7.7 35.0 3399
United Kingdom
UK: England and 
Wales
1 1.0 6.0 683 997 0.8 4.7 663 099 8.7 48.7 20 898
UK: Scotland 1 0.9 5.9 54 230 0.7 4.6 52 673 8.0 49.5 1557
UK: Northern Ireland 1 0.9 5.4 24 440 0.6 4.0 23 740 9.0 51.1 700
Iceland 1 0.7 3.6 4088 0.6 2.2 3 945 5.6 43.4 143
Norway 1 0.8 3.7 59 710 0.6 2.5 57 732 6.9 38.7 1978
Switzerland (2014) 1 0.9 5.5 84 881 0.6 3.9 81 833 8.6 47.6 3048
EUROPEAN PERINATAL HEALTH REPORT
160
C5_A: Distribution of gestational age for live births
Number of live births Percentage of live births
Gestational age in weeks
Country/coverage Source All stated Not stated 22-23 24-27 28-31 32-36 37-38 39-41 ≥42
Belgium 1 120 627 1613 0.0 0.3 0.7 7.0 26.7 65.1 0.2
Bulgaria (2014) 1 65 109 2476 0.0 0.2 0.8 6.3 21.5 70.5 0.6
Czech Republic 1 108 220 2544 0.0 0.3 0.8 6.4 19.1 70.2 3.1
Denmark 1,2,4 57 619 58 0.1 0.3 0.6 5.3 18.8 72.9 2.1
Germany 1 725 680 266 0.1 0.4 0.9 7.2 25.4 65.6 0.5
Estonia 1 13 906 1 0.1 0.3 0.7 4.7 17.8 73.9 2.6
Ireland 1 65 613 10 0.1 0.2 0.7 5.4 19.1 72.1 2.4
Greece 1 91 175 672 0.0 0.3 0.9 10.1 43.7 45.0
Spain 1 356 197 64,086 0.0 0.3 0.7 6.6 23.1 67.7 1.6
France 5 758 056 0 0.0 0.3 0.7 6.1 21.6 70.4 0.8
France (Survey, 
2016)
1 13 212 20 0.1 0.4 0.8 6.3 22.9 69.1 0.5
Croatia 1 37 252 0 0.1 0.3 0.5 5.6 21.9 69.5 2.0
Italy 1 482 976 1801 0.0 0.3 0.7 6.6 27.8 63.7 0.9
Cyprus 1 9237 157 0.1 0.3 0.8 10.9 43.7 44.1 0.2
Latvia 1 21 720 0 0.0 0.3 0.6 4.8 17.7 75.4 1.1
Lithuania1 1,2 28 896 2579 0.0 0.2 0.5 4.6 16.4 78.2 0.1
Luxembourg 1 6831 1 0.0 0.2 0.8 6.3 30.2 62.4 0.1
Hungary 1 91 635 45 0.0 0.5 0.9 7.3 26.5 64.6 0.2
Malta 1 4435 0 0.0 0.3 0.5 5.8 30.6 62.5 0.2
Netherlands 1 165 833 2592 0.1 0.3 0.7 5.8 23.6 68.2 1.3
Austria 1 83 607 0 0.1 0.3 0.8 6.7 24.5 67.3 0.4
Poland (2014) 1 375 642 5 0.1 0.3 0.7 6.2 22.1 69.1 1.5
Portugal 1 85 591 171 0.0 0.2 0.8 7.0 27.0 64.8 0.1
Romania 5 201 023 0 0.0 0.2 0.9 7.4 27.3 63.7 0.6
Slovenia 1 20 273 0 0.1 0.3 0.8 6.4 19.8 72.0 0.7
Slovakia 1 55 615 0 0.0 0.3 0.7 6.0 20.9 71.5 0.6
Finland 1 55 516 72 0.0 0.2 0.5 5.0 18.0 72.3 4.0
Sweden (2014) 1 115 229 17 0.1 0.3 0.6 4.8 18.5 68.8 7.0
United Kingdom
UK: England and 
Wales
1 692 902 3155 0.1 0.3 0.8 6.4 20.8 68.9 2.7
UK: Scotland 1 54 057 231 0.0 0.3 0.7 7.1 19.6 70.3 1.9
UK: Northern 
Ireland
1 24 462 0 0.0 0.2 0.8 6.3 20.5 71.3 0.8
Iceland 1 4086 2 0.1 0.2 0.5 5.3 16.8 75.2 1.9
Norway 1 59 513 198 0.0 0.3 0.6 5.3 18.3 71.7 3.8
Switzerland (2014) 1 84 866 25 0.1 0.3 0.6 6.2 26.5 65.7 0.5
Note 1. In Lithuania, live births with unknown GA and BW are not included.     
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C5_B: Distribution of gestational age by plurality for live births
Number of live births Percentage of live births
Gestational age in weeks
Country/coverage Source All stated Not stated 22-23 24-27 28-31 32-36 37-38 39-41 ≥42
Belgium 1 120 627 1613 0.0 0.3 0.7 7.0 26.7 65.1 0.2
Bulgaria (2014) 1 65 109 2476 0.0 0.2 0.8 6.3 21.5 70.5 0.6
Czech Republic 1 108 220 2544 0.0 0.3 0.8 6.4 19.1 70.2 3.1
Denmark 1,2,4 57 619 58 0.1 0.3 0.6 5.3 18.8 72.9 2.1
Germany 1 725 680 266 0.1 0.4 0.9 7.2 25.4 65.6 0.5
Estonia 1 13 906 1 0.1 0.3 0.7 4.7 17.8 73.9 2.6
Ireland 1 65 613 10 0.1 0.2 0.7 5.4 19.1 72.1 2.4
Greece 1 91 175 672 0.0 0.3 0.9 10.1 43.7 45.0
Spain 1 356 197 64,086 0.0 0.3 0.7 6.6 23.1 67.7 1.6
France 5 758 056 0 0.0 0.3 0.7 6.1 21.6 70.4 0.8
France (Survey, 
2016)
1 13 212 20 0.1 0.4 0.8 6.3 22.9 69.1 0.5
Croatia 1 37 252 0 0.1 0.3 0.5 5.6 21.9 69.5 2.0
Italy 1 482 976 1801 0.0 0.3 0.7 6.6 27.8 63.7 0.9
Cyprus 1 9237 157 0.1 0.3 0.8 10.9 43.7 44.1 0.2
Latvia 1 21 720 0 0.0 0.3 0.6 4.8 17.7 75.4 1.1
Lithuania1 1,2 28 896 2579 0.0 0.2 0.5 4.6 16.4 78.2 0.1
Luxembourg 1 6831 1 0.0 0.2 0.8 6.3 30.2 62.4 0.1
Hungary 1 91 635 45 0.0 0.5 0.9 7.3 26.5 64.6 0.2
Malta 1 4435 0 0.0 0.3 0.5 5.8 30.6 62.5 0.2
Netherlands 1 165 833 2592 0.1 0.3 0.7 5.8 23.6 68.2 1.3
Austria 1 83 607 0 0.1 0.3 0.8 6.7 24.5 67.3 0.4
Poland (2014) 1 375 642 5 0.1 0.3 0.7 6.2 22.1 69.1 1.5
Portugal 1 85 591 171 0.0 0.2 0.8 7.0 27.0 64.8 0.1
Romania 5 201 023 0 0.0 0.2 0.9 7.4 27.3 63.7 0.6
Slovenia 1 20 273 0 0.1 0.3 0.8 6.4 19.8 72.0 0.7
Slovakia 1 55 615 0 0.0 0.3 0.7 6.0 20.9 71.5 0.6
Finland 1 55 516 72 0.0 0.2 0.5 5.0 18.0 72.3 4.0
Sweden (2014) 1 115 229 17 0.1 0.3 0.6 4.8 18.5 68.8 7.0
United Kingdom
UK: England and 
Wales
1 692 902 3155 0.1 0.3 0.8 6.4 20.8 68.9 2.7
UK: Scotland 1 54 057 231 0.0 0.3 0.7 7.1 19.6 70.3 1.9
UK: Northern 
Ireland
1 24 462 0 0.0 0.2 0.8 6.3 20.5 71.3 0.8
Iceland 1 4086 2 0.1 0.2 0.5 5.3 16.8 75.2 1.9
Norway 1 59 513 198 0.0 0.3 0.6 5.3 18.3 71.7 3.8
Switzerland (2014) 1 84 866 25 0.1 0.3 0.6 6.2 26.5 65.7 0.5
% of live births % of live singleton births % of live multiple births
Gestational age in weeks Gestational age in weeks Gestational age in weeks
Country/coverage Source All stated <32 32-36 All Stated <32 32-36 All Stated <32 32-36
Belgium 1 120 627 1.1 7.0 116 474 0.8 5.5 4153 9.5 49.1
Bulgaria (2014) 1 65 109 1.1 6.3 62 819 0.8 4.9 2290 9.0 43.0
Czech Republic 1 108 220 1.1 6.4 105 050 0.9 5.2 3170 10.4 46.4
Denmark 1,2,4 57 619 0.9 5.3 55 692 0.7 4.2 1927 8.3 36.7
Germany 1 725 937 1.3 7.2 698 955 0.9 5.6 27 382 11.7 47.0
Estonia 1 13 906 1.1 4.7 13 453 0.7 3.7 453 12.4 34.2
Ireland 1 65 613 1.1 5.4 63 148 0.7 3.9 2465 9.5 43.8
Greece 1 91 175 1.3 10.1 86 482 0.8 7.3 4693 8.9 61.6
Spain 1 356 197 1.0 6.6 340 215 0.7 4.9 15 982 7.1 42.6
France 5 758 056 1.0 6.1 731 479 0.7 4.8 26 577 8.9 42.6
France (Survey, 
2016)
1 13 212 1.2 6.3 12 753 0.9 5.1 459 10.9 38.3
Croatia 1 37 252 0.9 5.6 36 150 0.7 4.6 1102 8.1 40.0
Italy 1 482 976 1.0 6.6 466 813 0.7 5.0 16 163 9.1 51.8
Cyprus 1 9237 1.1 10.9 8756 0.7 8.3 481 9.4 58.8
Latvia 1 21 720 0.9 4.8 21 073 0.8 4.0 647 7.0 31.4
Lithuania1 1 28 896 0.8 4.6 28 097 0.6 3.7 799 7.5 36.9
Luxembourg 1 6831 1.1 6.3 6589 0.5 4.9 242 14.9 42.6
Hungary NA NA NA NA NA NA NA NA NA
Malta 1 4435 0.9 5.8 4303 0.7 4.7 132 8.3 43.2
Netherlands 1 165 833 1.1 5.8 160 578 0.9 4.5 5255 9.0 43.5
Austria 1 83 607 1.2 6.7 81 012 0.9 5.3 2595 10.4 50.2
Poland (2014) 1 375 642 1.1 6.2 365 902 0.8 5.0 9740 9.5 52.8
Portugal 1 85 591 1.0 7.0 82 637 0.7 5.3 2954 9.2 55.5
Romania 5 201 023 1.1 7.4 196 892 0.9 6.6 4131 8.2 41.7
Slovenia 1 20 273 1.1 6.4 19 497 0.8 4.6 776 9.9 50.5
Slovakia 1 55 615 1.0 6.0 54 217 0.8 5.0 1398 9.9 45.0
Finland 1 55 516 0.8 5.0 54 036 0.6 3.9 1480 7.3 45.4
Sweden (2014) 1 115 229 0.9 4.8 111 827 0.7 3.9 3402 8.5 34.2
United Kingdom
UK: England and 
Wales
1 692 902 1.2 6.4 671 040 0.9 5.0 21 862 9.8 49.3
UK: Scotland 1 54 056 1.1 7.1 52 501 0.9 5.7 1555 8.7 56.2
UK: Northern 
Ireland
1 24 462 1.1 6.3 23 762 0.8 4.9 700 12.0 53.4
Iceland 1 4086 0.8 5.3 3943 0.6 3.8 143 5.6 48.3
Norway 1 59 513 0.9 5.3 57 543 0.7 4.0 1970 7.7 41.6
Switzerland (2014) 1 84 866 1.0 6.2 81 818 0.7 4.7 3048 9.5 48.5
Note 1. In Lithuania, live births with unknown GA and weight are not included.     
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C6_A: Maternal mortality ratio (numbers and ratios per 100 000 live births) from routine statistics  
    
Note: 1. Numbers of deaths for the United Kingdom are the sum of the numbers of registered deaths in England and Wales, Scotland and Northern Ireland      
 
Country/coverage Source Number of live 
births
(2011-2015) 
Number of 
maternal deaths
Maternal Mortality 
Ratio
per 100 000 live 
births
Alternate years of 
data provided
Enhanced
Belgium 1 629 650 29 4.6
Bulgaria 1 349 643 24 6.9 2010-2014
Czech Republic Yes
Denmark 3,4 287 862 9 3.1
Germany 2 3470 800 145 4.2
Estonia 3,4 69 886 3 4.3 Yes
Ireland 1,2 347 706 9 2.6 Yes
Greece 1 484 929 14 2.9
Spain 1 2266 532 71 3.1 2010-2014
France 3 4107 315 264 6.4 2010-2014 Yes
France (Survey, 2016)
Croatia 2 199 976 11 5.5
Italy 5 2938 004 107 3.6 2006-2012 Yes
Cyprus 4 48 017 3 6.2 Yes 
Latvia 2 101 415 25 24.7
Lithuania 2,3 152 423 10 6.6
Luxembourg 3 33 111 2 6.0 2012-2013
Hungary 1,2 450 197 59 13.1
Malta 2 21 392 0 0.0
Netherlands Yes
Austria 2 401 581 44 11.0
Poland 1 1932 709 37 1.9 2010-2014
Portugal 1 437 687 26 5.9
Romania 1 1008 913 151 15.0
Slovenia 2 105 618 6 5.7
Slovakia 2 281 758 12 4.3
Finland 2 291 387 8 2.7
Sweden 1 554 769 20 3.6 2010-2014
United Kingdom1 EW:2
Scotland: 2
NI: 3”
3952 352 242 6.1 Yes
Iceland 1 21 766 1 4.6
Norway 1 300 264 13 4.3
Switzerland 1 411 163 20 4.9 2010-2014
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C6_B: Maternal mortality ratio (numbers and ratios per 100 000 live births) from enhanced data systems  
    
Country/coverage Source Number of live 
births
(2011-2015) 
Number of 
maternal deaths
Maternal Mortality 
Ratio
per 100 000 live 
births
Alternate years of 
data provided
Enhanced
Belgium 1 629 650 29 4.6
Bulgaria 1 349 643 24 6.9 2010-2014
Czech Republic Yes
Denmark 3,4 287 862 9 3.1
Germany 2 3470 800 145 4.2
Estonia 3,4 69 886 3 4.3 Yes
Ireland 1,2 347 706 9 2.6 Yes
Greece 1 484 929 14 2.9
Spain 1 2266 532 71 3.1 2010-2014
France 3 4107 315 264 6.4 2010-2014 Yes
France (Survey, 2016)
Croatia 2 199 976 11 5.5
Italy 5 2938 004 107 3.6 2006-2012 Yes
Cyprus 4 48 017 3 6.2 Yes 
Latvia 2 101 415 25 24.7
Lithuania 2,3 152 423 10 6.6
Luxembourg 3 33 111 2 6.0 2012-2013
Hungary 1,2 450 197 59 13.1
Malta 2 21 392 0 0.0
Netherlands Yes
Austria 2 401 581 44 11.0
Poland 1 1932 709 37 1.9 2010-2014
Portugal 1 437 687 26 5.9
Romania 1 1008 913 151 15.0
Slovenia 2 105 618 6 5.7
Slovakia 2 281 758 12 4.3
Finland 2 291 387 8 2.7
Sweden 1 554 769 20 3.6 2010-2014
United Kingdom1 EW:2
Scotland: 2
NI: 3”
3952 352 242 6.1 Yes
Iceland 1 21 766 1 4.6
Norway 1 300 264 13 4.3
Switzerland 1 411 163 20 4.9 2010-2014
Country/coverage Source Number of live births
(2011-2015) 
Number of maternal 
deaths
Maternal mortality 
ratio
per 100 000 live births
Alternate years of data 
provided
Belgium
Bulgaria
Czech Republic 2 433 860 33 7.6
Denmark
Germany
Estonia 3,4 69 886 9 12.9
Ireland 1,3 347 706 32 9.2
Greece
Spain
France 4 4130 285 369 8.9 2008-2012
France (Survey, 2016)
Croatia
Italy 10 2132 333 207 9.7 2008-2012
Cyprus
Latvia
Lithuania
Luxembourg
Hungary
Malta
Netherlands 2 855 310 44 5.1
Austria
Poland
Portugal
Romania
Slovenia
Slovakia
Finland
Sweden
United Kingdom 2 2341 624 200 8.5 2012-2014
Iceland
Norway
Switzerland
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C7: Multiple birth rate (rates per 1000 women)
Number of women Multiple birth rate
 per 1000 women
Country/coverage Source All stated Not stated Twins Triplets or more Multiples
Belgium 1 120 681 0 17.3 0.3 17.6
Bulgaria1 (2014) 1 64 427 0 17.8 0.2 18.0
Czech Republic 2 107 618 0 14.5 0.1 14.7
Denmark2 1,2,4 56 895 0 16.9 0.2 17.0
Germany 1 714 574 0 18.8 0.4 19.2
Estonia 1 13 731 0 16.6 0.1 16.7
Ireland 1 64 650 0 18.7 0.5 19.2
Greece3 1 88 554 4 13.2 0.1 13.3
Spain 1 412 266 0 22.1 0.3 22.4
France 5 748 589 0 17.1 0.3 17.5
France (Survey, 2016) 1 13 077 0 17.3 0.4 17.7
Croatia 1 36 866 0 14.8 0.2 15.0
Italy 9 478 003 403 16.4 0.4 16.9
Cyprus 1 9171 0 26.0 0.9 26.8
Latvia 1 21 496 0 15.1 0.1 15.2
Lithuania4 1,2 28 608 0 13.4 0.4 13.7
Luxembourg 1 6762 0 17.9 0.4 18.3
Hungary (2012)3 1 88 819 0 16.0 0.3 16.4
Malta 1 4385 0 15.1 0.2 15.3
Netherlands 1 166 700 0 16.7 0.3 17.0
Austria 1 82 565 0 15.4 0.3 15.7
Poland (2014) 1 372 046 0 13.0 0.2 13.2
Portugal 1 84 556 0 17.3 0.2 17.5
Romania3 1 199 646 0 10.1 0.2 10.4
Slovenia2 1 20 003 0 19.3 0.2 19.5
Slovakia 1 55 112 0 12.7 0.1 12.8
Finland 1 55 080 0 13.4 0.1 13.5
Sweden (2014) 1 113 999 0 14.9 0.2 15.1
United Kingdom
UK: England and Wales 2 689 751 0 15.8 0.2 16.1
UK: Scotland 1 53 689 62 14.2 0.3 14.6
UK: Northern Ireland 3 23 937 0 14.3 0.3 14.6
Iceland 1 4026 0 17.4 0.2 17.6
Norway 1 58 927 0 16.6 0.2 16.9
Switzerland (2014) 1 83 696 0 18.0 0.4 18.3
Note 1. In Bulgaria, mothers of babies with unknown GA are not included.       
2. In Denmark and Slovenia, data are based on mothers delivering live or stillbirths (and terminations).     
3. In Greece, Hungary and Romania multiple maternity rate was calculated based on number of births. N total births for Greece = 92 159;  
N total births for Hungary = 90 305; N total births for Romania = 201 760      
4. In Lithuania, mothers with babies of unknown GA are not included        
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Number of women Multiple birth rate
 per 1000 women
Country/coverage Source All stated Not stated Twins Triplets or more Multiples
Belgium 1 120 681 0 17.3 0.3 17.6
Bulgaria1 (2014) 1 64 427 0 17.8 0.2 18.0
Czech Republic 2 107 618 0 14.5 0.1 14.7
Denmark2 1,2,4 56 895 0 16.9 0.2 17.0
Germany 1 714 574 0 18.8 0.4 19.2
Estonia 1 13 731 0 16.6 0.1 16.7
Ireland 1 64 650 0 18.7 0.5 19.2
Greece3 1 88 554 4 13.2 0.1 13.3
Spain 1 412 266 0 22.1 0.3 22.4
France 5 748 589 0 17.1 0.3 17.5
France (Survey, 2016) 1 13 077 0 17.3 0.4 17.7
Croatia 1 36 866 0 14.8 0.2 15.0
Italy 9 478 003 403 16.4 0.4 16.9
Cyprus 1 9171 0 26.0 0.9 26.8
Latvia 1 21 496 0 15.1 0.1 15.2
Lithuania4 1,2 28 608 0 13.4 0.4 13.7
Luxembourg 1 6762 0 17.9 0.4 18.3
Hungary (2012)3 1 88 819 0 16.0 0.3 16.4
Malta 1 4385 0 15.1 0.2 15.3
Netherlands 1 166 700 0 16.7 0.3 17.0
Austria 1 82 565 0 15.4 0.3 15.7
Poland (2014) 1 372 046 0 13.0 0.2 13.2
Portugal 1 84 556 0 17.3 0.2 17.5
Romania3 1 199 646 0 10.1 0.2 10.4
Slovenia2 1 20 003 0 19.3 0.2 19.5
Slovakia 1 55 112 0 12.7 0.1 12.8
Finland 1 55 080 0 13.4 0.1 13.5
Sweden (2014) 1 113 999 0 14.9 0.2 15.1
United Kingdom
UK: England and Wales 2 689 751 0 15.8 0.2 16.1
UK: Scotland 1 53 689 62 14.2 0.3 14.6
UK: Northern Ireland 3 23 937 0 14.3 0.3 14.6
Iceland 1 4026 0 17.4 0.2 17.6
Norway 1 58 927 0 16.6 0.2 16.9
Switzerland (2014) 1 83 696 0 18.0 0.4 18.3
Note 1. In Bulgaria, mothers with babies of unknown GA are not included.        
2. In Denmark and Slovenia, data are based on mothers delivering live or stillbirths (and terminations).      
3. In Greece, Hungary, and Romania data are based on babies.          
4. In Lithuania, mothers with babies of unknown GA and weight are not included.        
5. In Hungary and Romania, data are based on live births only. In Hungary, data include 10 births <22 weeks and <500 g which could not be removed.   
        
C8: Distribution of maternal age (rates per 100 women)      
       
Number of Women
Percentage of women delivering live or stillbirths
Age in years
Country/coverage Source All stated Not stated
<15 15-17 18-19 20-24 25-29 30-34 35-39 40-44 45-49 ≥50
Belgium 1 120 618 63 0.0 0.4 1.3 11.9 33.9 33.9 15.2 3.1 0.2 0.0
Bulgaria1 (2014) 1 64 427 0 0.5 4.3 5.4 21.7 30.9 23.6 11.5 2.0 0.1 0.0
Czech Republic 2 107 545 73 0.0 0.0 2.4 12.3 29.9 34.4 17.7 3.2 0.1 0.0
Denmark2 1,2,4 56 895 0 0.0 0.1 0.9 11.0 32.7 34.1 17.3 3.7 0.2 0.0
Germany 1 714 574 0 0.0 0.6 1.6 10.9 28.5 35.3 19.2 3.9 0.2 0.0
Estonia 1 13 731 0 0.0 0.7 2.0 14.6 33.9 29.0 15.6 4.0 0.2 0.0
Ireland 1 64 648 2 0.0 0.5 1.4 8.8 19.0 36.1 28.0 6.0 0.3 0.0
Greece3 1 92 159 0 0.1 1.0 1.4 8.0 22.5 37.3 23.7 5.2 0.7 0.1
Spain 1 412 266 0 0.0 0.7 1.3 7.2 18.0 35.4 29.7 7.1 0.4 0.0
France 5 748 581 8 0.1 0.4 1.5 12.5 31.7 33.2 16.4 3.9 0.2 0.0
France (Survey, 2016) 1 13 071 6 2.0 11.9 31.2 33.7 17.2 3.8 0.2
Croatia 1 36 866 0 0.0 0.8 2.2 14.2 30.6 33.2 15.9 2.8 0.2 0.0
Italy 9 478 061 345 0.0 0.3 1.0 8.2 21.1 33.1 26.5 9.0 0.7 0.1
Cyprus 1 9153 18 0.0 0.4 1.0 9.2 30.5 37.5 17.4 3.7 0.3 0.0
Latvia 1 21 496 0 0.0 0.9 2.5 17.1 32.7 28.4 14.5 3.6 0.2 0.0
Lithuania4 1,2 28 608 2552 0.0 1.0 2.8 16.5 35.2 28.8 12.9 2.7 0.1 0.0
Luxembourg 1 6762 0 0.1 0.3 1.1 8.5 25.2 37.4 22.7 4.4 0.3 0.0
Hungary3,5 1 91 690 0 0.1 2.3 4.0 14.6 25.1 30.0 19.6 4.2 0.1 0.0
Malta 1 4385 0 0.1 1.1 1.8 11.6 30.0 36.3 16.1 2.9 0.1 0.0
Netherlands 1 166 696 4 0.0 0.2 0.7 9.3 30.9 38.1 17.6 3.1 0.1 0.0
Austria 1 82 565 0 0.0 0.5 1.6 13.2 29.8 34.2 16.7 3.7 0.2 0.0
Poland (2014) 1 372 046 0 0.0 0.9 2.7 16.1 34.5 31.1 12.4 2.2 0.1 0.0
Portugal 1 84 552 4 0.1 0.8 1.8 10.3 22.4 35.2 24.0 5.2 0.2 0.0
Romania3,5 5 201 023 0 0.3 4.3 5.0 19.1 32.7 24.1 12.1 2.3 0.1 0.0
Slovenia2 1 20 003 0 0.0 0.2 0.8 10.5 33.6 36.2 15.7 2.8 0.1 0.0
Slovakia 1 55 078 34 0.1 2.3 3.9 15.9 30.0 30.9 14.3 2.5 0.1 0.0
Finland 1 55 080 0 0.0 0.3 1.4 14.0 29.4 34.1 17.2 3.4 0.2 0.0
Sweden (2014) 1 112 769 1230 0.0 0.2 1.0 12.8 30.9 33.6 17.3 4.0 0.2 0.0
United Kingdom
UK: England and Wales 2 689 751 0 0.0 0.9 2.6 15.6 28.5 31.2 17.2 3.8 0.3 0.0
UK: Scotland 1 53 751 0 0.0 1.1 2.9 15.9 27.9 31.5 17.0 3.5 0.2 0.0
UK: Northern Ireland 1 24 544 0 0.0 0.8 2.3 14.0 27.3 33.2 18.4 3.6 0.3 0.0
Iceland 1 4026 0 0.0 0.3 1.8 16.0 32.4 29.3 16.3 3.5 0.3 0.0
Norway 1 58 927 0 0.0 0.2 1.1 12.2 32.8 33.5 16.7 3.3 0.2 0.0
Switzerland (2014) 1 83 696 0 0.0 0.1 0.6 8.2 25.6 38.2 22.2 4.7 0.3 0.0
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C9: Distribution of parity (rates per 100 women)       
Number of live births Percentage of women delivering live or stillbirths
Parity
Country/coverage Source All stated Not stated 0 1 2 3 4+
Belgium 1 120 615 66 42.5 34.5 14.7 5.3 3.0
Bulgaria1 (2014) 1 65 503 99 51.2 36.0 7.7 2.5 2.7
Czech Republic 2 107 618 0 48.3 35.7 11.3 2.9 1.8
Denmark2 1,2,4 56 895 0 45.5 37.5 12.8 2.9 1.4
Germany 1 714 574 0 49.0 34.3 11.4 3.5 2.0
Estonia 1 13 731 0 42.3 37.3 14.4 4.0 2.1
Ireland 1 64 650 0 38.2 34.8 17.8 6.1 3.1
Greece1 1 92 159 0 47.8 39.0 9.8 3.4
Spain 1 412 266 0 51.5 48.5
France 
France (Survey, 2016) 1 13 074 3 42.5 35.4 14.3 4.8 3.0
Croatia 1 36 866 0 49.0 33.3 12.0 3.2 2.4
Italy 9 478 154 252 52.7 35.0 9.5 2.1 0.8
Cyprus 1 9166 5 48.4 36.3 11.2 3.0 1.1
Latvia 1 21 496 0 43.1 37.3 13.8 3.6 2.1
Lithuania 2 31 587 14 47.4 37.6 10.6 2.5 1.8
Luxembourg 1 6762 0 47.6 35.5 11.8 3.6 1.6
Hungary1,3 1 91 449 241 46.7 32.3 13.5 4.1 3.3
Malta 1 4385 0 50.7 34.8 9.5 3.1 1.9
Netherlands 1 166 659 41 44.6 36.1 13.4 3.8 2.0
Austria 1 82 565 0 48.8 35.0 11.4 3.2 1.6
Poland (2014) 1 372 036 10 48.1 37.3 10.2 2.7 1.7
Portugal 1 84 556 0 53.5 35.6 8.0 2.0 0.8
Romania1,3 2 201 760 0 54.5 29.3 8.4 3.4 4.4
Slovenia2 1 20 003 0 49.0 38.0 10.0 2.0 1.0
Slovakia 1 49 480 5632 41.7 37.0 12.0 4.1 5.2
Finland 1 55 080 0 41.6 34.3 14.4 4.9 4.8
Sweden (2014) 1 113 815 184 43.1 37.4 13.5 3.7 2.2
United Kingdom
UK: England and Wales 2 686 587 3164 38.8 36.1 15.5 5.8 3.8
UK: Scotland 1 53 624 127 43.2 35.5 13.7 4.7 2.7
UK: Northern Ireland 1 24 544 0 38.4 34.8 17.7 6.2 2.9
Iceland 1 4025 1 39.8 35.4 18.5 4.8 1.6
Norway 1 58 924 3 42.7 36.6 15.0 3.9 1.8
Switzerland (2014) 1 83 377 319 49.5 36.5 11.1 2.3 0.7
 
Note 1. In Bulgaria, Greece, Hungary and Romania data are based on babies.          
2. In Denmark and Slovenia, data are based on mothers delivering live or stillbirths (and terminations).       
3. In Hungary and Romania, data are based on live births only. In Hungary, data include 10 births <22 weeks and <500 g which could not be removed.     
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C10: Mode of delivery (rates per 100 total births)       
Number of live births Percentage of women delivering live or stillbirths
Parity
Country/coverage Source All stated Not stated 0 1 2 3 4+
Belgium 1 120 615 66 42.5 34.5 14.7 5.3 3.0
Bulgaria1 (2014) 1 65 503 99 51.2 36.0 7.7 2.5 2.7
Czech Republic 2 107 618 0 48.3 35.7 11.3 2.9 1.8
Denmark2 1,2,4 56 895 0 45.5 37.5 12.8 2.9 1.4
Germany 1 714 574 0 49.0 34.3 11.4 3.5 2.0
Estonia 1 13 731 0 42.3 37.3 14.4 4.0 2.1
Ireland 1 64 650 0 38.2 34.8 17.8 6.1 3.1
Greece1 1 92 159 0 47.8 39.0 9.8 3.4
Spain 1 412 266 0 51.5 48.5
France 
France (Survey, 2016) 1 13 074 3 42.5 35.4 14.3 4.8 3.0
Croatia 1 36 866 0 49.0 33.3 12.0 3.2 2.4
Italy 9 478 154 252 52.7 35.0 9.5 2.1 0.8
Cyprus 1 9166 5 48.4 36.3 11.2 3.0 1.1
Latvia 1 21 496 0 43.1 37.3 13.8 3.6 2.1
Lithuania 2 31 587 14 47.4 37.6 10.6 2.5 1.8
Luxembourg 1 6762 0 47.6 35.5 11.8 3.6 1.6
Hungary1,3 1 91 449 241 46.7 32.3 13.5 4.1 3.3
Malta 1 4385 0 50.7 34.8 9.5 3.1 1.9
Netherlands 1 166 659 41 44.6 36.1 13.4 3.8 2.0
Austria 1 82 565 0 48.8 35.0 11.4 3.2 1.6
Poland (2014) 1 372 036 10 48.1 37.3 10.2 2.7 1.7
Portugal 1 84 556 0 53.5 35.6 8.0 2.0 0.8
Romania1,3 2 201 760 0 54.5 29.3 8.4 3.4 4.4
Slovenia2 1 20 003 0 49.0 38.0 10.0 2.0 1.0
Slovakia 1 49 480 5632 41.7 37.0 12.0 4.1 5.2
Finland 1 55 080 0 41.6 34.3 14.4 4.9 4.8
Sweden (2014) 1 113 815 184 43.1 37.4 13.5 3.7 2.2
United Kingdom
UK: England and Wales 2 686 587 3164 38.8 36.1 15.5 5.8 3.8
UK: Scotland 1 53 624 127 43.2 35.5 13.7 4.7 2.7
UK: Northern Ireland 1 24 544 0 38.4 34.8 17.7 6.2 2.9
Iceland 1 4025 1 39.8 35.4 18.5 4.8 1.6
Norway 1 58 924 3 42.7 36.6 15.0 3.9 1.8
Switzerland (2014) 1 83 377 319 49.5 36.5 11.1 2.3 0.7
 
Number of total births
Percentage of total births
Mode of delivery
Country/coverage Source All stated Not stated Vaginal -
spontaneous
Vaginal -
instrument
Vaginal -
total
Caesarean -
no labour or 
elective
Caesarean -
during 
labour or 
emergency
Caesarean -
total
Belgium 1 121 185 1653 69.2 9.5 78.7 11.3 10.0 21.3
Bulgaria (2014) 2 62 912 1435 57.0 43.0
Czech Republic1 2 107 618 0 71.2 2.7 73.9 17.4 8.7 26.1
Denmark 1,2,4 57 847 0 72.0 6.4 78.4 11.3 10.3 21.6
Germany 1 728 496 0 60.9 6.8 67.8 16.1 16.1 32.2
Estonia 1 13 961 0 76.3 4.2 80.5 6.6 12.9 19.5
Ireland 1 65 912 1 53.6 15.1 68.7 31.3
Greece
Spain 2 385 478 27 965 60.4 15.1 75.4 8.5 16.0 24.6
France 5 758 890 2990 67.9 11.2 79.1 7.1 13.8 20.9
France2 (Survey, 
2016)
1 13 301 10 67.6 12.1 79.8 9.8 10.5 20.2
Croatia 1 37 428 0 77.0 1.4 78.4 11.5 10.1 21.6
Italy 9 480 217 6340 61.1 3.5 64.6 22.7 12.8 35.4
Cyprus 1 9422 3 39.4 3.7 43.1 40.5 16.4 56.9
Latvia 1 21 826 0 75.6 2.4 78.0 9.3 12.7 22.0
Lithuania 1,2 29 019 2582 76.3 1.9 78.1 8.4 13.4 21.9
Luxembourg 1 6861 1 56.1 11.2 67.3 16.9 15.8 32.7
Hungary 3 92 098 0 61.0 39.0
Malta 1 4453 0 63.8 4.2 68.0 19.5 12.5 32.0
Netherlands 1 165 295 3939 74.1 8.4 82.6 8.7 8.7 17.4
Austria 1 83 884 0 63.1 7.2 70.3 14.6 15.0 29.7
Poland (2014) 2 369 709 0 57.8 42.2
Portugal3 3 83 957 2091 67.1 32.9
Romania 4 153 746 48 004 52.6 0.5 53.1 3.6 43.3 46.9
Slovenia 1 20 336 0 75.9 2.8 78.8 9.8 11.5 21.2
Slovakia 1 55 824 0 66.8 2.1 68.9 17.7 13.4 31.1
Finland 1 55 759 0 74.4 9.2 83.6 6.4 10.0 16.4
Sweden (2014) 1 115 710 0 75.7 6.0 81.7 7.8 10.5 18.3
United Kingdom
UK: England 1 632 784 3446 60.0 13.0 73.0 11.5 15.5 27.0
UK: Wales 2 32 128 210 63.1 10.9 73.9 12.0 14.0 26.1
UK: Scotland4 1 54 273 240 55.3 12.2 67.5 14.9 17.6 32.5
UK: Northern Ireland 1 24 540 4 58.2 12.0 70.1 15.4 14.5 29.9
Iceland 1 4091 7 76.4 7.6 83.9 8.4 7.6 16.1
Norway 1 59 930 0 73.3 10.2 83.5 5.8 10.7 16.5
Switzerland2 (2014) 1,2,3 81 969 3237 54.9 10.8 65.8 17.8 16.4 34.2
 
Note. 1. In the Czech Republic, N corresponds to the number of mothers instead of babies.        
2. In Switzerland, there are 185 caesarean sections with unknown mode of onset that are not included here, and three in France     
3. In Portugal, N corresponds to the number of deliveries instead of babies.         
4. In Scotland, 181 vaginal deliveries with unknown mode of delivery (instrumental or not) are excluded here.         
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R8: Percentage of women who smoked during pregnancy in 2015
Definition of period Period 1 Period 2
Country/
coverage
Source Period 1 Period 2 All stated
N
Not stated
N
Smokers
%
All stated
N
Not stated
N
Smokers
%
Belgium
Bulgaria
Czech Republic 2 During pregnancy 107,618 0 7.2
Denmark 1 1st trimester 2nd trimester 56416 479 11.0 56 416 479 7.5
Germany 1 During pregnancy 490 834 203 740 9.0
Estonia 1 1st trimester During pregnancy 13128 603 7.6 13 128 603 6.1
Ireland
Greece
Spain
ES: Catalonia 3 Before pregnancy 3rd trimester 63400 7061 22.8 60 292 10 169 13.0
ES: Valencia 
(2016)
4 End of pregnancy 23 658 5886 18.3
France (Survey, 
2016)
1 Before pregnancy 3rd trimester 11702 1375 29.8 11 720 1357 16.3
Croatia 1 During pregnancy 35 847 1019 7.8
Italy (2013) 11 Before pregnancy During pregnancy 20.5 5.3
Cyprus 1 During pregnancy 8 858 313 6.3
Latvia 1 During pregnancy 21 496 0 7.9
Lithuania 1 Before pregnancy During pregnancy 28608 2552 8.0 28 608 2552 4.4
Luxembourg 1 1st trimester 3rd trimester 6720 42 13.3 6713 49 10.7
Hungary
Malta 1 At booking 4385 0 7.7
Netherlands 4 During pregnancy 1682 59 6.0
Austria 1 3rd trimester 62 326 20 239 12.5
Poland
Portugal
Romania
Slovenia 1 During pregnancy 20 003 0 9.5
Slovakia
Finland 1 1st trimester After 1st trimester 53988 1771 14.7 53 988 1771 7.5
Sweden 1 1st trimester 3rd trimester 110016 4973 5.1 109 308 5681 3.8
United Kingdom
UK: England 
(2015/16)
2 Booking Delivery 438099 126756 14.2 456 344 108 511 12.3
UK: Wales 2 3rd trimester 29 584 1576 17.3
UK: Scotland 1 At booking 52237 1539 16.4
UK: Northern 
Ireland
1 During pregnancy 24 172 15 14.3
Iceland
Norway 1 First visit End of pregnancy 53610 5317 5.5 50 009 8918 3.6
Switzerland
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R12: Distribution of maternal prepregnancy body mass index     
Prepregnancy body mass index Percentage of women delivering live or stillbirths
Country/coverage Source All stated Not stated <18.5 18.5-24.9 25.0-29.9 ≥30.0
Belgium 1 112 745 7964 5.4 59.1 22.8 12.7
Bulgaria
Czech Republic
Denmark 1 56 308 587 4.6 62.0 20.8 12.6
Germany 1 669 397 45 177 3.9 58.1 23.1 14.9
Estonia
Ireland
Greece
Spain
France, Survey (2016) 1 11 588 1489 7.4 60.8 20.0 11.8
Croatia 1 35 102 1764 5.5 67.6 19.0 7.8
Italy
Cyprus
Latvia
Lithuania
Luxembourg
Hungary
Malta 1 3475 910 2.8 59.7 23.8 13.7
Netherlands
Austria 1 79 100 3465 6.4 64.5 19.0 10.0
Poland
Portugal
Romania
Slovenia 1 19 983 20 4.7 66.1 19.6 9.6
Slovakia
Finland 1 54 577 1182 3.5 61.2 22.1 13.2
Sweden (2014) 1 108 218 6771 2.6 57.8 25.9 13.7
United Kingdom
UK: England (2015/16) 2 461 266 103 589 2.9 47.5 28.4 21.2
UK: Wales (2016) 1 24 040 0 2.4 43.6 28.4 25.6
UK: Scotland 1 52 387 1389 2.9 46.5 27.9 22.7
UK: Northern Ireland 1 23 871 316 1.9 47.9 29.8 20.4
Iceland
Norway 1 43 683 15 239 4.2 62.4 21.6 11.6
Switzerland
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Country Source N° Source name Start date Data 
from
Type of data Coverage Completeness Participation Linked 
Source
Institution Other comments on data 
source
P= Population 
H= hospital 
O= Other
C= 
Country 
level O= 
Other
U = Unknown O= Obligatory 
V= Voluntary
Y= Yes 
N=No
Austria 1 birth + cause 
of death 
statistics for 
infant death
1984 2015 P C 100% O Y Statistics Austria Linkage of birth statistics 
and causes of death 
statistics for infant death
Austria 2 Cause of death 
statistics
1970 2015 P C 99% O N Statistics Austria
Belgium 1 Civil 
Registration
1966 2015 H C 100% O Y Statistics Belgium 
(Statbel)
Bulgaria 1 Vital Statistics 2014 P C 100% O NA National Statistics 
Institute
Bulgaria 2 National birth 
register
2011 2014 P C 100% O N National center for 
public health and 
analysis
Bulgaria 3 National center 
for public 
health and 
analysis
2000 2014 P C U O N National center for 
public health and 
analysis
Croatia 1 Croatian 
Medical Birth 
Database
1990 2015 H C 100% O Y Croatian Public 
Health Institute
Croatia 2 Croatian 
Mortality 
Database
NA 2015 P C U O N Croatian Central 
Bureau of Statistics 
(CBS)
Cyprus 1 Birth Register 2007 2015 H C 100% O Y The Health 
Monitoring Unit, 
Cyprus ministry of 
health
The recording of medical 
data for births started from 
the year 2007 for all public 
maternity units. From 
the year 2014 the data 
also includes the private 
maternity units as well.
Cyprus 2 Death Register 2004 2015 P C 100% O Y The Health 
Monitoring Unit, 
Cyprus ministry of 
health
Death certificates, 
collected and coded by 
the Health monitoring unit. 
All administrative sources 
of information are used 
to collect data on deaths: 
medical death certificates, 
autopsy reports, coroner’s 
reports, population registry 
of ministry of interior, 
EMCDDA of Cyprus, police 
records, accidents at work 
from the Ministry of Labor, 
Ministry of Foreign Affairs 
for deaths abroad. Even 
press reports are used to 
corroborate data.
Cyprus 3 Combined 
data from 
Demographic 
Report and 
from the Death 
Register
2004-2007 2015 P C 100% O Y Health Monitoring 
Unit, Cyprus Ministry 
of Health
Cyprus 4 Combined 
data from the 
Birth register, 
Death register, 
and the 
Demographic 
Report
2011-2020 2015 P C 99% O Y Statistical Service  
and Ministry of Health
Covers all residents  except 
nationals who deliver out of 
the country.
Czech 
Republic
1 Czech 
Statistical 
Office (CZSO)
1987 2015 P C 100% O N Czech Statistical 
Office (CZSO)
Vital statistics
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Country Source N° Source name Start date Data 
from
Type of data Coverage Completeness Participation Linked 
Source
Institution Other comments on data 
source
Czech 
Republic
2 Institute 
of Health 
Statistics and 
Information 
of the Czech 
Republic
2001 2015 P C 99.5% O Institute of Health 
Statistics and 
Information of the 
Czech Republic
Denmark 1 Medical birth 
register
1973 2015 P C ± 100 % Y The Danish Health 
Data authority, under 
the Danish Ministry 
of Health
Hospital and home births 
included
Denmark 2 National patient 
register
1977 2015 P C ± 100 % N The Danish Health 
Data authority, under 
the Danish Ministry 
of Health
Contains information on all 
contacts with the Danish 
hospitals
Denmark 3 Danish causes 
of death 
register
1970 2015 P C 100% O N The Danish Health 
Data authority, under 
the Danish Ministry 
of Health
Causes of death, civil status 
and causes of death related 
data
Denmark 4 The Centralized 
Civil Register
2015 P
Estonia 1 Estonian 
Medical Birth 
Register
1992 2015 H/P (both) C 99.9% O Y National Institute for 
Public Health
Includes all deliveries in 
Estonia, including home 
deliveries
Estonia 2 Estonian 
Cause of Death 
Register
1983 2015 H/P (both) C 99.6% O Y National Institute for 
Public Health
Includes all deaths on the 
territory of Estonia, partly 
court decisions and deaths 
abroad of Estonian residents
Estonia 3 Linked Data 
from EMSR 
(Medical Birth) 
and SPR 
(Causes of 
Death)
1992 2015 O C 99.8% O Y National Institute for 
Public Health
Some births, occurring to 
residents abroad, can be 
registered in later years.
Estonia 4 Report of a 
health care 
institution 
on maternal 
deaths and 
child health
1960 2015 P C _ NA N Health Statistics Unit, 
National Institute for 
Public Health
Estonia 5 Statistics 
Estonia based 
on Registry 
of Causes of 
Death
1920 2015 P C NA NA N National Institute for 
Public Health
Finland 1 Medical Birth 
Register
1987 2015 P C 100% O Y National Institute for 
Health and Welfare 
THL
Covers all occurring births in 
Finland despite citizenship 
or residence.
Finland 2 Cause-of-
Death Register
1936 2015 P C 100% O N Statistics Finland Includes Finnish citizens and 
permanent residents (with 
valid ID number).
France 1 National 
Perinatal 
Survey
2016 2016 P C 100% for the 
minimum 
data set (core 
indicators)
V N INSERM Representative sample of 
births in France.
France 2 Civil 
Registration
1900 2015 P C 100% O N INSEE (National 
Institute Of Statistics 
and Economics 
Studies)
Recording of births, deaths 
on the French territory
France 3 Routine death 
statistics
1979 2015 P C 100% O N National centre of 
statistics for medical 
causes of death 
(CépiDc)
France 4 National 
confidential 
survey on 
maternal 
mortality, 
ENCMM
1996 2015 O C 100% V Y Inserm UMR 
1153-Obstetrical, 
Perinatal 
and Pediatric 
Epidemiology 
Research Team
death certificates of women 
of reproductive age, birth 
registers and national 
hospital discharge data
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France 5 PMSI 1998 2015 H O 99% O N ATIH : Technical 
agency of 
hospitalization 
information
Linkage of hospital episodes 
is feasible. covers both 
public and private hospitals 
in France and the overseas 
districts
Germany 1 IQTIG 2015 2015 H C 95-98% with 
90% certainty
O Federal Institute for 
the Quality of Medical 
Care
Germany 2 Destatis 1834 2015 P C 99.9% O Y Federal Statistical 
Office
Germany 3 Destatis 
terminations
1976 2015 P C 99.5% O N Federal Statistical 
Office
A special register of the 
Federal Bureau of statistics 
for terminations
Greece 1 Hellenic 
Statistical 
authority
2015 P C O
Hungary 1 Hungarian 
Central 
Statistical 
Office
1865 2015 P C 100% O Y
Hungary 2 WHO, UNICEF, 
UNFPA, World 
Bank Group 
and United 
Nations 
Population 
Division 
Maternal 
Mortality 
Estimation 
Inter-Agency 
Group
1990 2015 P C 100% O Y
Hungary 3 National Health 
Insurance Fund 
of Hungary
2015 H C 100% O Y
Iceland 1 The Icelandic 
Birth 
Registration 
(IBR)
1972 2015 P C 99% O Y
Ireland 1 National 
Perinatal 
Reporting 
System (NPRS)
1985 2015 P C 100% O N The National Perinatal 
Reporting System 
(NPRS), managed 
by the Healthcare 
Pricing Office (HPO) 
at the Health Service 
Executive (HSE)
The birth notification form 
(BNF01)  is completed 
where the birth takes place 
(either hospital/home).
Ireland 2 Central 
Statistical 
Office
2015 Central Statistics 
Office
link provided by SC 
member https://www.
cso.ie/en/statistics/
birthsdeathsandmarriages/ ( 
data from online PDF)
Ireland 3 Confidential 
Maternal Death 
Enquiry Ireland
2015 National Perinatal 
Epidemiology Centre, 
Cork
link provided by SC member 
https://www.ucc.ie/en/npec/
publications/ ( data from 
online PDF)
Italy 1 Birth 
certificates 
(CEDAP, 
Certificato di 
assistenza al 
parto)
1978 2015 P C 99% O N Ministry of Health
Italy 2 Survey on 
hospital 
discharges for 
spontaneous 
abortion
1979 2015 H C 95% O N National Institute 
of Statistics of Italy 
(ISTAT)
Data are collected using an 
individual form containing 
information on the woman 
and on the operation.
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Italy 3 Survey on 
induced 
abortion
1979 2015 H C 100% O N National Institute 
of Statistics of Italy 
(ISTAT)
Data are collected using an 
individual form containing 
information on the woman 
and on the operation.
Italy 4 Death Register 
before the first 
year of life
2015 P C 100% O N National Institute 
of Statistics of Italy 
(ISTAT)
Italy 5 Death Register 
beyond the first 
year of life
1871 2015 P C 100% O N National Institute of 
Health
Italy 6 Hospital 
Discharge
1995 2015 H C 100% O N Regional authorities 
and Ministry of Health
Italy 7 Merged 
Datasource 
(1,2,3,4,6)
Y
Italy 8 Merged 
Datasource 
(1,2,3,6)
Y
Italy 9 Merged 
Datasource 
(1,2,6)
Y
Italy 10 Merged 
Datasource 
(5,6)
Y
Italy 11 Survey on 
health status 
and use of 
health services
1993 2013 P C 100% O N National Institute 
of Statistics of Italy 
(ISTAT)
The survey uses a stratified 
random sampling to obtain 
national representativeness
Latvia 1 Newbos 
Register of 
Latvia (The 
Medical Birth 
Register)
2000 2015 P C 99% O Y The Centre for 
Disease Prevention 
and Control of Latvia
Covers all deliveries, except 
nationals who deliver out of 
the country.
Latvia 2 Register of 
Causes of 
Death
1996 2015 P C 99% O Y The Centre for 
Disease Prevention 
and Control of Latvia
Also includes Latvians who 
have died abroad if possible
Latvia 3 The Medical 
Birth Register 
and Register 
of Cause of 
Death
2015 Y Combined data source
Lithuania 1 Medical Date of 
Births
1993 2015 H C 99% O N HI HIC responsible 
for processing, 
Children's Hospital, 
Affiliate of Vilnius 
University Hospital 
Santariskiu 
Klinikos Centre 
of Neonatology 
responsible for 
analysing
Standard forms filled in 
maternity hospitals
Lithuania 2 Database of the 
Demographic 
Statistics
1994 2015 P C 100% O Y Central Statistical 
Office (Statistics 
Lithuania)
Lithuania 3 Causes of 
Death register
2010 2015 P C 100% O Y Institute of Hygiene 
Healf Information 
Centre (HI HIC)
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Luxembourg 1 Perinatal Health 
Monitoring 
System
2009 2015 H C 100% O N Luxembourg institute 
of Health
Available in all maternity 
units and liberal midwifes 
attending home deliveries.
Luxembourg 2 Stillbirths and 
early neonatal 
causes of 
death register
1967 2015 P C 99% O Y Ministry of Health - 
Direction of Health
Luxembourg 3 Cause of Death 
Register- 
Registre des 
causes de 
décès du 
certificat de 
décès
1967 2015 P C 99% O Y Ministry of Health - 
Direction of Health
Malta 1 National 
Obstetrics 
Information 
System
1999 2015 P C 100% V N Directorate for Health 
Information and 
Research
Records all births on the 
Maltese islands
Malta 2 National 
Mortality 
Register
1995 2015 P C 100% O N Directorate for Health 
Information and 
Research
Norway 1 Medical Birth 
Register of 
Norway
1967 2015 P C 99% O NA The Norwegian 
Institute of Public 
Health
Includes stillbirths and 
livebirths 12-16 weeks GA 
and up.
Poland 1 Central 
Statistical 
Office
1946 2014 P C 100% O N Central Statistical 
Office
Birth and death certificates
Poland 2 Ministry of 
Health Data 
(Hospital 
discharge data 
MZ-29)
2014 H C 100% O N Centrum Systemów 
Informacyjnych 
Ochrony Zdrowia
Portugal 1 National 
Statistics - Live 
births and fetal, 
neonatal and 
infant deaths
1935 2015 P C Almost 100% O N National Statistics 
Institute (INE) / 
Department of 
Demographic and 
Social Statistis 
/ Demographic 
Statistics Unit (INE/
DES/DM)
Based on routine data from 
birth and death certificates 
at a national level.
Portugal 2 Hospital 
Discharge 
Data
2015 H C 100% of public 
hospitals
O N Central 
Administration of the 
Health System (ACSS)
Diagnosis-related Group 
classification according to 
ICD9, developed for financial 
purposes. We have used all 
cases coded as "Pregnancy, 
Delivery and Puerperium”.
Portugal 3 Hospitals' 
survey
2000 2015 H C Almost 100% O N National Statistics 
Institute AND General 
Directorate for Health
Romania 1 National Centre 
for Statistics 
and Informatics 
in Public Health 
(NCSIPH) for 
maternal 
deaths
1945 2015 C 100% O N NICSPH
Romania 2 NIS births & 
NCSIPH fetal/
neonatal/infant 
deaths
2000 2015 H C 100% O N National Institute for 
Statistics data for 
fetal deaths.  National 
Center for Statistics 
and Informatics in 
Public Health for fetal 
deaths as a modality 
to validate the cause 
of death.
National Institute for 
Statistics data for births and 
National Centre for Statistics 
and Informatics in Public 
Health for fetal/neonatal/
infant deaths
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Romania 3 NCSIPH fetal/
neonatal/infant 
deaths
2000 2015 H C 100% O N National Institute for 
Statistics data for 
fetal deaths.  National 
Center for Statistics 
and Informatics in 
Public Health for fetal 
deaths as a modality 
to validate the cause 
of death.
National Centre for Statistics 
and Informatics in Public 
Health for fetal/neonatal/
infant deaths
Romania 4 NCSIPH DRG 2007 2015 H O Public hospitals 
only
O Y NCSIPH NCSIPH data from the DRG 
system. Public hospitals 
only.
Romania 5 National 
Institute for 
Statistics 
demographic 
statistics for 
births
2000 2015 H C U O N NIS
Slovakia 1 NCZI SOR SON 2015 H C 100% O N National health 
information center
Slovakia 2 Statistical 
Office SR
2015 P C 100% O NA Statistical office
Slovenia 1 National 
Perinatal 
Information 
System of 
Slovenia
1986 2015 H C 100% O N Institute of Public 
Health
Slovenia 2 Death 
certificates 
database
2015 P C U O NA Institute for Public 
Health
Spain 1 Vital Statistics 1858 2015 P C U O N National Statistics 
Office.
Collects Vital Statistics 
among others statistics,
Spain 2 Minimum Data 
set
1997 2015 H C 93.2% V N Ministry of Health All public hospital and 
around 66% of private 
hospitals in 2015
Spain: 
Catalonia
3 Register of 
babies
1993 2015 H C O N Subdirectorate-
General for 
Epidemiological 
Surveillance and 
Public Health 
Emergency 
Response. Public 
Health Agency 
of Catalonia. 
Department of Health.
Spain: 
Valencia
4 Obstetrics 
Medical Record 
Primary Care
2004 2016 O O 60% O N Regional Health 
Authority
Sweden 1 Medical Birth 
Register
1973 2014 P C 98% O Y The National Board of 
Health and Welfare
All pregnancies and 
deliveries in Sweden
Switzerland 1 BEVNAT, 
statistics 
of natural 
population 
change (vital 
statistics)
1871 2014 P C ±  100% O Y Swiss Federal 
Statistical Office
Some underreporting of 
fetal deaths (including TOP) 
and births occurring outside 
the country
Switzerland 2 MS, Medical 
Hospital 
Statistics 
combined with 
data from
1998 2014 H C ±97% O Y Swiss Federal 
Statistical Office
National hospital data (plus 
some birthing homes)
Switzerland 3 The Swiss 
Federation of 
Midwifes
2005 2014 O C ± 99% O N Swiss Federal 
Statistical Office, 
Swiss Federation of 
Midwifes
the Swiss Federation of 
Midwifes (births at home 
and in the remaining 
birthing home0s)
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The 
Netherlands
1 Perined 1982 2015 P C 99% V Y The Netherlands 
Perinatal Registry
The Netherlands Perinatal 
Registry (PRN) includes 
data on pregnancies, 
deliveries, mothers and their 
babies and care process. 
PRN is a linked database 
which includes information 
from LVR1 (the midwife 
register),  LVRh (the general 
practitioner register),  LVR2 
(the obstetrician register) 
and LNR the paediatrician 
and neonatologist register"
The 
Netherlands
2 Maternal Death 
Commitee of 
NVOG (Dutch 
Association of 
Gynaecology 
and Obstetrics)
The 
Netherlands
3 Statistics 
Netherlands 
(municipal base 
administration)
2015 P C O
The 
Netherlands
4 Survey on 
breastfeeding 
and smoking
2015 TNO
UK_England 1 Maternity 
Hospital 
Episode 
Statistics
1989/90 2015 H O:England Many missing 
data items
O N NHS Digital Births in private hospitals 
and most home births 
missing, but under one per 
cent of births are in private 
hospitals and under three 
per cent at home
UK_England 2 MIS 2015-16 2015-
16
H England Still very 
incomplete
Obligatory in 
theory
N National Maternity 
and Perinatal Audit 
(NMPA)
UK_England 
and Wales
1 Civil 
registration 
of births and 
deaths linked 
to notification 
of births
2005 2014 
and 
2015
P O: 
England 
and Wales
100% O Y Office for National 
Statistics
Linkage of infant deaths 
to births began in 1975. 
Linkage of registered 
births to birth notifications 
started with a pilot in 2005, 
mainstreamed from 2006 
onwards
UK_England 
and Wales
2 Civil 
registration 
of births and 
deaths
1837 2015 P O: 
England 
and Wales
100% O N Office for National 
Statistics
Registration of stillbirths 
began in 1927. Linkage of 
infant deaths to births began 
in 1975.
UK_NI 1 Northern 
Ireland 
Maternity 
System 
(NIMATS)
2011 2015 H O: 
Northern 
Ireland
100% O N Dept. of Health, NI Each of the 5 HSC Trusts 
trusts in Northern Ireland 
feed into this Hospital 
Maternity Administration 
System. Data can be 
accessed by the Department 
of Health, NI.
UK_NI 2 Perinatal Death 
notifications to 
NIMACH office 
and MBRRACE 
system
2009 2015 H and P O: 
Northern 
Ireland
100% O Y MMBRACE UK GRONI Registrar General 
Annual Report and Patient 
Administration System.
UK_NI 3 General 
Register Office 
for Northern 
Ireland (GRONI).
Civil 
Registration 
Data. Through 
NISRA.
1922 2015 P O: 
Northern 
Ireland
100% O N General Register 
Office for Northern 
Ireland.
1864 – All Ireland
1922 – Northern Ireland 
only.
GRONI statistics produced 
by Northern Ireland 
Statistics and Research 
Agency (NISRA) with general 
registration statistics 
reported in the Registrar 
General Annual Report.
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UK_Scotland 1 Composite 
file created by 
linking 3 data 
sources:
Y Information Services 
Division of NHS 
National Services 
Scotland
Creating the composite 
file: SMR02 records 
were extracted for all live 
births 22+ weeks and all 
fetal deaths 22+ weeks 
(including therapeutic 
abortions). A data linkage 
was carried out to match 
NRS Stillbirths and Deaths 
(infant deaths among babies 
born in 2015) to the SMR02 
base file.
a) SMR02 
- Scottish 
Morbidity 
Record 02 
(Maternity 
Inpatients and 
Daycases)
1975 2015 H O: 
Scotland
~98% V
b) National 
Records of 
Scotland 
Stillbirths 
registrations
1974 2015 P O: 
Scotland
100% O
c) National 
Records of 
Scotland Death 
Registrations
1974 2015-
2016
P O: 
Scotland
100% O
UK_Scotland 2 National 
Records of 
Scotland Death 
Registrations
1974 2015-
2016
P O: 
Scotland
100% O N Information Services 
Division of NHS 
National Services 
Scotland
All deaths (including infant 
and maternal) are included 
in this register.
UK_Wales 1 Maternity 
Indicators 
Dataset
2015 2015/
2016
H O: Wales Any patients 
treated in Welsh 
Hospitals
O Y NWIS (NHS Wales 
Informatics Service)
UK_Wales 2 Maternity 
Indicators 
Dataset (Birth 
records only)
2016 2016 H O: Wales U O N NHS Wales 
Informatics Service
United 
Kingdom
1 MMBRACE UK 2013 2015 P C Full for neonatal 
deaths from 20 
weeks gestation. 
Full for stillbirths 
from 24 weeks 
gestation. We 
request data 
from 22 weeks 
gestation for 
fetal deaths but 
cannot confirm 
coverage as they 
are not registered 
deaths. We think 
they are fairly 
well completed.
O N University of Oxford 
and University of 
Leicester
Previous system ran from 
1992 to 2010.
United 
Kingdom
2 Confidential 
Enquiry into 
Maternal 
Deaths
1928 2012-
2014
P C 100% O Y MMBRACE -UK . 
National Perinatal 
Epidemiology Unit, 
University of Oxford
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